You are on page 1of 89

PNdex ������������.

indd 5 24/3/2553 18:13:05


4th Edition

ª×èÍ˹ѧÊ×Í
ÀÒÉÒä·Â ÃٻẺàÀÊѪÀѳ±Çѵ¶ØÍÍ¡Ä·¸ÔìáÅÐÂÒàʾµÔ´ãËŒâ·É
»ÃÐà·Èä·Â 2553
ÀÒÉÒÍѧ¡ÄÉ PNDEX THAILAND 2010
(Psychotropics & Narcotics Index 2010)
ISBN 974-244-092-1
¨Ñ´·íÒáÅÐ ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´ Êíҹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
ÃǺÃÇÁâ´Â ¡ÃзÃǧÊÒ¸ÒóÊØ¢
â·Ã/â·ÃÊÒÃ 0 2590 7346
ÍÕàÁŏ : narcotic@fda.moph.go.th
àÃÕºàÃÕ§ ºÃÔÉÑ· ·ÔÁʏ (»ÃÐà·Èä·Â) ¨íÒ¡Ñ´
áÅШѴ¾ÔÁ¾â´Â 58-60 ÊØ¢ØÁÇÔ· 62 ºÒ§¨Ò¡ ¾ÃÐ⢹§ ¡ÃØ§à·¾Ï 10260
â·Ã 0 2741 5354 â·ÃÊÒÃ 0 2741 5360

All rights reserved.


ʧǹÅÔ¢ÊÔ·¸ÔìµÒÁ¾ÃÐÃÒªºÑÞÞѵÔ

AW_PNdex front 20100402.indd 1 2/4/2553 13:57:04


OBJECTIVES
Çѵ¶Ø»ÃÐʧ¤
1. ÊíÒËÃѺ㪌໚¹¤Ù‹Á×ͧ͢਌Ò˹ŒÒ·ÕèÊÒ¸ÒóÊآ㹡ÒþÔÊÙ¨¹àÍ¡Åѡɳ áÅÐÃÙ»¾Ãó
(Identification) ¢Í§Çѵ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàʾµÔ´ãËŒâ·É ¡Ã³Õ·Õèà¡Ô´ÍÒ¡ÒÃ
äÁ‹¾Ö§»ÃÐʧ¤¨Ò¡¡ÒÃ㪌ÂÒ ËÃ×Í¡ÒÃ㪌ÂÒà¡Ô¹¢¹Ò´
2. ÊíÒËÃѺ㪌໚¹¤ÙÁ‹ Í× ¢Í§à¨ŒÒ˹ŒÒ·Õ»è ͇ §¡Ñ¹áÅлÃÒº»ÃÒÁ´ŒÒ¹Çѵ¶ØàʾµÔ´ã¹¡ÒþÔʨ٠¹
àÍ¡Åѡɳ áÅÐÃÙ»¾Ãó (Identification) ¢Í§Çѵ¶ØÍÍ¡Ä·¸Ôì áÅÐÂÒàʾµÔ´ãËŒâ·É
¡Ã³Õ·ÕèÁÕ¡ÒáÃзíÒ½†Ò½„¹¡®ËÁÒÂ
3. 㪌໚¹¤Ù‹Á×Í͌ҧÍÔ§ËÃ×Í㪌»ÃÐ⪹Í×è¹æ ã¹·Ò§¡ÒÃᾷ
¤³Ð¼ÙŒ¨Ñ´·íÒ
·Õè»ÃÖ¡ÉÒ
¹¾.¾Ô¾Ñ²¹ ÂÔè§àÊÃÕ àÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
¹¾.¾§È¾Ñ¹¸ ǧȏÁ³Õ ÃͧàÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ
ÀÞ.¹ÔµÂÒ áÂŒÁ¾ÂѤ¦ àÀÊѪ¡ÃàªÕèÂǪÒÞ´ŒÒ¹ÃкҴÇÔ·ÂҢͧÇѵ¶ØàʾµÔ´
À¡.ÇÔâ蹏 ÊØ‹ÁãËÞ‹ ¼ÙŒª‹ÇÂàÅ¢Ò¸Ô¡Òä³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ

¤³Ð·íÒ§Ò¹ ¹Ò§¨Ñ¹·¹Ò »Ò¹»ÃÕªÒ ¼ÙŒÍíҹǡÒáͧ¤Çº¤ØÁÇѵ¶ØàʾµÔ´


¹Ò¨ÔÃÇѲ¹ ÈÃÕÁ§¤Å¡ØÅ àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
¹Ò§¨Ñ¹·¹Ò ¸ÃÃÁÇÕÃо§É àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
¹Ò§ÊØÀÒÇ´Õ ÇѨ¹Ð¾ÃÊÔ·¸Ôì àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
¹Ò¸ÕÃÐ ªÑ¾ÔÃÔÂÐÈÑ¡´Ôì àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
¹Ò§¹ÑÂ¹Ò ¾ÑªÃä¾ÈÒÅ àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒþÔàÈÉ
¹ÒÂÊع·Ã ¾Ø·¸ÈÃÕ¨ÒÃØ àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
¹Ò§¢¹ÔÉ°Ò µÑ¹µÔÈÔÃÔ¹·Ã àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
¹Ò§ÊÒǸÕøà Á⹸ÃÃÁ àÀÊѪ¡Ã ªíÒ¹ÒÞ¡ÒÃ
¹Ò§ÊÒÇ°»¹Õ à¨ÃÔÞÊÔ¹ àÀÊѪ¡Ã »¯ÔºÑµÔ¡ÒÃ
¹Ò§ÊÒÇ¡ÁŪ¹¡ ÊØÃÔ¡ØÅ ³ ÍÂظÂÒ àÀÊѪ¡Ã »¯ÔºÑµÔ¡ÒÃ

AW_PNdex front 20100402.indd 2 2/4/2553 13:57:04


CONTENTS
ÊÒúÑÞ
OBJECTIVES : วัตถุประสงค์ 2
HOW TO USE : วิธีการใช้หนังสือ 5
PRODUCT IDENTIFICATION SEQUENCE
ลำาดับการจัดภาพยาเม็ด ด้วยสี รูปร่าง และขนาด 9
PRODUCT IDENTIFICATION CHART
หมวดรูปภาพเภสัชภัณฑ์ 10-39
สีขาว 10
สีเหลือง 14
สีส้ม 15
สีแดง 16
สีชมพู 16
สีมวง 19
สีฟา/น้ําเงิน 19
สีเขียว 21
สีน้ําตาล 23
สีเทา/ดํา 23
หลายสี 23
PINK PAGES
หมวดหน้าสีชมพู 40-61
CLASSIFICATION OF PSYCHOTROPICS AND NARCOTICS
การจัดประเภทของวัตถุออกฤทธิ์และยาเสพติดให้โทษที่ขึ้นทะเบียน
ในประเทศไทย 40
NATIONAL LIST OF ESSENTIAL MEDICINE (FOR PSYCHOTROPICS AND NARCOTICS)
วัตถุออกฤทธิ์และยาเสพติดให้โทษในบัญชียาหลักแห่งชาติ 42
IMPORTANT DRUG NOTES
ข้อมูลที่สำาคัญของตัวยาที่ขึ้นหรือเคยขึ้นทะเบียนในประเทศไทย 48
P2 วัตถุออกฤทธิ์ในประเภท 2 48
P3 วัตถุออกฤทธิ์ในประเภท 3 53
P4 วัตถุออกฤทธิ์ในประเภท 4 54
N2 ยาเสพติดให้โทษประเภท 2 58
N3 ยาเสพติดให้โทษประเภท 3 60

AW_PNdex front 20100402.indd 3 2/4/2553 13:57:04


4

INDEX
หมวดดัชนีต่างๆ 62-86
CONTROLLED SUBSTANCE CLASS
ดัชนีเภสัชภัณฑ์เรียงตามประเภทกลุ่มยา และชื่อตัวยาจาก A-Z 62-65
P2 วัตถุออกฤทธิ์ในประเภท 2 62
P3 วัตถุออกฤทธิ์ในประเภท 3 62
P4 วัตถุออกฤทธิ์ในประเภท 4 63
N2 ยาเสพติดให้โทษในประเภท 2 64
N3 ยาเสพติดให้โทษในประเภท 3 65

MANUFACTURER’S INDEX
ดัชนีเภสัชภัณฑ์เรียงตามชื่อผู้ผลิต 66-70

GENERIC AND BRAND NAME INDEX


ดัชนีรวมชือ่ สามัญและชื่อการค้า จัดเรียงตาม A-Z 71-86

แบบสำ�รวจ 87-88

AW_PNdex front 20100402.indd 4 5/4/2553 17:45:15


HOW TO USE5
ÇÔ¸Õ¡ÒÃ㪌˹ѧÊ×Í
1 ·ÃÒºµÑÇÍ‹ҧ ÃÙ»¾Ãó àÍ¡Åѡɳ ËÃ×Í ÅѡɳТͧÂÒàÁç´

PRODUCT IDENTIFICATION SEQUENCE


การจัดลำาดับยาเม็ดด้วยสี รูปร่าง ขนาด ... หน้า 9

PRODUCT IDENTIFICATION CHART


ค้นหารูปภาพเภสัชภัณฑ์ ... หน้า 10-39

ชื่อผู้ผลิต (Manufacturer’s name)


ชื่อการค้า (Trade name)
ชื่อสามัญ (Generic name)
ประเภทวัตถุออกฤทธิ์ หรือยาเสพติดให้โทษ

น้ําหนักของเม็ด
ภาพเม็ดยา จะมีขนาดเทาของจริง

ภาพผลิตภัณฑที่ไมใชเม็ดยา จะเปนขนาดยอ

หมายเลขของภาพ

AW_PNdex front 20100402.indd 5 2/4/2553 13:57:05


6

2 ·ÃÒºª×èÍ¡ÒäŒÒËÃ×ͪ×èÍÊÒÁÑޢͧÇѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É

GENERIC AND BRAND NAME INDEX


ดัชนีรวมชื่อสามัญและชื่อการค้า... หน้า 71-86

PRODUCT IDENTIFICATION CHART


รูปภาพเภสัชภัณฑ์ ... หน้า 10-39
ค้นตามหมายเลขภาพมุมลางซ้าย

3 ·ÃÒºª×èÍÊÒÁÑޢͧÇѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É

NATIONAL LIST OF ESSENTIAL MEDICINE


ข้อกำาหนดบัญชียาหลักแห่งชาติ ... หน้า 42-47
(เฉพาะวัตถุออกฤทธิ์และยาเสพติดให้โทษ)
ค้นตามชื่อสามัญ เรียงลําดับชื่อ A-Z

AW_PNdex front 20100402.indd 6 2/4/2553 13:57:06


4 ·ÃÒº»ÃÐàÀ·¢Í§·ÐàºÕ¹Çѵ¶ØÍÍ¡Ä·¸ÔìËÃ×ÍÂÒàʾµÔ´ãËŒâ·É
7

CONTENTS CLASSIFICATION OF
สารบัญ ... หน้า 3-4 PSYCHOTROPICS & NARCOTICS
การจัดกลุ่มประเภทและสาระตามกฏหมาย...หน้า 40-41
สาระสําคัญในการควบคุมตามกฎหมาย
รายชื่อตัวยา (ชื่อสามัญ) ของวัตถุออกฤทธิ์และยาเสพติดให้โทษจัดตาม
กลุม/ประเภท ตามกฎหมาย

CONTROLLED SUBSTANCE CLASS INDEX IMPORTANT DRUG NOTES


ดัชนีกลุ่ม/ประเภทของทะเบียน...หน้า 62-65 ข้อมูลสำาคัญของตัวยา...หน้า 48-61
ค้นตามชื่อสามัญ เรียงลําดับชื่อ A-Z ในแตละกลุม ค้นตามชื่อสามัญ จาก A-Z ในแตละกลุม

AW_PNdex front 20100402.indd 7 2/4/2553 13:57:07


8

5 ·ÃÒºª×èͺÃÔÉÑ·¼ÙŒ¼ÅÔµ

MANUFACTURE’S INDEX
ดัชนีรวมชื่อสามัญและชื่อการคา... หนา 66-70

PRODUCT IDENTIFICATION CHART


รูปภาพเภสัชภัณฑ ... หนา 10-39
คนตามหมายเลขภาพมุมลางซาย

6 ¡ÒþÔÊÙ¨¹ÊÑÞÅѡɳ¨Ò¡ Ἃ¹«Õ´Õ PNdex (powered by MIMS.com)

โปรแกรมรูปภาพเภสัชภัณฑ
ใหกดเลือกหรือพิมพคุณลักษณะที่สําคัญ
ควรเลือกคุณสมบัติที่เดนที่สุดเทานั้น ไมควรเลือกทั้งหมด
สีที่ 1
สีที่ 2 (เลือกกรณีมีมากกวาหนึ่งสี)
รูปราง
มีรอยบากกลาง
มีอักษรหรือเลข (ใหพิมพตัวเลขหรืออักษร)
มีโลโก
ชื่อการคา (ใหพิมพชื่อ)
ชื่อตัวยา (ใหพิมพชื่อสามัญ)
ประเภทของทะเบียนผลิตภัณฑ
ชื่อผูผลิต (ใหพิมพชื่อ)
กลุมการออกฤทธิ์หรือการรักษา
ENTER
กดปุมคนหา หรือ ปุมลบเพื่อเลือกใหม กดปุมเขาสูโปรแกรม

AW_PNdex front 20100402.indd 8 7/4/2553 9:45:42


9

PRODUCT IDENTIFICATION SEQUENCE


ÅíҴѺ¡ÒèѴÀÒ¾ÂÒàÁç´

หมายเหตุ :
สีที่ปรากฏในหนังสืออาจคลาดเคลื่อนกับสีจริงของเม็ดยา แนะนําให้ตรวจด้วยคุณลักษณะอื่นรวมด้วย เชน ขนาด สัญลักษณ

AW_PNdex front 20100402.indd 9 2/4/2553 13:57:09


10 PRODUCT IDENTIFICATION CHART PN DEX 2010
PHENOBARBITAL ATLANTIC ANXIRA ⌫
WHITE  Lorazepam 1 mg
Phenobarbital Na 32.5 mg P4
Tablet P4 [100 mg]
[86 mg]
DILOMIL† 
Diphenoxylate HCl 2.5 mg 022
XN3 011
LIZAVAN 
PHENOBARBITAL ATLANTIC Lorazepam 1 mg
001
 XP4
Phenobarbital Na 65 mg [100.4 mg]
BUPRINE  P4
[95 mg]
Buprenorphine HCl 0.2 mg 023
P2
[50 mg] 012 KEMORA 
Lorazepam 1 mg
002 LORAZENE  P4
Lorazepam 1 mg [100 mg]
LORAZEP ⌫ XP4
Lorazepam 1 mg 024
P4
[65 mg] 013 LORAMED 
Lorazepam 1 mg
003 ZEDA ☯  ⌫ XP4
Lorazepam 0.5 mg
CODEINE GPO  P4
Codeine Phosphate (Analgesic) 15 mg [90 mg]
025
N2
014
[73 mg]
LORAPAM 
DIANO  Lorazepam 1 mg
004 Diazepam 2 mg XP4
P4
PHENOBARBITONE [80 mg]
NEW LIFE PHARMA  026
Phenobarbital Na 30 mg 015
XP4 LORAVAN 
LORA-P ⌫ ⌫ ⌫ Lorazepam 1 mg
Lorazepam 1 mg P4
XP4 [100 mg]
005 [113.37 mg]

LOMOTIL†  016


027
Diphenoxylate HCl 2.5 mg
DIAZEPAM T P DRUG ⌫ ⌫  ATIVAN 
N3
Lorazepam 1 mg
[63 mg] Diazepam 2 mg
XP4
XP4

006
028
017
TEMGESIC  ⌫
Buprenorphine HCl 0.2 mg CODEINE GPO 
PHENOBARBITAL ACDHON 
P2 Phenobarbital Na 60 mg
Codeine Phosphate (Analgesic) 30 mg XP4
[59.98 mg] N2
[113 mg]
007
029
018
DITROPINE† ⌫
ORA 
Diphenoxylate HCl 2.5 mg LONZA ⌫ Lorazepam 1 mg
XN3 Lorazepam 1 mg P4
P4 [100 mg]
[85 mg]
008 030
019
SPASIL† ⌫ ANTA   VALAX ⌫   
Diphenoxylate HCl 2.5 mg Diazepam 2 mg
Lorazepam 1 mg
N3 XP4
P4
[79.97 mg]
[100 mg]

009 020 031

DIAPINE  MEILAX  RAZEPAM 


Diazepam 2 mg Ethyl Loflazepate 1 mg Lorazepam 1 mg
P4 XP4 XP4
[100 mg]

010 021 032



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 11
LORAZEPAM ACDHON  LORAZIN  PRENARPIL 
Lorazepam 1 mg Lorazepam 1 mg Clonazepam 2 mg
XP4 P4 P4
[103.02 mg] [148.76 mg]

033 044
054
TRANAVAN  PSEUDOEPHEDRINE MILANO
Lorazepam 1 mg  RIVOTRIL 
P4 Pseudoephedrine HCl 60 mg Clonazepam 2 mg
[100 mg] P4
P2
[130 mg] [170 mg]
034

LORAPINE ⌫ 055


Lorazepam 1 mg 045
XP4
PHENOBARB ⌫ ⌫ ⌫ SIPAM 
Diazepam 2 mg
Phenobarbital Na 60 mg
P4
035 XP4
[164 mg]
[130 mg]
LORA 
Lorazepam 1 mg 056
P4 046
[130 mg] ALPRAX 
PSEUDOEPHEDRINE Alprazolam 1 mg
036 ASIAN PHARM ⌫ XP4
Pseudoephedrine HCl 60 mg [190 mg]
FRISIUM ⌫ P2
Clobazam 10 mg [155 mg]
XP4 057

047
TAZCINE ☯ ⌫
037 Pentazocine HCl 25 mg
ZOPAM   XP3
RUBIFEN   Diazepam 2 mg [149 mg]
Methylphenidate HCl 10 mg
P4
P2
[160 mg]
[190 mg]
058
048
VOMED ⌫ 
038
DIVOPAN     Diazepam 2 mg
MED-ZEPAM  Diazepam 2 mg XP4
Diazepam 2 mg P4
XP4 [180 mg]

059
049
039
DIAZEPAM BJ BENJAOSOTH DONNATAL† 
Phenobarbital Na 16.2 mg
DIPAM  ☯⌫  XP4
Diazepam 2 mg Diazepam 2 mg
XP4 P4
[158.25 mg]

050 060
040
GRANDAXIN ⌫⌫ DIAZ 
RITALIN ⌫ Diazepam 2 mg
Methylphenidate HCl 10 mg Tofisopam 50 mg
P4 XP4
P2 [180 mg]
[140 mg] [180 mg]

051 061
041
DIAZEPAM GPO  NITRADOS 
ALPRALAN  Diazepam 2 mg Nitrazepam 5 mg
Alprazolam 0.25 mg P4 P2
P4 [182 mg]
[154.7 mg]

052 062
042
MED-ZEPOXIDE  WINOPAM 
FRISIUM ⌫⌫ Diazepam 2 mg
Clobazam 5 mg Chlordiazepoxide HCl 10 mg
XP4 XP4
P4
[120 mg] [198.8 mg]

043 053 063

 †
Indicates brands that contain more than 1 ingredient
12 PRODUCT IDENTIFICATION CHART PN DEX 2010
VORAPAM ⌫   PARADEINE†  REINBAMATE 
Diazepam 2 mg Codeine Phosphate (Analgesic) 15 mg Meprobamate 400 mg
P4 N3 XP3
[180 mg] [470 mg] [525 mg]

064

VALENIUM 
Diazepam 2 mg 074
082
XP4
TYLENOL WITH CODEINE†  PARADYL 
Codeine Phosphate (Analgesic) 15 mg Codeine Phosphate (Analgesic) 8 mg
N3
XN3
065 [432.5 mg]

DIAZEPAM LERD SINGH 


Diazepam 2 mg
P4
[180 mg] 075
083
TYLENOL WITH CODEINE† 
066
Codeine Phosphate (Analgesic) 30 mg DIETIL RETARD 
Diethylpropion HCl 75 mg
POVANIL   N3
[478.72 mg] P2
Clonazepam 2 mg [755 mg]
P4
[150 mg]

067 076

DIMED  PARCOD† ⌫   084


Diazepam 2 mg Codeine Phosphate (Analgesic) 15 mg
XP4 XN3 ANAX 
[600 mg] Alprazolam 0.25 mg
P4
[130 mg]
068
085
XANAX XR 
Alprazolam 1 mg 077 ANZION 
P4
[347.19 mg] ALODORM  Alprazolam 0.25 mg
XP4
Nitrazepam 5 mg
[132.25 mg]
P2
[556 mg]
069 086

LEXOTAN  ALNAX ⌫


Bromazepam 1.5 mg Alprazolam 0.25 mg
P4 XP4
[200 mg] 078 [130 mg]
PARCONO†  087
Codeine Phosphate (Analgesic) 8 mg
070 N3
[600 mg]
ANPRESS ☯  
COCET†  Alprazolam 0.25 mg
P4
Codeine Phosphate (Analgesic) 15 mg
[131.2 mg]
XN3

088
079
DIZOLAM 
NASA WITH CODEINE †
 Alprazolam 0.25 mg
071 Codeine Phosphate (Analgesic) 15 mg P4
N3
CEMOL - CODEINE†   [600 mg]
[130 mg]
Codeine Phosphate (Analgesic) 15 mg
XN3 089

MARZOLAM 
Alprazolam 0.25 mg
080 P4
072 [129.75 mg]
MOGADON 
COTENOL† ⌫ ⌫  Nitrazepam 5 mg 090
Codeine Phosphate (Analgesic) 15 mg P2
XN3 XANACINE ⌫
Alprazolam 0.25 mg
P4
[110 mg]

073 081 091



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 13
FARZOLAM  ALLAM    PARAGEN CO† 
Alprazolam 0.25 mg Alprazolam 0.25 mg Codeine Phosphate (Analgesic) 15 mg
XP4 P4 XN3
[130 mg] [478.77 mg]

092 103

ZOLAM  INZOLAM 


Alprazolam 0.25 mg Alprazolam 0.25 mg 113
P4 P4
[131.55 mg] [132 mg] CONCERTA  
Methylphenidate HCl 36 mg
P2
093 104 [515 mg]
MOXINAX  ALPRAMED 
Alprazolam 0.25 mg Alprazolam 0.5 mg
P4 P4
[130 mg] [130 mg] 114

094 REGENON RETARD 


105 Diethylpropion HCl 75 mg
XALAM  P2
Alprazolam 0.25 mg MITRANAX  [755 mg]
XP4 Alprazolam 0.25 mg
P4
[130 mg]

095
106
XANAX 
Alprazolam 0.25 mg SUNAX  115
P4 Alprazolam 0.25 mg
[128.25 mg] XP4
[130.03 mg]
PARDEX ⌫
Dextropropoxyphene Napsylate 32.5 mg
096 XN3
ALCELAM   107
Alprazolam 0.25 mg
P4 XIEMED ⌫
[130 mg] Alprazolam 0.25 mg
P4
116
[130.01 mg]
097
METHYLPHENIDATE HEXAL
SIAMPRAXOL  108
 
Alprazolam 0.25 mg Methylphenidate HCl 10 mg
P4 ALPRAZOLAM FRX  P2
[125 mg] Alprazolam 0.25 mg [174.98 mg]
XP4
098 [130 mg]
117
MANEX ⌫  
Alprazolam 0.25 mg 109
Capsule
P4
[130 mg] STILNOX ⌫ ZEPOXIN 
Zolpidem Tartrate 10 mg Chlordiazepoxide HCl 10 mg
P2
099 XP4
[126 mg]
[100 mg]
ALPAZAM 
Alprazolam 0.25 mg 118
110
XP4
POPAM   KAPANOL 
Diazepam 2 mg Morphine Sulfate 20 mg
100 XP4 N2
[142.8 mg]
PHARNAX ⌫  
Alprazolam 0.25 mg
P4 111
[131.65 mg] 119
CODIGESIC† 
Codeine Phosphate (Analgesic) 15 mg
KAPANOL 
101 Morphine Sulfate 50 mg
N3
N2
LORAMET   [550 mg]
[323.3 mg]
Lormetazepam 1 mg
P2

102 112 120

 †
Indicates brands that contain more than 1 ingredient
14 PRODUCT IDENTIFICATION CHART PN DEX 2010
KAPANOL  RAZEPAM  DIAZEPAM SAMAKEEPHAESAJ
Morphine Sulfate 100 mg Lorazepam 2 mg ⌫
N2 XP4 Diazepam 5 mg
[620.5 mg] XP4

131

VALAX ⌫ 142


Diazepam 5 mg
XP4 PSEUDOEPHEDRINE
121 ASIAN PHARM ⌫
Pseudoephedrine HCl 30 mg
132 P2
YELLOW DOPAM  ⌫  ⌫ [145 mg]

Clorazepate Dipotassium 5 mg
Tablet XP4 143
PHENOBARBITAL ACDHON  [153 mg]
AMA† 
Phenobarbital Na 30 mg
133 Amobarbital 50 mg
XP4
P3
DIAZEPAM VESCO  [208.7 mg]
Diazepam 5 mg
122
P4
LORA-P ⌫ ⌫ ⌫ [109 mg] 144
Lorazepam 2 mg
134 ZOPAM  
XP4
Diazepam 5 mg
[113.43 mg]
PSEUDOEPHEDRINE P4
123 BJ BENJAOSOTH ☯⌫  [160 mg]
Pseudoephedrine HCl 60 mg
BELLOID† ⌫⌫  P2
145
Butobarbital 30 mg [158.22 mg]
XP4 DIVOPAN    
135 Diazepam 5 mg
P4
124 PSEUDOEPHEDRINE MILANO [209 mg]
ANTA   
Pseudoephedrine HCl 30 mg
Lorazepam 2 mg P2 146
P4 [110 mg]
[100 mg] VOMED ⌫ 
136 Diazepam 5 mg
125 XP4

METHADONE GPO DIPAM 


Diazepam 5 mg
 XP4
Methadone HCl 5 mg 147
N2
[110 mg] DIAZEPAM GENERAL DRUGS
137
HOUSE 
126 COZEP   Diazepam 5 mg
Chlordiazepoxide HCl 10 mg P4
LORAZENE  P4 [160 mg]
Lorazepam 2 mg [179.55 mg]
XP4
148
138
127 PORA ⌫ DIAZEPAM GPO 
Lorazepam 1 mg Diazepam 5 mg
LORAPAM  XP4
P4
Lorazepam 2 mg [182 mg]
XP4
139
149
128 DIANO  VALENIUM 
Diazepam 5 mg
ATIVAN  P4
Diazepam 5 mg
Lorazepam 2 mg XP4
[110.2 mg]
XP4
140
150
129 PHENYLPROPANOLAMINE
PHARMASANT   DIZEPAM 
TRANOLAN  Phenylpropanolamine HCl 25 mg Diazepam 5 mg
Diazepam 2 mg XP2 P4
P4 [170 mg]
[150.62 mg]

130 141 151



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 15
VALIUM  DIAZEPAM POND’S CHEMICAL
Capsule
Diazepam 5 mg ⌫
XP4 Diazepam 5 mg POSENE 
XP4 Clorazepate Dipotassium 5 mg
XP4
152 [140 mg]
162
DIAZA 
Diazepam 5 mg DIAZEPAM T MAN ⌫  
XP4 Diazepam 5 mg 172
[172 mg] XP4
TRANCAP ⌫ ⌫ 
Clorazepate Dipotassium 10 mg
153 XP4
163
SIPAM 
Diazepam 5 mg DIMED 
P4 Diazepam 5 mg 173
[164 mg] XP4
PREFAMONE 
Diethylpropion HCl 75 mg
154 P2
164
DIAZEPAM T P DRUG ⌫ ⌫ 
Diazepam 5 mg CO-COF† 
XP4 Codeine Phosphate (Antitussive) 10 mg
N3
[294.9 mg]

155
174
ALPRAX  165
Alprazolam 0.25 mg DIAPINE  POZAPAM  
P4 Prazepam 10 mg
Diazepam 5 mg P4
[189.74 mg]
P4 [336.5 mg]
[280 mg]

156

DIAZ  166


Diazepam 5 mg
XP4 MILA-TERCON† 
[180 mg] Codeine Phosphate (Antitussive) 8 mg 175
N3
[410.05 mg]
157 ORANGE
ROPAM  ⌫  ⌫ Tablet
Diazepam 5 mg 167
XP4 MEILAX 
[170 mg] TRIALAM  Ethyl Loflazepate 2 mg
Triazolam 0.25 mg XP4
P2
158 [100 mg]

VORAPAM ⌫   176


Diazepam 5 mg 168
P4 TRANOLAN 
[183 mg] CONCERTA   Diazepam 5 mg
Methylphenidate HCl 18 mg P4
P2 [150.85 mg]
[268 mg]
159

DIAZEPAM H K PHARM 177


169
  
Diazepam 5 mg POPAM   DILIUM 
P4 Diazepam 5 mg Diazepam 2 mg
[160 mg] XP4 XP4

160
178
170
DIAZEPAM LERD SINGH  ZORA 
Diazepam 5 mg DIZEP  Lorazepam 2 mg
P4 Diazepam 2 mg
P4
[175 mg] P4
[130 mg]
[115.05 mg]

161 171 179

 †
Indicates brands that contain more than 1 ingredient
16 PRODUCT IDENTIFICATION CHART PN DEX 2010
PHENOBARBITONE DIZEP  Capsule
NEW LIFE PHARMA  Diazepam 5 mg
Phenobarbital Na 60 mg P4
[115.05 mg]
CORYNIL† 
XP4 Codeine Phosphate (Antitussive) 10 mg
XN3
190 [430 mg]
180

COZEP   Capsule


200
Chlordiazepoxide HCl 25 mg DIAZEPION 
P4 Diazepam 10 mg ROPECT†   ⌫
[206.23 mg] XP4 Codeine Phosphate (Antitussive) 10 mg
[100 mg] N3
181 [558.5 mg]

VICTAN ⌫ 191


Ethyl Loflazepate 2 mg 201
XP4
RED CODEPECT†  
Codeine Phosphate (Antitussive) 10 mg
Tablet N3
182
[430 mg]
PONDNEBIUM ⌫
MST CONTINUS  Chlordiazepoxide HCl 10 mg
Morphine Sulfate 60 mg XP4
N2 202
[74.82 mg]
[154 mg]
ROLAR†  
192 Codeine Phosphate (Antitussive) 10 mg
183 N3
EPOXIDE ⌫ ⌫ ⌫ [430 mg]
PSEUDOEPHEDRINE MEDICINE Chlordiazepoxide HCl 25 mg
PRODUCTS ⌫ XP4
Pseudoephedrine HCl 60 mg [205.49 mg]
203
P2
[144.7 mg] 193 ROTUSS†   ⌫
Codeine Phosphate (Antitussive) 10 mg
BENPINE  N3
184 Chlordiazepoxide HCl 25 mg [456.5 mg]
P4
MENOBARB  [165.2 mg]
Phenobarbital Na 60 mg
XP4
194
[120 mg] 204
CHLORDIXIDE 
185 Chlordiazepoxide HCl 10 mg ZEPOXIN 
P4 Chlordiazepoxide HCl 5 mg
POVANIL   [237 mg] XP4
[100 mg]
Clonazepam 0.5 mg
P4 195
[150 mg]
205
CLINOPECT† 
Codeine Phosphate (Antitussive) 10 mg
186 XN3 PINK
[217 mg]
EPOXIDE ⌫ ⌫ ⌫ Tablet
Chlordiazepoxide HCl 10 mg
196
XP4 PAM-5 ⌫ ⌫ 
[284.17 mg]
ZORITUSS    Diazepam 5 mg
Codeine Phosphate (Antitussive) 10 mg XP4
XN3
187
206
NEOCOF† 
197
Codeine Phosphate (Antitussive) 10 mg BELLERGAL† ⌫
XN3
NEO-COPHEN ⌫ Phenobarbital Na 20 mg
Codeine Phosphate (Antitussive) 10 mg XP4
XN3

188 207
198
PACOGESIC†  PHENOBARBITAL ATLANTIC
Codeine Phosphate (Analgesic) 8 mg NEOPECT†  
XN3 Codeine Phosphate (Antitussive) 10 mg Phenobarbital Na 16.25 mg
[580 mg] N3 XP4
[399.73 mg] [84.99 mg]

189 199 208



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 17
PHENOBARB ⌫ ⌫ ⌫ S.CO ZEPAM    ANAX 
Phenobarbital Na 30 mg Diazepam 5 mg Alprazolam 0.5 mg
XP4 XP4 P4
[90 mg] [130 mg]

209
230
220
LORAMED  ANZION 
Lorazepam 2 mg BELLADONNA ALKALOIDS WITH
Alprazolam 0.5 mg
P4 PHENOBARBITAL† ⌫ XP4
[100 mg] Phenobarbital Na 16.2 mg [132.5 mg]
XP4
210 [160 mg]
231
DIAZEPAM T MAN ⌫   ALNAX ⌫
Diazepam 5 mg 221
P4 Alprazolam 0.5 mg
[62.46 mg] DIAZEPAM BJ BENJAOSOTH XP4
☯⌫  [130 mg]
211 Diazepam 10 mg
P4 232
ORA  [233 mg]
Lorazepam 2 mg DIZOLAM 
XP4 Alprazolam 0.5 mg
222 P4
[130 mg]
212
KENSPA† 
Chlordiazepoxide HCl 5 mg
233
VISPAM ⌫ P4
Diazepam 5 mg
[246 mg] PRAZOL 
XP4 Alprazolam 0.5 mg
[70.02 mg] P4
223
[216.36 mg]
213 DIZEPAM 
Diazepam 2 mg 234
ALPRALAN  P4
Alprazolam 0.5 mg [170 mg] MARZOLAM 
P4 Alprazolam 0.5 mg
[157.28 mg] P4
224 [130 mg]
214
CENTRODINE CD†  
PORA ⌫ Codeine Phosphate (Antitussive) 10 mg 235
N3
Lorazepam 2 mg
XP4 [205.2 mg]
XANACINE ⌫ 
Alprazolam 0.5 mg
P4
225 [110 mg]
215

DIAZEPAM POND’S CHEMICAL TAZCINE ☯ ⌫ 236


Pentazocine HCl 50 mg
⌫ XP3 ZOLAM 
Diazepam 5 mg
Alprazolam 0.5 mg
P4
P4
[145.6 mg]
[133.8 mg]
226
216
LORAZIN  237
LORA  Lorazepam 2 mg
Lorazepam 2 mg P4 MOXINAX 
P4 [200 mg] Alprazolam 0.5 mg
[200 mg] P4
[130 mg]
227
217

DIAZEPAM H K PHARM
LEXOTAN  238
Bromazepam 3 mg XALAM 
   P4
Diazepam 2 mg Alprazolam 0.5 mg
[200 mg]
P4 XP4
[130 mg]
228
218 239
PHENOCON 
AZEPAM  Phenobarbital Na 60 mg XANAX 
Diazepam 2 mg XP4 Alprazolam 0.5 mg
XP4 P4
[100 mg] [128.56 mg]

219 229 240

 †
Indicates brands that contain more than 1 ingredient
18 PRODUCT IDENTIFICATION CHART PN DEX 2010
ALCELAM   ALPRAMED  ANXENE ⌫ 
Alprazolam 0.5 mg Alprazolam 0.25 mg Clorazepate Dipotassium 10 mg
P4 P4 XP4
[130 mg] [130 mg]

241 252
262
FARZOLAM ⌫ MITRANAX 
Alprazolam 0.5 mg Alprazolam 0.5 mg MANOTRAN 
XP4 P4 Clorazepate Dipotassium 10 mg
[130 mg] XP4
[150 mg]
242 253

SIAMPRAXOL  SUNAX  263


Alprazolam 0.5 mg Alprazolam 0.5 mg
P4
[125.75 mg]
XP4
[129.95 mg]
CLORAMED 
Clorazepate Dipotassium 10 mg
XP4
243 254

MANEX ⌫   CODICET PINK† ⌫  


Alprazolam 0.5 mg Codeine Phosphate (Analgesic) 15 mg 264
P4 XN3
[130 mg] DEDA   
Clorazepate Dipotassium 10 mg
244 P4
255
[130 mg]
ALPAZAM  ALPRAZOLAM FRX 
Alprazolam 0.5 mg Alprazolam 0.5 mg
XP4
P4
[130 mg] 265

245
256 CLORAZE 
Clorazepate Dipotassium 10 mg
ALPAZAM  TRANSPON FORTE  XP4
Alprazolam 1 mg Clorazepate Dipotassium 10 mg [120 mg]
XP4
XP4
[190 mg]

246 266
257
PHARNAX ⌫   UPTRAN 
Alprazolam 0.5 mg Capsule Clorazepate Dipotassium 10 mg
P4
[131.9 mg] SANOR  XP4
Clorazepate Dipotassium 10 mg
XP4
247
267
ANPRESS ⌫
Alprazolam 0.5 mg 258 POLIZEP 
P4 Clorazepate Dipotassium 10 mg
[130 mg] SERENE MASA LAB  XP4
Clorazepate Dipotassium 10 mg [234 mg]
248 XP4
[173.5 mg]
XIEMED ☯  
Alprazolam 0.5 mg
P4 268
[130.25 mg] 259
TENMED 
DIPOSEF ⌫ Clorazepate Dipotassium 10 mg
249 Clorazepate Dipotassium 10 mg P4
XP4 [234 mg]
ALLAM    [140 mg]
Alprazolam 0.5 mg
P4
[130 mg]
260 269
250
TRANMED  POLYDINE CD†  
INZOLAM  Clorazepate Dipotassium 10 mg Codeine Phosphate (Antitussive) 10 mg
Alprazolam 0.5 mg XP4 XN3
[163.13 mg]
P4
[132.81 mg]

251 261 270



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 19
TRANXENE ⌫ ANZION  MANEX ⌫  
Clorazepate Dipotassium 10 mg Alprazolam 1 mg Alprazolam 1 mg
XP4 XP4 P4
[133.12 mg] [130 mg]

280 291
271
ALNAX ⌫ PHARNAX ⌫  
TRANCLOR  Alprazolam 1 mg Alprazolam 1 mg
Clorazepate Dipotassium 10 mg XP4 P4
XP4 [100 mg] [132.41 mg]

281 292

272 ANPRESS ☯   ALLAM   


Alprazolam 1 mg Alprazolam 1 mg
CEXENE ⌫    P4 P4
Clorazepate Dipotassium 10 mg [131.2 mg] [130 mg]
XP4

282 293

MARZOLAM  INZOLAM 


273 Alprazolam 1 mg Alprazolam 1 mg
FLULIUM   P4
[130 mg]
P4
[134.39 mg]
Clorazepate Dipotassium 10 mg
XP4
283 294

XANACINE ⌫ MITRANAX 


Alprazolam 1 mg Alprazolam 1 mg
274 P4 P4
[110 mg] [130 mg]
DAVOL †
☯⌫ 
Dextropropoxyphene HCl 32.5 mg 284 295
XN3
[377.5 mg] ZOLAM  XIEMED ⌫
Alprazolam 1 mg Alprazolam 1 mg
P4 P4
[136.67 mg] [130 mg]

285
296
275 XALAM  DIZOLAM 
Alprazolam 1 mg Alprazolam 1 mg
XP4
PURPLE P4
[130 mg]
Tablet 286
297
CALMIPAM  XANAX 
Diazepam 5 mg
Alprazolam 1 mg BRONPECT† 
XP4 Codeine Phosphate (Antitussive) 10 mg
P4
[129.12 mg] N3
[573.5 mg]
276
287
PHENOBARBITAL ATLANTIC
 ALCELAM   298
Phenobarbital Na 100 mg Alprazolam 1 mg
P4 P4 AZEPAM 
[128.97 mg] [130.2 mg] Diazepam 5 mg
XP4
277 288

MST CONTINUS  FARZOLAM ⌫


Alprazolam 1 mg 299
Morphine Sulfate 30 mg
N2 XP4
[154 mg] BLUE
278 289 Tablet
ZEPOXIDE ⌫ ⌫  SIAMPRAXOL  ANXIRA ⌫
Chlordiazepoxide HCl 10 mg Alprazolam 1 mg Lorazepam 0.5 mg
P4 XP4 P4
[91.2 mg] [50 mg]

279 290 300

 †
Indicates brands that contain more than 1 ingredient
20 PRODUCT IDENTIFICATION CHART PN DEX 2010
LORAZENE  PHENOBARBITAL VISPAM ⌫
Lorazepam 0.5 mg CHEW BROTHERS  Diazepam 10 mg
XP4 Phenobarbital Na 30 mg P4
XP4 [102.26 mg]
[70 mg]
301 323
312
LORAVAN  LORAZIN 
Lorazepam 0.5 mg LONZA ⌫ Lorazepam 0.5 mg
P4 Lorazepam 0.5 mg P4
[50 mg] P4 [103.03 mg]
[50 mg]
324
302 313
LOZEPAM  DIAZEPAM VESCO 
LORAPINE ⌫    Diazepam 2 mg
Lorazepam 0.5 mg Lorazepam 0.5 mg P4
XP4 XP4 [110 mg]

325
303 314
DILIUM 
ANTA   RAZEPAM  Diazepam 5 mg
Lorazepam 0.5 mg Lorazepam 0.5 mg XP4
P4 XP4
[49.6 mg]

315 326
304
VEMED ⌫ DIAZEPAM T MAN ⌫  
LIZAVAN  Diazepam 10 mg
Lorazepam 0.5 mg
Lorazepam 0.5 mg XP4
XP4
XP4
[50.22 mg]
316 327
305
LORAZEPAM ACDHON  ZORA 
LORAMED  Lorazepam 0.5 mg Lorazepam 0.5 mg
Lorazepam 0.5 mg XP4 P4
XP4 [50 mg] [130 mg]

317 328
306
DIAZEPAM GENERAL DRUGS DIAPAM  
TRANAVAN  HOUSE  Diazepam 5 mg
Lorazepam 0.5 mg Diazepam 2 mg P4
P4 P4 [152 mg]
[50 mg] [139.83 mg]
329
318
307
DIPAM 
ATIVAN 
LORA-P ⌫ ⌫ ⌫ Diazepam 10 mg
Lorazepam 0.5 mg XP4
Lorazepam 0.5 mg
XP4
XP4
[105.2 mg]
330
319
308 ZOPAM  
DIAZEPAM SOMMAI BHAESAJ
LORAZEP ⌫ 
Diazepam 10 mg
P4
Lorazepam 0.5 mg
Diazepam 5 mg [180 mg]
P4
XP4
[50 mg]
331
309 320 BLUCON† ⌫  
ORA  HAWKCOPAX  ⌫  ⌫ Codeine Phosphate (Antitussive) 10 mg
XN3
Lorazepam 0.5 mg Lorazepam 0.5 mg [175.2 mg]
P4 P4
[50.02 mg] [100 mg]
332
310 321
DIAZEPAM CHAROEN BHAESAJ
LORAPAM  VALAX ⌫    
Lorazepam 0.5 mg Diazepam 10 mg Diazepam 2 mg
XP4 XP4 XP4
[43.67 mg]

311 322 333



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 21
DIAZEPAM GPO  XANAX XR  Capsule
Diazepam 10 mg Alprazolam 0.5 mg
P4 P4 ZEPAM 
[182 mg] [346.11 mg]
Diazepam 5 mg
XP4
334 344
MANODIAZO  NEOCOD†  354
Diazepam 10 mg
P4
Codeine Phosphate (Antitussive) 10 mg BLUCO†    
XN3 Codeine Phosphate (Antitussive) 10 mg
[160 mg] [497.3 mg] N3
[249.7 mg]
335
345
MED-ZEPAM 
Diazepam 5 mg NEO-CODEIN† ⌫ 355
XP4 Codeine Phosphate (Antitussive) 10 mg
XN3
[503 mg] GREEN
336 Tablet
PRENARPIL  346 PHENOBARBITAL ACDHON 
Clonazepam 1 mg Phenobarbital Na 15 mg
PARA-CO 
P4 XP4
[147.79 mg]
Codeine Phosphate (Analgesic) 15 mg
N3
[390.09 mg]
356
337
LORAZEP ⌫
DIAZA  Lorazepam 2 mg
Diazepam 2 mg 347 P4
XP4 [65 mg]
[172 mg] TRYCAM 
Triazolam 0.25 mg 357
P2
338 CHLORDIXIDE 
Chlordiazepoxide HCl 5 mg
SIPAM  348 P4
Diazepam 10 mg [232 mg]
P4 DIADON 
[160 mg] Diazepam 5 mg 358
XP4
CHLORZEP ⌫
339 Chlordiazepoxide HCl 5 mg
349 XP4
DIAZEPAM T P DRUG ⌫ ⌫ 
Diazepam 10 mg HALCION ⌫
XP4 Triazolam 0.25 mg 359
P2
[97.408 mg] ZEDA ☯  ⌫
Lorazepam 1 mg
340 350 P4
[90 mg]
DIAZ  DORMICUM 
Diazepam 10 mg Midazolam 15 mg 360
XP4 P2
[180 mg] [208 mg] CALMIPAM 
Diazepam 2 mg
XP4
341 351

CLONARIL ⌫  CODICET BLUE
361
Clonazepam 1 mg    
P4 Codeine Phosphate (Analgesic) 15 mg COMOBEN    
[150 mg] N3 Chlordiazepoxide HCl 5 mg
[365 mg] P4
[125.82 mg]
342
352 362
DIAZEPAM H K PHARM
   XANAX XR  DIAZEPAM SAMAKEEPHAESAJ
Diazepam 10 mg Alprazolam 2 mg ⌫
P4 P4 Diazepam 2 mg
[166.62 mg] [345.69 mg] XP4

343 353 363

 †
Indicates brands that contain more than 1 ingredient
22 PRODUCT IDENTIFICATION CHART PN DEX 2010
DIAZEPAM T MAN ⌫   WINOPAM  DIRAX† 
Diazepam 2 mg Diazepam 5 mg Chlordiazepoxide HCl 5 mg
P4 XP4 P4
[115 mg] [200 mg]

364
375
385
HAWKCOPAX  ⌫  ⌫
Lorazepam 1 mg POBRAX†   DIAPINE 
XP4 Chlordiazepoxide HCl 5 mg Diazepam 10 mg
XP4
P4
[320 mg]
365

VISPAM ⌫ 376


386
Diazepam 2 mg
MODURAX† ⌫
XP4
[140 mg] Chlordiazepoxide HCl 5 mg
TERCO-C† ⌫  
P4 Codeine Phosphate (Antitussive) 10 mg
[250 mg] N3
366
[591.1 mg]
DIAZEPAM POND’S CHEMICAL
⌫ 377
Diazepam 2 mg 387
P4 CLINOPRONT† 
[122 mg] Codeine Phosphate (Antitussive) 10 mg CODEE-C† 
N3 Codeine Phosphate (Antitussive) 10 mg
367 [283.31 mg] N3
[345.02 mg]
LORA 
Lorazepam 0.5 mg 378
P4 388
[100 mg] LICON†  
Chlordiazepoxide HCl 5 mg SECO† ⌫
368 XP4 Codeine Phosphate (Antitussive) 10 mg
N3
DIAPAM   [331.56 mg]
Diazepam 2 mg
P4 379
[142 mg]
CEBARAX†  389
369 Chlordiazepoxide HCl 5 mg
P4
TOCODYL† ⌫  ⌫
PORA ⌫ [250 mg]
Codeine Phosphate (Antitussive) 10 mg
Lorazepam 0.5 mg XN3
XP4 [325.82 mg]

380
370
LIBRAX†  390
PONDNEBIUM ⌫ Chlordiazepoxide HCl 5 mg
CODESIA† ⌫
Chlordiazepoxide HCl 5 mg P4
[299 mg] Codeine Phosphate (Antitussive) 10 mg
P4 N3
[200 mg] [350 mg]

371 381

LORAZEPAM MACROPHAR CHLORDIBRAX† ⌫ 391


 Chlordiazepoxide HCl 5 mg
XP4 RADIBRAX†  
Lorazepam 1 mg
XP4 Chlordiazepoxide HCl 5 mg
[120 mg] XP4

372 382

CHLORDIAZEPOXIDE T MAN UTORAX† ⌫ 392


⌫   Chlordiazepoxide HCl 5 mg
Chlordiazepoxide HCl 10 mg XP4 ALPRAMED 
P4 Alprazolam 1 mg
[168.8 mg] P4
[259 mg]
373 383
393
DIAZEPAM BJ BENJAOSOTH ZEPOBRAX† 
☯⌫  Chlordiazepoxide HCl 5 mg ROHYPNOL 
Diazepam 5 mg
XP4 Flunitrazepam 1 mg
P2
P4
[175 mg]
[190.2 mg]

374 384 394



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 23
PARAMED-CO†  BENERA† ⌫  ⌫
Codeine Phosphate (Analgesic) 15 mg Phenobarbital Na 20 mg MIXED COLORS
XN3 XP4
[601.1 mg] [135.5 mg] Tablet
404 CODICET †
⌫  
Codeine Phosphate (Analgesic) 15 mg
LOZEPAM  N3
395
Lorazepam 1 mg [565 mg]
XP4
VASON 
Diazepam 2 mg
P4 405
414
[110 mg]
MST CONTINUS 
Morphine Sulfate 10 mg Capsule
396 N2
CELIUM ⌫
[154 mg] FREXENE  
Medazepam 5 mg Clorazepate Dipotassium 5 mg
406 XP4
P4
[110 mg]
PRENARPIL 
Clonazepam 0.5 mg 415
397 P4
[147.22 mg] TRANPATE ⌫  
Capsule Clorazepate Dipotassium 5 mg
P4
EUHYPNOS 20  ⌫  407 [146 mg]
Temazepam 20 mg
P2 RIVOTRIL 
[868.96 mg] Clonazepam 0.5 mg
P4 416
[150 mg]
DIZAN 
Diazepam 5 mg
408 XP4
398 [175 mg]

ZEPAM  ALPRAX 


Alprazolam 0.5 mg
Diazepam 2 mg XP4
XP4 417
[189.98 mg]
DITRAN  
Diazepam 2 mg
399 409 P4
[163 mg]
TUMAX† ⌫ MASAPARA WITH CODEINE† 
Chlordiazepoxide HCl 5 mg Codeine Phosphate (Analgesic) 15 mg
P4 N3
[180 mg] [500 mg] 418

FREXENE  


Clorazepate Dipotassium 10 mg
400 XP4
STESOLID  410
Diazepam 2 mg
XP4 BLACK 419

Tablet
CONZEP 
Clorazepate Dipotassium 10 mg
401
KEMORA  XP4

POSENE  Lorazepam 0.5 mg


Clorazepate Dipotassium 10 mg P4
XP4 [50 mg] 420

411 CLOZENE 


Clorazepate Dipotassium 5 mg
402 BENPINE  XP4
Chlordiazepoxide HCl 5 mg [165 mg]
P4
BROWN [136.82 mg]
421
Tablet 412
TRANCON ⌫
NEURAMIZONE† ⌫ ZEPOXIDE ⌫ ⌫  Clorazepate Dipotassium 10 mg
Phenobarbital Na 20 mg Chlordiazepoxide HCl 5 mg XP4
P4 XP4 [140 mg]
[30.3 mg]

403 413 422

 †
Indicates brands that contain more than 1 ingredient
24 PRODUCT IDENTIFICATION CHART PN DEX 2010
POMADOM   DIPOT ⌫ TRANPON 
Clorazepate Dipotassium 10 mg Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
P4 P4 XP4
[140 mg] [145 mg] [173 mg]

423 432 441

PHENTERMINE TRENKER CLORAZE  CLOZEPATE 


 Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
Phentermine Resinate 30 mg P4 XP4
P2 [120 mg]
[180 mg]

442
433

TRANZEP  FLULIUM  


Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
XP4
424 XP4
[160 mg]
PANBESY 
Phentermine HCl 15 mg
P2
434 443
[310 mg]
MANOTRAN  POLIZEP 
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
XP4 P4
[150 mg] [234 mg]
425

SANOR 
Clorazepate Dipotassium 5 mg
XP4 435 444
[149.55 mg]
CLORAXENE 5 ⌫  ⌫ TAMYLAB-S ⌫
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
P4 XP4
426 [121.8 mg] [220 mg]

DIPOSEF ⌫
Clorazepate Dipotassium 5 mg
XP4 436
445
[140 mg]
DEDA    T-FIVE ⌫  
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
P4
427 XP4
[160 mg]
TRANMED 
Clorazepate Dipotassium 5 mg
P4
437 446
[163.1 mg]
TRANXENE  TRANADON-S 
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
428 P4 XP4
[145 mg] [220 mg]
CLORAMED 
Clorazepate Dipotassium 5 mg
XP4
438
447
TRANCLOR  GAXENE ⌫  
429
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
ANXENE ⌫  XP4
XP4
Clorazepate Dipotassium 5 mg
XP4

439 448
430
TENMED  ZETRAN 
SERENE V S PHARMA ⌫   Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg
Clorazepate Dipotassium 5 mg P4 XP4
XP4 [234 mg] [166 mg]
[163.1 mg]

431 440 449



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 25
CEXENE ⌫    ANXIELAX  MED-ZEPOXIDE 
Clorazepate Dipotassium 5 mg Clorazepate Dipotassium 5 mg Chlordiazepoxide HCl 5 mg
XP4 XP4 XP4
[248 mg]

468
450

PHENTERMINE OSMOPHARM MANODIAZO 


460 Diazepam 2 mg

Phentermine HCl 15 mg PANBESY  P4
[165 mg]
P2 Phentermine HCl 30 mg
[130.01 mg] P2
[320 mg]
469

TRANCAP ⌫ ⌫ 


Clorazepate Dipotassium 5 mg
451
461 P4
[160 mg]
CLOZENE  ZEPAXID ☯ ⌫
Clorazepate Dipotassium 10 mg
XP4 Diazepam 5 mg
[165 mg] P4
470

DZP2  


452 Diazepam 2 mg
462
XP4
A-ZERAX ⌫ A-ZERAX ⌫
Diazepam 2 mg
Diazepam 5 mg
P4
P4 471
[145 mg]
[145 mg]
DIAZEPAM ACDHON 
Diazepam 2 mg
453 XP4
CONZEP  463
Clorazepate Dipotassium 5 mg
XP4
DOMAR  472
Pinazepam 5 mg
P4 DIAPINE 
[101 mg] Diazepam 2 mg
454
P4
POMADOM   [146 mg]
Clorazepate Dipotassium 5 mg
464
XP4
V DAY ZEPAM ⌫ ⌫ ⌫ 473
Diazepam 5 mg
455
P4 DIAZEPION 
TRANCON ⌫ [200 mg]
Diazepam 5 mg
Clorazepate Dipotassium 5 mg XP4
P4 [100 mg]
[140 mg]
465
474
PHENTERMINE TRENKER
456  V DAY ZEPAM ⌫ ⌫ ⌫
Phentermine Resinate 15 mg Diazepam 2 mg
DIZAN  P2
P4
Diazepam 2 mg [200 mg]
[160 mg]
XP4
[175 mg]
475
457 DITRAN  
Diazepam 5 mg
PRASEPINE  466 P4
Prazepam 5 mg [165 mg]
XP4 CHLORDIAZEPOXIDE
MARCH PHARMA 
Chlordiazepoxide HCl 25 mg
458 476
P4
POZAPAM   [346 mg] MINOXIDE ☯⌫ 
Prazepam 5 mg Chlordiazepoxide HCl 10 mg
P4 P4
[170 mg] [149.5 mg]

459 467 477

 †
Indicates brands that contain more than 1 ingredient
26 PRODUCT IDENTIFICATION CHART PN DEX 2010
DALMADORM  DUROMINE    BENPINE 
Flurazepam 15 mg Phentermine Resinate 30 mg Chlordiazepoxide HCl 10 mg
P2 P2 P4
[291 mg] [130 mg]

478
488
STESOLID  498
Diazepam 10 mg EXAN ⌫ DUROMINE   
XP4 Clorazepate Dipotassium 5 mg Phentermine Resinate 15 mg
XP4
P2
[291.03 mg]
479
489
DIAZEPION 
Diazepam 2 mg UPZENE 
XP4 Clorazepate Dipotassium 5 mg 499
[100 mg] XP4
CHLORDIAZEPOXIDE
480 CHAROEN BHAESAJ 
490 Chlordiazepoxide HCl 10 mg
METAXIDE ☯ ⌫ XP4
Chlordiazepoxide HCl 10 mg COMOBEN    
P4 Chlordiazepoxide HCl 10 mg
[120 mg] P4
[211.36 mg] 500

481 CHLORDIAZEPOXIDE ACDHON


491 
DIAMED  Chlordiazepoxide HCl 10 mg
Diazepam 5 mg EXAN ⌫ XP4
P4 Clorazepate Dipotassium 10 mg
[168.5 mg] XP4

501
492
482 MANODIAZO 
MEDAZINE 
CODIPRONT†  ⌫  Diazepam 5 mg
Codeine Resinate 30 mg P4
Medazepam 10 mg XN3 [165 mg]
P4 [234 mg]
[165 mg]

502
493
483
DIAMED 
DIAPINE  CODIPRONT†  Diazepam 2 mg
Codeine Resinate 30 mg P4
Diazepam 5 mg N3
P4 [165.53 mg]
[298.6 mg]
[147 mg]

503
494
484
MIRAPRONT N 
STESOLID  CLINEPECT†  D-norpseudoephedrine HCl 20 mg
Diazepam 5 mg Codeine Phosphate (Antitussive) 10 mg P2
XN3
XP4
[270 mg]

504
485
495 D-NORPSEUDOEPHEDRINE SR
REGENON RETARD 
Diethylpropion HCl 75 mg MONOZIDE  ⌫ ⌫ ⌫ OSMOPHARM 
P2 Diazepam 2 mg D-norpseudoephedrine Resinate 20 mg
[480 mg] XP4 P2
[173.28 mg]

496

ATRACTIL 
486 Diethylpropion Resinate 75 mg 505
P2
MEDAZINE  [402.64 mg] ZEPAXID ☯ ⌫
Medazepam 5 mg Diazepam 2 mg
P4 P4
[165 mg]

487 497 506



Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 27
*COMODINE COUGH †
*PHENOBARBITAL ELIXIR *BROMTUSSIA DC† ⌫
    ACDHON  Codeine Phosphate (Antitussive) 60 mL
Codeine Phosphate (Antitussive) 60 mL Phenobarbital Na 20 mg/5 mL x 240 mL XN3
XN3 XP4

507 511 515

*PHENOBARBITAL ELIXIR *PHENOBARBITAL ELIXIR *CODESIA† ⌫


ACDHON  ACDHON  Codeine Phosphate (Antitussive)
Phenobarbital Na 20 mg/5 mL x 30 mL Phenobarbital Na 20 mg/5 mL x 450 mL 10 mg/5 mL x 60 mL
XP4 XP4 N3

508 512 516

*PHENOBARBITAL ELIXIR *PHENOBARBITAL ELIXIR *PHENOTAL ELIXIR ⌫


ACDHON  ACDHON  Phenobarbital Na 20 mg/5 mL x 60 mL
Phenobarbital Na 20 mg/5 mL x 60 mL Phenobarbital Na 20 mg/5 mL x 500 mL P4
XP4 XP4

509 513 517

*PHENOBARBITAL ELIXIR *PHENOBARBITAL ELIXIR *PSEUDOEPHEDRINE SYRUP


ACDHON  ACDHON  ASIAN PHARM ⌫
Phenobarbital Na 20 mg/5 mL x 120 mL Phenobarbital Na 20 mg/5 mL x 1000 mL Pseudoephedrine HCl 30 mg/5 mL x 60 mL
XP4 XP4 P2

510 514 518

 *Shown smaller than actual size


28 PRODUCT IDENTIFICATION CHART PN DEX 2010
*TENADRIN-C† ⌫   *PSEUDOEPHEDRINE SYRUP *BROWN MIXTURE GPO†
Codeine Phosphate (Antitussive) 60 mL BJ BENJAOSOTH ⌫  
XN3 Pseudoephedrine HCl 30 mg/5 mL x 60 mL Camphorated Opium Tinct
P2 0.6 mL/5 mL x 180 mL
N3

519 523 527

*TERADENE† ⌫   *PHENSODI†  *BROWN MIXTURE GPO†


Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 60 mL 
XN3 XN3 Camphorated Opium Tinct
0.6 mL/5 mL x 450 mL
N3

520 524 528

*COFCODYL COUGH †
*PHENSODI †
 *CAMPHORATED OPIUM
 Codeine Phosphate (Antitussive) 120 mL TINCTURE BP 1980† 
Codeine Phosphate (Antitussive) 60 mL XN3 Opium Tinct 5 mL/100 mL x 1000 mL
XN3 N3

521 525 529

*COFCODYL COUGH† *PHENSODI†  *COUGH SYRUP GPO†


 Codeine Phosphate (Antitussive) 1000 mL 
Codeine Phosphate (Antitussive) 100 mL XN3 Camphorated Opium Tinct
XN3 0.6 mL/5 mL x 60 mL
XN3

522 526 530


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 29
*MIST. SCILL AMMON. GPO †
*MASADYL COUGH †
 *NEO COUGH† 
 Codeine Phosphate (Antitussive) 100 mL Codeine Phosphate (Antitussive) 240 mL
Camphorated Opium Tinct XN3 XN3
0.6 mL/5 mL x 180 mL
N3

531 535 539

*TERADYL SYRUP †
*MASADYL COUGH †
 *CODYL COUGH† 
    Codeine Phosphate (Antitussive) 240 mL Codeine Phosphate (Antitussive)
Codeine Phosphate (Antitussive) 60 mL XN3 9 mg/5 mL x 60 mL
XN3 N3

532 536 540

*TERADYL SYRUP† *NEO COUGH†  *CODYL COUGH† 


    Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive)
Codeine Phosphate (Antitussive) 1000 mL XN3 9 mg/5 mL x 100 mL
XN3 N3

533 537 541

*MASADYL COUGH †
 *NEO COUGH †
 *CODYL COUGH† 
Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 100 mL Codeine Phosphate (Antitussive)
XN3 XN3 9 mg/5 mL x 1000 mL
XN3

534 538 542

 *Shown smaller than actual size


30 PRODUCT IDENTIFICATION CHART PN DEX 2010
*CODYL COUGH†  *PSEUDOEPHEDRINE SYRUP *BENADRYL CD† 
Codeine Phosphate (Antitussive) MILANO  Codeine Phosphate (Antitussive) 1000 mL
9 mg/5 mL x 4500 mL Pseudoephedrine HCl 30 mg/5 mL x 60 mL XN3
XN3 P2

543 547 551

*MENOBARB ELIXIR  *POLY-COF SYRUP†  *BENYLIN CD† 


Phenobarbital Na 15 mg/5 mL x 60 mL Codeine Phosphate (Antitussive) Codeine Phosphate (Antitussive) 60 mL
XP4 9 mg/5 mL x 60 mL XN3
N3

544 548 552

*MENOBARB-20 ELIXIR  *POLY-COF SYRUP †


 *PHENSEDYL† 
Phenobarbital Na 20 mg/5 mL x 60 mL Codeine Phosphate (Antitussive) Codeine Phosphate (Antitussive)
XP4 9 mg/5 mL x 100 mL 9 mg/5 mL x 100 mL
N3 N3

545 549 553

*MILA-CONO†  *BENADRYL CD†  *BROWN MIXTURE


Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) 60 mL OSOTH INTERLAB† 
XN3 XN3 Camphorated Opium Tinct
0.6 mL/5 mL x 180 mL
N3

546 550 554


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 31
*HISEDYL †
 *P-CODYL †
 *PONDNADYL† ⌫
Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive) Codeine Phosphate (Antitussive)
XN3 9 mg/5 mL x 120 mL 9 mg/5 mL x 60 mL
XN3 N3

555 559 563

*HISEDYL †
 *PHENOBARB ELIXIR *PONDNADYL† ⌫
Codeine Phosphate (Antitussive) 120 mL ⌫ ⌫ ⌫ Codeine Phosphate (Antitussive)
XN3 Phenobarbital Na 20 mg/5 mL x 60 mL 9 mg/5 mL x 100 mL
XP4 N3

556 560 564

*MIXTURE SCILLAE AMMON† *BONADINE CD†   *PONDNADYL† ⌫


 Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive)
Camphorated Opium Tinct XN3 9 mg/5 mL x 1000 mL
2 mL/15 mL x 180 mL XN3
XN3

557 561 565

*P-CODYL †
 *PERCIDYL COUGH† ⌫ *NORDYL LINCTUS†  
Codeine Phosphate (Antitussive) Codeine Phosphate (Antitussive) 100 mL Codeine Phosphate (Antitussive)
9 mg/5 mL x 60 mL XN3 9 mg/5 mL x 100 mL
XN3 N3

558 562 566

 *Shown smaller than actual size


32 PRODUCT IDENTIFICATION CHART PN DEX 2010
*NORDYL LINCTUS†   *PHENOSIL ELIXIR ⌫ *MIXTURE TUSSIS† 
Codeine Phosphate (Antitussive) Phenobarbital Na 20 mg/5 mL x 450 mL Camphorated Opium Tinct
9 mg/5 mL x 500 mL XP4 0.45 mL/5 mL x 60 mL
XN3 N3

567 571 575

*NORTUSS LINCTUS†   *DECOS† ⌫ *MIXTURE TUSSIS† 


Codeine Phosphate (Antitussive) 100 mL Codeine Phosphate (Antitussive) Camphorated Opium Tinct
XN3 9 mg/5 mL x 100 mL 0.45 mL/5 mL x 120 mL
N3 N3

568 572 576

*NORTUSS LINCTUS †
  *ELIXIR PHENOBARB  *MIXTURE TUSSIS† 
Codeine Phosphate (Antitussive) 500 mL Phenobarbital Na 60 mL Camphorated Opium Tinct
XN3 XP4 0.45 mL/5 mL x 240 mL
N3

569 573 577

*PHENOSIL ELIXIR ⌫ *MIXTURE TUSSIS†  *MIXTURE TUSSIS† 


Phenobarbital Na 20 mg/5 mL x 60 mL Camphorated Opium Tinct Camphorated Opium Tinct
XP4 0.45 mL/5 mL x 30 mL 0.45 mL/5 mL x 450 mL
N3 N3

570 574 578


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 33
*MIXTURE TUSSIS †
 *CONADYL †
⌫  ⌫ *PHENCODIN† ⌫  
Camphorated Opium Tinct Codeine Phosphate (Antitussive) 60 mL Codeine Phosphate (Antitussive)
0.45 mL/5 mL x 1800 mL XN3 9 mg/5 mL x 500 mL
XN3 XN3

579 583 587

*MIXTURE TUSSIS†  *PHENOCO ELIXIR ⌫  ⌫ *PHENCODIN† ⌫  
Camphorated Opium Tinct Phenobarbital Na 20 mg/5 mL x 450 mL Codeine Phosphate (Antitussive)
0.45 mL/5 mL x 3600 mL P4 9 mg/5 mL x 1000 mL
XN3 XN3

580 584 588

*MANTADYL COUGH† ⌫   *PHENOCO ELIXIR ⌫  ⌫ *TUSSIDYL† ⌫  
Codeine Phosphate (Antitussive) 60 mL Phenobarbital Na 20 mg/5 mL x 3800 mL Codeine Phosphate (Antitussive)
XN3 XP4 9 mg/5 mL x 60 mL
N3

581 585 589

*COSEDYL COUGH LINCTUS† *PHENCODIN† ⌫   *MIST TUSSIS† 
⌫ ⌫  Codeine Phosphate (Antitussive) Camphorated Opium Tinct
Codeine Phosphate (Antitussive) 60 mL 9 mg/5 mL x 60 mL 0.6 mL/5 mL x 450 mL
XN3 N3 N3

582 586 590

 *Shown smaller than actual size


34 PRODUCT IDENTIFICATION CHART PN DEX 2010
*SQUILL AND AMMONIA MIXTURE† *ORAMORPH   *FENTANYL ANTIGEN 
 Morphine Sulfate 20 mg/mL x 30 mL Fentanyl Citrate 0.05 mg/mL x 10 mL
Camphorated Opium Tinct N2 N2
1.3 mL/10 mL x 450 mL
N3

591 595 599

*DIMETANE EXPECTORANT DC† *METHADONE GPO *DIAPINE 


  Diazepam 5 mg/mL x 1 mL
Codeine Phosphate (Antitussive) 2.5 L Methadone HCl 10 mg/mL x 1000 mL P4
XN3 N2

592 596 600

*CODIPRONT †
  *PENTAZOCINE ALL PLANTS *DIAPINE 
Codeine Resinate 60 mL  Diazepam 10 mg/2 mL x 2 mL
XN3 Pentazocine 30 mg/mL x 1 mL P4
XP3

593 597 601

*ORAMORPH   *FENTANYL ANTIGEN  *PETHIDINE BIOLAB 


Morphine Sulfate 10 mg/5 mL x 250 mL Fentanyl Citrate 0.05 mg/mL x 2 mL Pethidine HCl 100 mg/2 mL x 2 mL
N2 N2 N2

594 598 602


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 35
*DIAZEPAM GPO  *PANGON  ⌫  ⌫ *PETHIDINE
Diazepam 10 mg/2 mL x 2 mL Pentazocine 30 mg/mL x 1 mL M & H MANUFACTURING
P4 P3    
Pethidine HCl 50 mg/mL x 1 mL
N2

603 607 611

*EPHEDRINE GPO  *ROPAM  ⌫  ⌫ *PETHIDINE


Ephedrine HCl 30 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL M & H MANUFACTURING
P2 P4    
Pethidine HCl 100 mg/2 mL x 2 mL
N2

604 608 612

*FENTANYL JANSSEN-CILAG *MORPHINE SULFATE INJ BLUE *MANOLIUM 


⌫     Diazepam 10 mg/2 mL x 2 mL
Fentanyl Citrate 0.05 mg/mL x 2 mL Morphine Sulfate 10 mg/mL x 1 mL P4
N2 N2

605 609 613

*FENTANYL JANSSEN-CILAG *MORPHINE SULFATE INJ PURPLE *ZEPAM 


⌫     Diazepam 10 mg/2 mL x 2 mL
Fentanyl Citrate 0.05 mg/mL x 10 mL Morphine Sulfate 10 mg/mL x 1 mL XP4
N2 N2

606 610 614

 *Shown smaller than actual size


36 PRODUCT IDENTIFICATION CHART PN DEX 2010
*TRANOLAN  *TEMGESIC  ⌫ *FENTANYL SANDOZ
Diazepam 10 mg/2 mL x 2 mL Buprenorphine HCl 0.3 mg/mL x 1 mL  
P4 P2 Fentanyl Citrate 0.05 mg/mL x 2 mL
N2

615 619 623

*V DAY ZEPAM ⌫ ⌫ ⌫ *VALIUM  *SOSEGON ⌫


Diazepam 10 mg/2 mL x 2 mL Diazepam 10 mg/2 mL x 2 mL Pentazocine 30 mg/mL x 1 mL
P4 XP4 P3

616 620 624

*V DAY ZEPAM NL ⌫ ⌫ ⌫ *DORMICUM  *DIAZA 


Diazepam 10 mg/2 mL x 2 mL Midazolam 5 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL
P4 P2 XP4

617 621 625

*FORTWIN ⌫ *DORMICUM  *SIPAM 


Pentazocine 30 mg/mL x 1 mL Midazolam 15 mg/3 mL x 3 mL Diazepam 10 mg/2 mL x 2 mL
XP3 P2 P4

618 622 626


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 37
*DIAZEPAM T P DRUG ⌫ ⌫  *PETHIDINE T.P. DRUG ⌫ ⌫  *LAYLIUM-10 
Diazepam 10 mg/2 mL x 2 mL Pethidine HCl 50 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL
P4 N2 XP4

627 631 635

*MORPHINE T.P. DRUG ⌫ ⌫  *MONOZIDE-10  ⌫ ⌫ ⌫ *VESCOPAM 
Morphine Sulfate 10 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL Diazepam 10 mg/2 mL x 2 mL
N2 P4 P4

628 632 636

*MORPHINE T.P. DRUG ⌫ ⌫  *TAZCINE ☯ ⌫ *RIVOTRIL 
Morphine Sulfate 10 mg/mL x 1 mL Pentazocine 30 mg/mL x 1 mL Clonazepam 1 mg/mL x 1 mL
N2 XP3 XP4

629 633 637

*MORPHINE T.P. DRUG ⌫ ⌫  *ZEPAXID ☯ ⌫ *GARDENAL ⌫⌫
Morphine Sulfate 10 mg/mL x 1 mL Diazepam 10 mg/2 mL x 2 mL Phenobarbital Na 200 mg/4 mL
N2 P4 P4

630 634 638

 *Shown smaller than actual size


38 PRODUCT IDENTIFICATION CHART PN DEX 2010
*NEMBUTAL ⌫   *KETALAR  *FENTANYL SANDOZ
Pentobarbital Na 50 mg/mL x 20 mL Ketamine HCl 50 mg/mL x 10 mL  
P3 P2 Fentanyl Citrate 0.05 mg/mL x 10 mL
N2

639 643 644

*AMYTAL ⌫ ⌫ *FENTANYL GPO  ⌫⌫


Amobarbital Na 0.5 g Fentanyl 12 mcg/hr
XP3 N2

640 645

*CALYPSOL ⌫⌫  *FENTANYL GPO  ⌫⌫


Ketamine HCl 50 mg/mL x 10 mL Fentanyl 25 mcg/hr
P2 N2

641 646

*KETA-HAMELN  *FENTANYL GPO  ⌫⌫


Ketamine HCl 50 mg/mL x 10 mL Fentanyl 50 mcg/hr
P2 N2

642 647


Indicates brands that contain more than 1 ingredient 
PN DEX 2010 PRODUCT IDENTIFICATION CHART 39
*FENTANYL HEXAL  ⌫ *DUROGESIC ⌫
Fentanyl 12 mcg/hr Fentanyl 50 mcg/hr x 5 mg
N2 N2

648 652

*FENTANYL HEXAL  ⌫ *DUROGESIC ⌫


Fentanyl 25 mcg/hr Fentanyl 100 mcg/hr x 10 mg
N2 N2

649 653

*FENTANYL HEXAL  ⌫


Fentanyl 50 mcg/hr
N2

650

*DUROGESIC ⌫
Fentanyl 25 mcg/hr x 2.5 mg
N2

651

 *Shown smaller than actual size


CLASSIFICATION OF PSYCHOTROPICS & NARCOTICS
 ⌫ ⌫ ⌫

  
      ⌦    ⌦
 ⌫ ⌫ ⌫ 
⌫ ⌦⌫⌫  
    
     
      ⌦     
 ⌫ ⌫ ⌫⌫
 ⌦⌫⌫  
        
  
       ⌫ 
⌫ ⌫
  
   ⌫⌦  
 ⌫ ⌫ ⌦
   ⌦  ⌫ 
  
 ⌫  ⌦  ⌫  ⌫⌫ ⌦ 
       
1. AMFEPRAMONE 20. METHYLPHENIDATE 1. ALLOBARBITAL 27. LORAZEPAM
(DIETHYLPROPION) 21. MIDAZOLAM 2. ALPRAZOLAM 28. MEDAZEPAM
2. AMINEPTINE 22. N-ETHYLAMPHETAMINE 3. BARBITAL 29. MEFENOREX
3. AMINOREX 23. NIMETAZEPAM 4. BENZPHETAMINE 30. METHYPHENOBARBITAL
4. BROTIZOLAM 24. NITRAZEPAM 5. BROMAZEPAM 31. METHYPRYLON
5. BUPRENORPHINE 25. PEMOLINE 6. BUTOBARBITAL 32. NORDAZEPAM
6. BUTORPHANOL 26. PHENCYCLIDINE 7. CAMAZEPAM 33. OXAZEPAM
7. CATHINE 27. PHENDIMETRAZINE 8. CHLORAL HYDRATE AND 34. OXAZOLAM
(D-NORPSEUDOEPHEDRINE) 28. PHENMETRAZINE ITS ADDUCTS 35. PERLAPINE
8. EPHEDRINE 29. PHENTERMINE 9. CHLORDIAZEPOXIDE 36. PHENOBARBITAL
9. ESTAZOLAM 30. PHENYLPROPANOLAMINE 10. CHLORPHENTERMINE 37. PINAZEPAM
10. FENCAMFAMIN 31. PIPRADROL 11. CLOBAZAM 38. PRAZEPAM
11. FENETHYLLINE 32. PSEUDOEPHEDRINE 12. CLONAZEPAM 39. PROPYLHEXEDRINE
12. FLUNITRAZEPAM 33. QUAZEPAM 13. CLORAZEPATE 40. PYROVALERONE
13. FLURAZEPAM 34. SECOBARBITAL 14. CLORTERMINE 41. SECBUTABARBITAL
14. HALOXAZOLAM 35. TEMAZEPAM 15. CLOTIAZEPAM 42. SPA
15. KETAMINE 36. TRIAZOLAM 16. CLOXAZOLAM 43. TETRAZEPAM
16. LOPRAZOLAM 37. ZALEPLON 17. DIAZEPAM 44. TOFISOPAM
17. LORMETAZEPAM 38. ZIPEPROL 18. DELORAZEPAM 45. VINYLBITAL
18. MAZINDOL 39. ZOLPIDEM 19. ETHCHLORVYNOL
19. MESOCARB 40. ZOPICLONE 20. ETHINAMATE
21. ETHYL LOFLAZEPATE
    22. FENPROPORAX
1. AMOBARBITAL 5. MEPROBAMATE 23. FLUDIAZEPAM
2. BUTALBITAL 6. PENTAZOCINE 24. HALAZEPAM
3. CYCLOBARBITAL 7. PENTOBARBITAL 25. INORGANIC BROMIDES
4. GLUTETHIMIDE 26. KETAZOLAM

Pink Pages_2010_Tip.pmd 40 7/4/2553, 09:28


PN DEX 2010 41


 ⌫  ⌦ ⌫  ⌫⌫ ⌦ 
     
1. ACETYLDIHYDROCODEINE 52. LEVORPHANOL 1. CODEINE
2. ACETYLMETHADOL 53. MEDICINAL OPIUM 2. DIPHENOXYLATE
3. ALFENTANIL 54. METAZOCINE 3. OPIUM TINCTURE/CAMPORATED
4. ALLYLPRODINE 55. METHADONE OPIUM TINCTURE
5. ALPHACETYLMETHADOL 56. METHADONE INTERMEDIATE
6. ALPHAMEPRODINE 57. METHYLDESORPHINE
7. ALPHAMETHADOL 58. METHYLDIHYDROMORPHINE
8. ALPHAPRODINE 59. METOPON
9. ANILERIDINE 60. MORAMIDE-INTERMEDIATE
10. BENZETHIDINE 61. MORPHERIDINE
11. BENZYLMORPHINE 62. MORPHINE
12. BETACETYLMETHADOL 63. MORPHINE METHOBROMIDE
13. BETAMEPRODINE 64. MORPHINE N-OXIDE
14. BETAMETHADOL 65. MYROPHINE
15. BETAPRODINE 66. NICOCODINE
16. BEZITRAMIDE 67. NICODICODINE
17. CLONITAZENE 68. NICOMORPHINE
18. COCA BUSH 69. NORACYMETHADOL
19. COCAINE 70. NORCODEINE
20. CODEINE 71. NORLEVORPHANOL
21. CODOXIME 72. NORMETHADONE
22. CONCENTRATE OF POPPY STRAW 73. NORMORPHINE
23. DEXTROMORAMIDE 74. NORPIPANONE
24. DEXTROPROPOXYPHENE 75. OPIUM
25. DIAMPROMIDE 76. OXYCODONE
26. DIETHYLTHIAMBUTENE 77. OXYMORPHONE
27. DIFENOXIN 78. PETHIDINE
28. DIHYDROCODEINE 79. PETHIDINE-INTERMEDIATE-A
29. DIHYDROMORPHINE 80. PETHIDINE-INTERMEDIATE-B
30. DIMENOXADOL 81. PETHIDINE-INTERMEDIATE-C
31. DIMEPHEPTANOL 82. PHENADOXONE
32. DIMETHYLTHIAMBUTENE 83. PHENAMPROMIDE
33. DIOXAPHETYLBUTYRATE 84. PHENAZOCINE
34. DIPHENOXYLATE 85. PHENOMORPHAN
35. DIPIPANONE 86. PHENOPERIDINE
36. DROTEBANOL 87. PHOLCODINE
37. ECGONINE 88. PIMINODINE
38. ETHYLMETHYLTHIAMBUTENE 89. PIRITRAMIDE
39. ETHYLMORPHINE 90. PROHEPTAZINE
40. ETONITAZENE 91. PROPERIDINE
41. ETOXERIDINE 92. PROPIRAM
42. FENTANYL 93. RACEMETHORPHAN
43. FURETHIDINE 94. RACEMORAMIDE
44. HYDROCODONE 95. RACEMORPHAN
45. HYDROMORPHINOL 96. REMIFENTANIL
46. HYDROMORPHONE 97. SUFENTANIL
47. HYDROXYPETHIDINE 98. THEBACON
48. ISOMETHADONE 99. THEBAINE
49. LEVOMETHORPHAN 100. TILIDINE
50. LEVOMORAMIDE 101. TRIMEPRIDINE
51. LEVOPHENACYLMORPHAN

Pink Pages_2010_Tip.pmd 41 7/4/2553, 09:28


NATIONAL LIST OF ESSENTIAL MEDICINES (NLEM)
⌫

 
 ⌫   
  
  ⌧  ⌫ ⌫  
 ⌫ 
   ⌫
⌫  ⌫
  ⌫ ⌫  
⌫   ⌫ ⌫   
       ⌫⌫
⌦    ⌫   
   ⌫        
 ⌦⌦⌫      
   ⌫    
    
 ⌦⌦  ⌫ ⌦   
 
 ⌫  ⌫ ⌫ ⌦ ⌫ ⌫  
  ⌦   ⌫ ⌫ 
 ⌦⌦⌫ ⌫     ⌫ ⌫

Pink Pages_2010_Tip.pmd 42 7/4/2553, 09:28


PN DEX 2010 43

 ⌫   ⌫ ⌫  ⌫ ⌫ ⌫⌫


⌫    ⌫ ⌫ ⌫⌫ 
     
 ⌫⌫ ⌫⌫⌫  
       ⌫
   ⌫  ⌦ ⌫        ⌫

⌫  ⌦ ⌫


⌫ ⌫⌫
⌫⌫⌫

⌫  ⌦ ⌫ ⌫ ⌫   
 ⌫  

⌫  ⌦ ⌫     ⌫  


  ⌫ ⌦ ⌫ 
⌫  ⌦   ⌫
⌫       
  ⌫ ⌫ ⌫  ⌫
⌫  ⌫⌫  ⌫
 ⌫  ⌫
⌫  ⌦ ⌫ ⌫  ⌫ ⌫ ⌫ ⌫
⌫   ⌫ ⌫  ⌦ ⌫ ⌫ 
⌫     ⌫
             
⌦
 ⌫ ⌫       
⌫ ⌦ 
   ⌫ 

Pink Pages_2010_Tip.pmd 43 7/4/2553, 09:28


44 PN DEX 2010

⌫  ⌫ ⌫⌫⌫


  
⌫  
  ⌫ 

⌫      
⌫⌫⌫ ⌫

⌫     ⌫ ⌫  ⌦ ⌫
⌦    ⌦  ⌫
  
 

 
  ⌫   ⌫ ⌫⌫ ⌫
⌫
 ⌫    
 ⌦  


⌫    ⌫⌫ ⌫ ⌫⌫ 
 ⌫    ⌫  ⌫ ⌫  
    ⌦⌫      ⌫ 
⌫    ⌫     ⌦
  ⌫ ⌫  


Pink Pages_2010_Tip.pmd 44 7/4/2553, 09:28


PN DEX 2010 45

   ⌫  


    ⌫   ⌦ 
⌫   

    ⌫     
(Generic Name) ⌫
Alprazolam P4 tab  4.1. Hypnotics and 
anxiolytics

Buprenorphine P2 sublingual tab,  4.7.1. Opioid


hydrochloride sterile sol analgesics

Chloral hydrate P4 oral sol (hosp)  4.1. Hypnotics


and anxiolytics

Chlordiazepoxide P4 cap, tab  4.1. Hypnotics


and anxiolytics

Clonazepam P4 tab  4.1. Hypnotics and


anxiolytics

4.8.1. Drugs used


in the control of
epilepsy

4.9. Drugs used in


movement disorders

Codeine N2 tab  3.6.1. Cough


phosphate suppressants

4.7.1. Opioid
analgesics

Diazepam P4 cap, tab, sterile sol  4.1. Hypnotics


and anxiolytics

Dipotassium P4 cap, tab  4.1. Hypnotics


clorazepate and anxiolytics

Ephedrine P2 nasal drop (hosp)  12.2.2. Topical nasal


hydrochloride ( 0.5-3%) decongestants

sterile sol  2.7.2. Vasoconstrictor


sympathomimetics

   ⌫  ⌫     

Pink Pages_2010_Tip.pmd 45 7/4/2553, 09:28


46 PN DEX 2010

    ⌫     
(Generic Name) ⌫
Fentanyl N2 transdermal  4.7.1. Opioid    ⌫ ⌫
therapeutic system analgesics 
(as base)

Fentanyl citrate N2 sterile sol  15.1.4. Sedative


and analgesic
peri-operative drugs

Ketamine P2 sterile sol  15.1.1. Intravenous   ⌫ 


hydrochloride anaesthetics 
⌫  ⌫


Lorazepam P4 tab  4.1. Hypnotics


and anxiolytics

Methadone N2 oral sol  4.10. Drugs used   ⌫


hydrochloride in substance
dependence

tab, oral sol 4.7.1. Opioid


analgesics

Methylphenidate P2 tab (10 mg)  4.4. Central  Attention-


nervous system Deficit Hyper-
stimulants activity
Disorder (ADHD)

Midazolam P2 sterile sol  15.1.4. Sedative       


hydrochloride and analgesic  ⌦    
peri-operative ⌫⌫
drugs  
 ⌦

4.8.2. Drugs used in 


refractory
epilepticus status status epilepticus

Midazolam P2 tab  15.1.4. Sedative ⌫  


maleate and analgesic  ⌦
peri-operative (premedication)
drugs 
  
⌦ 

   ⌫  ⌫     

Pink Pages_2010_Tip.pmd 46 7/4/2553, 09:28


PN DEX 2010 47

    ⌫     
(Generic Name) ⌫
Morphine N2 cap, tab, SR cap,  4.7.1. Opioid
sulfate SR tab, sterile sol analgesics

sterile sol  15.1.4. Sedative


and analgesic
peri-operative drugs

Nitrazepam P2 tab  4.8.1. Drugs used ⌫


in the control of  
epilepsy  infantile
spasms

Opium and N2 mixt (hosp)  3.6.1. Cough


Glycyrrhiza suppressants
Mixture
Compound
(Mist. Tussis;
Brown Mixture)

Pethidine N2 sterile sol  15.1.4. Sedative


hydrochloride and analgesic
peri-operative drugs

4.7.1. Opioid
analgesics
Phenobarbital P4 tab (as base or  4.8.1. Drugs used
sodium) in the control of
epilepsy

Phenobarbital P4 sterile pwdr  4.8.2. Drugs used in


sodium status epilepticus

(Phenobarbitone  16. Antidotes      ⌫


sodium) 

Pseudoephedrine P2 tab, syr  3.7. Systemic nasal


hydrochloride decongestants

Squill and N3 mixt (hosp)  3.6.1. Cough


Ammonia Mixture suppressants

   ⌫  ⌫     

Pink Pages_2010_Tip.pmd 47 7/4/2553, 09:28


IMPORTANT DRUG NOTES
⌫ ⌫ ⌫
Provides useful information on significant contraindications, precautions, adverse reactions and
interactions of drugs, presented according to the Psychotropic & Narcotic Drugs List of Thailand.
Note: I: Indications; CI: Contraindications; SP: Precautions; AR: Adverse Reactions;
DI: Drug Interactions.

CI: Acute alcoholism; convulsive disorders; head


P2 - Psychotropic Substance injuries; increased intracranial pressure; comatose
Schedule 2 patients; resp depression & obstructive airway
disease; patients on established opioid agonists.
AMFEPRAMONE SP: Hepatic or renal disease; pregnancy, lactation;
hypothyroidism; adrenocortical insufficiency;
(DIETHYLPROPION) asthma; prostatic hyperplasia; shock; hypotension;
inflammatory or obstructive bowel disorders;
     ⌫ ⌫  myasthaenia gravis; infants/neonates. Reduce dose
in elderly & debilitated patients. May precipitate
I: Obesity. withdrawal symptoms in narcotic addicts.
CI: Advanced arteriosclerosis. Hyperthyroidism. AR: Sedation, nausea, dizziness, vertigo,
Hypersensitivity. Glaucoma. Agitated states. hypotension, miosis, headache, hypoventilation,
History of drug abuse. Pulmonary HTN or severe resp or CNS depression; tachycardia, bradycardia,
hypertension. Heart murmur or valvular disorders. urinary retention, coma, vomiting, drowsiness,
Emotional instability. History of psychiatric illness. sweating, confusion, dry mouth, diaphoresis,
Concomitant use w/ other anorectic agents. MAOI withdrawal syndrome.
therapy or w/in 2 wk of discontinuation. Pregnancy
& lactation. Child & elderly. DI: Plasma-buprenorphine concentrations may be
affected when co-administered w/ drugs that
SP: Increased risk of developing primary pulmonary induce or inhibit cytochrome P450 isoenzyme
HTN (PPH). HTN & severe CV disease. Prolonged CYP3A4. Enhanced depressant effects w/ other
use may induce dependence w/ withdrawal CNS depressants e.g. alcohol, anaesthetics,
symptoms on cessation of therapy; do not use for anxiolytics, hypnotics, TCAs & antipsychotics.
more than 3 months. May increase convulsions in Diazepam may produce resp & cardiac collapse.
some epileptic patients. Toxic psychosis. Peptic
ulceration. Prostatic hyperplasia.
AR: CV & CNS disturbances; GI effects; allergic
reactions; impotence; changes in libido, CATHINE
gynecomastia, menstrual upset; hematopoietic (D-NORPSEUDOEPHEDRINE)
effects; dyspnea, hair loss, muscle pain, dysuria,
increased sweating, polyuria.
DI: Hypertensive risk w/ MAOIs. b-blockers,
guanethidine, tricyclic antidepressants, urinary

alkalinisers or acidifiers. Alters antidiabetic drug I: Obesity.
requirements. CI: Patients treated w/ MAOI or stopped MAOI w/in
the last 2 wk; moderate or severe hypertension;
pulmonary hypertension; structural cardiac
⊗ abnormalities or advanced arteriosclerosis; adrenal
BUPRENORPHINE
tumour; hyperthyroidism or hyperexcitability; coronary
thrombosis; closed-angle glaucoma; pregnancy.
SP: Heart disease, mild hypertension, CHF or angina
⌦ of effort; prostate hyperplasia; patients w/ history
I: As a perioperative analgesic supplement. of drug or alcohol abuse; DM; psychotic patients; renal
Moderate to severe pain. Premedication before disease. Growth retardation may occur in children.
anaesthesia. AR: Headache, tachycardia, precordial pain,

Registration expired

Pink Pages_2010_Tip.pmd 48 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 49
giddiness, restlessness or insomnia; dry mouth & CI: Preexisting CNS depression or coma, resp
thrist, nausea, vomiting, sweating; difficulty in depression, acute pulmonary insufficiency or sleep
micturition; muscular weakness & tremors; apnoea; severe hepatic impairment; chronic
tolerance & /or dependence may occur. psychosis, phobic or obsessional states; may
DI: Reduced effect of guanethidine. Increased risk precipitate suicide or aggressive behavior; not to
of arrhythmia in patients treated w/ digitalis due to be used alone to treat depression or anxiety
its sympathomimetic effects. Increased risk of associated w/ depression; glaucoma. Pregnancy,
arrhythmia w/ chloroform, cyclopropane, halothane lactation. Neonates.
or other halogenated anesthetics. The effect of SP: Chronic pulmonary insufficiency; elderly or
cathine may be reduced/enhanced by tricyclic anti- debilitated patients; muscle weakness, impaired
depressants. Cathine should not be used in patients liver or kidney function; drowsiness may affect
treated w/ a MAOI or w/in 14 days of stopping MAOI skilled tasks; monitor cardio-respiratory function
as hypertensive crisis may occur if used. when used for deep sedation; personality disorders
or organic brain changes; history of alcohol or drug
addiction; resp depression & hypotension w/
parenteral admin; this route should only be used
EPHEDRINE when facilities for reversing resp depression are
available.
AR: Drowsiness & lightheadedness, sedation,
  muscle weakness & ataxia; less frequently vertigo,
I: Relief of moderate to severe acute asthma, relief headache, confusion, depression, slurred
of broncoconstiction. speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
CI: Hypersensitivity. Hypertension, thyrotoxicosis, changes in salivation & amnesia.
BPH. Lactation.
DI: Enhanced sedation or resp & CV depression
SP: Ischaemic heart disease, hyperthyroidism, w/ drugs w/ CNS depressant properties eg,
diabetes mellitus, hypertension, angle-closure antidepressants, antihistamines, antipsychotics,
glaucoma, renal impairment; prostatic general anaesthetics, other hypnotics or sedatives,
enlargement; pregnancy, elderly. opioid analgesics & cisapride. Alcohol. Calcium-
AR: Anxiety, tachycardia, tremor, dry mouth, channel blockers; clonidine; diaxozide; disulfiram;
hypertension, cardiac arrhythmias, impaired clozapine; diuretics; moxonidine; nabitone; nitrates;
circulation to the extremities, nervousness, insomnia, cimetidine, esomeprazole & omeprazole; muscle
palpitations. Difficulty in micturition in patients w/ relaxants; dopaminergics; lofexidine; hydralazine,
prostatic enlargement. Nasal drops: Local irritation, minoxidil & nitroprusside; antifungals; angiotensin
rebound nasal congestion & drug-induced rhinitis on II receptor antagonist; antiepileptics; β-blockers;
prolonged use. Delusions, hallucinations. Seen w/ antibacterials. Drugs which alter the hepatic
hypersensitivity & overdosage. Acute CNS & CVS microsomal enzymes.
stimulation presenting as vomiting, fever,
hypertension, psychosis. Cardiac arrhythmias.
DI: Reduces antihypertensive effect of bethanidine ⊗
& guanethidine. May increase clearance of FLURAZEPAM
dexamethasone. Increased incidence of adverse
effects when used w/ theophylline. Severe HTN when
combined w/ MAOIs or within 2 wk of discontinuance
of MAOI treatment. Increased risk of arrhythmias w/

cardiac glycosides, quinidine or tricyclic I: Short-term management of insomnia.
antidepressants. Increased vaso-constriction or
pressor effects w/ ergot alkaloids or oxytocin. CI: Hypersensitivity; porphyria. Pregnancy (3 rd
trimester); neonates.
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; muscle weakness, impaired
FLUNITRAZEPAM liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
when used for deep sedation; personality disorders
 or organic brain changes; history of alcohol or drug
addiction. Respiratory depression & hypotension
I: Induction of anaesthesia. Premedication in w/ parenteral admin. Dependence; lactation. Safety
surgery. Short-term management of insomnia. & efficacy are not proven in child <15 yr.

Registration expired

Pink Pages_2010_Tip.pmd 49 7/4/2553, 09:28


50 IMPORTANT DRUG NOTES PN DEX 2010
AR: Drowsiness & lightheadedness, sedation,

muscle weakness & ataxia; less frequently vertigo, LORMETAZEPAM
headache, confusion, depression, slurred
speech, changes in libido, tremor, visual
disturbances, urinary retention, GI disturbances,
changes in salivation & amnesia.  
DI: Antidepressants, antihistamines, anti- I: Short-term management of insomnia.
psychotics, general anesthetics, other hypnotics CI: CNS depression; resp depression, acute
or sedatives, opioid analgesics & cisapride. pulmonary insufficiency or sleep apnoea; severe
Increased toxicity by amprenavir, cimetidine, hepatic impairment; chronic psychosis, phobic or
ciprofloxacin, clarithromycin, clozapine, CNS obsessional states; not to be used alone to treat
depressants, diltiazem, disulfiram, digoxin, depression or associated anxiety; unstable
erythromycin, ethanol, levodopa, loxapine, myasthenia gravis; glaucoma. Pregnancy &
metoprolol, metronidazole, miconazole, lactation, children
nefazodone, nelfinavir, omeprazole, phenytoin,
SP: Chronic pulmonary insufficiency; elderly or
rifabutin, rifampicin, ritonavir, troleandromycin,
debilitated patients; muscle weakness, impaired
valproic acid & verapamil. Effect is decreased by
liver or kidney function; personality disorders or
carbamazepine, rifampicin & rifabutin. Alcohol.
organic brain changes; history of alcohol or drug
addiction.
AR: Drowsiness & lightheadedness, muscle
KETAMINE weakness & ataxia, vertigo, headache, confusion,
depression, slurred speech, changes in libido,
tremor, visual disturbances, urinary retention, GI
disturbances, changes in salivation & amnesia.
 ⌫
 DI: Enhanced sedation or resp & CV depression
    w/ drugs w/ CNS depressant properties eg,
antidepressants, antihistamines, antipsychotics,
I: Induction of anaesthesia. general anaesthetics, other hypnotics or
sedatives, opioid analgesics & alcohol.
CI: Hypertension, history of cerebrovascular
accident. Eye injury, raised ocular & intracranial
pressure. Psychotic disorders.
SP: Minimise verbal & tactile stimulation during METHYLPHENIDATE
recovery period. Chronic alcoholic & alcohol-
intoxicated patients. Preanaesthetic elevated
CSF pressure. Dependence & tolerance may     
develop. May impair ability to drive or operate
machinery. Monitor cardiac function in patients I: Hyperactivity disorders. Narcolepsy.
w/ HTN or cardiac decompensation. Pregnancy CI: Marked anxiety, tension, agitation; glaucoma;
& lactation. Tourette’s syndrome or tics. Known severe
AR: Emergence reactions e.g. vivid dreams, structural cardiac abnormalities, cardiomyopathy,
hallucinations, confusion, irrational behaviour. serious heart rhythm abnormalities, or other
Increased muscle tone sometimes resembling serious cardiac disorders that could increase the
seizures. Temporary HTN & tachycardia. risk of sudden death. Extended-release form:
Hypotension, bradycardia, arrhythmias. Severe hypertension, heart failure, arrhythmia,
Respiratory depression, apnoea, laryngospasm, hyperthyroidism, recent MI or angina.
diplopia, nystagmus, nausea, vomiting, SP: Pregnancy & lactation. History of alcohol or
lachrymation, hypersalivation, raised intraocular drug abuse. Hypertension & other CV disorders
& CSF pressure, skin rash & pain at inj site. that might be exacerbated by increases in BP or
DI: May increase effects of nondepolarising heart rate. Pre-existing psychosis or bipolar
muscle relaxants. May reduce hypnotic effect of disorder; monitor for symptoms of aggression or
thiopental. Prolonged recovery time w/ hostility. History of seizure disorder. Children <6
barbiturates/narcotics. Reduced cardiac output, yr (growth suppression); monitor growth during
BP & pulse rate w/ halothane. Increased risk of therapy. May impair ability to drive or operate
HTN & tachycardia w/ thyroid hormones. machinery. Transdermal: Avoid exposure of
Seizures & tachycardia may occur when used application site to any direct external heat source.
w/ theophyllines. AR: Angina, arrhythmia, cerebral arteritis, cerebral

Registration expired

Pink Pages_2010_Tip.pmd 50 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 51
occlusion, changes in BP, MI, necrotising vasculitis, respiration rate; apnoea; headache; hiccup;
palpitation, pulse changes, tachycardia; nausea, increased appetite, vomiting; cough;
depression, dizziness, drowsiness, fever, oversedation; seizure-like activity (paediatrics);
headache, insomnia, nervousness, neuroleptic paradoxical reactions; kernicterus; nystagmus;
malignant syndrome (NMS), Tourette’s syndrome, skin rash, pruritus; reduced alertness, confusion,
toxic psychosis; erythema multiforme, exfoliative euphoria, hallucinations, fatigue, dizziness, ataxia,
dermatitis, hair loss, rash, urticaria; growth post-op sedation, anterograde amnesia; jaundice;
retardation; abdominal pain, anorexia, diarrhoea, cardiac arrest, heart rate changes, thrombosis;
nausea, vomiting, wt loss; anaemia, leukopenia, anaphylaxis; laryngospasm, bronchospasm. Resp
thrombocytopenic purpura, thrombocytopenia; depression, resp arrest; hypotension.
abnormal LFTs, hepatic coma, increased DI: Increased CNS depression w/ alcohol, opioids,
transaminases; arthralgia, dyskinesia; blurred barbiturates, other sedatives & anaesthetics.
vision, visual accommodation disturbance; cough, Increased resp depression w/ opiates,
pharyngitis, sinusitis, upper resp tract infection; phenobarbital, other benzodiazepines. Plasma
accidental injury, hypersensitivity. Transdermal: concentrations increased by CYP3A4 inhibitors
Insomnia, decreased appetite; nausea; tic, e.g. cimetidine, erythromycin, clarithromycin,
emotional instability; vomiting, anorexia; nasal diltiazem, verapamil, ketoconazole & itraconazole,
congestion, nasopharyngitis; wt loss. antiretroviral agents, quinupristin w/ dalfopristin.
DI: May reduce effects of antihypertensive agents. Midazolam conc decreased by phenytoin,
Reduced serum level w/ carbamazepine. Increased carbamazepine, phenobarbital, rifampicin.
serum levels or effects w/ CYP2D6 inhibitors e.g. Halothane, thiopental requirements may be
chlorpromazine, delavirdine, fluoxetine, reduced during concurrent use.
miconazole, paroxetine, pergolide, quinidine,
quinine, ritonavir, ropinirole. May increase serum
levels of phenytoin, TCAs. Possible severe HTN &
tachycardia w/ sibutramine. CNS depression w/ NITRAZEPAM
alcohol. Severe toxic reactions w/ clonidine.
Increased risk of hypertensive crisis w/ MAOIs.

 
MIDAZOLAM I: Infantile spasms. Short-term management of
insomnia.
CI: Myasthenia gravis, narrow-angle glaucoma,
severe resp insufficiency, sleep apnoea
  syndrome, severe hepatic impairment, porphyria.
I: Induction of anaesthesia. Premedication in SP: May induce anterograde amnesia; caution
surgery. Sedation for dental & minor surgical patients to have uninterrupted sleep of 7-8 hr
procedures. Sedation in critical care. Short-term after ingestion of dose. May impair ability to drive
management of insomnia. or operate machinery. Depression, esp if suicidal
CI: Acute narrow-angle glaucoma; coma or patients risk may be present. History of drug abuse or
in shock; acute alcohol intoxication; intrathecal & acute alcoholism. Hepatic & renal impairment.
epidural admin. Acute pulmonary insufficiency or Respiratory disease. Debilitated patients. Patients
marked neuromuscular resp weakness including who are at risk of falls. Children, elderly. Pregnancy
unstable myasthenia gravis; severe resp & lactation.
depression. AR: Hypotension, palpitation; agitation,
SP: Paediatric patients w/ CV instability; chronic aggressiveness, amnesia, ataxia, confusion,
renal failure; open-angle glaucoma; cardiac delusions, disorientation, dizziness, fatigue,
disease; resp disease; myasthenia gravis; hallucination, hangover, headache, irritability,
neonates; history of drug or alcohol abuse; elderly nightmares, psychoses, rage, restlessness,
& debilitated (reduce dose); avoid prolonged use sedation; rash; changes in libido; constipation,
or abrupt withdrawal; hepatic impairment; severe diarrhoea, excessive salivation, heartburn,
fluid or electrolyte disturbances. May impair ability nausea, vomiting; granulocytopenia, leukopenia;
to drive or operate machinery; titrate dose carefully; falling, muscle weakness; blurred or double vision;
monitor for early signs of hypoventilation, airway tinnitus (associated w/ withdrawal); aspiration,
obstruction, or apnea. Pregnancy, lactation. increased bronchial secretion, dyspnoea.
AR: Physical & psychological dependence w/ DI: CNS depressant effect increased w/ alcohol,
withdrawal symptoms; decreased tidal vol & barbiturates, TCAs, phenothiazines, morphine

Registration expired

Pink Pages_2010_Tip.pmd 51 7/4/2553, 09:28


52 IMPORTANT DRUG NOTES PN DEX 2010
derivatives. Effects may be antagonised by disorders e.g. arteriosclerosis, HTN or aneurysms;
theophylline. Increased levels/effects w/ DM & closed-angle glaucoma; renal impairment,
probenecid. Reduced levels/effects w/ rifampicin. prostatic enlargement. Pregnancy; lactation.
May reduce effects of levodopa. AR: Anginal pain; rebound congestion &
rhinorrhoea; fear, anxiety, restlessness, tremor,
insomnia, confusion, irritability & psychotic states;
reduced appetite, nausea, vomiting; gangrene;
PHENTERMINE cerebral haemorrhage & pulmonary oedema; reflex
bradycardia, tachycardia & cardiac arrhythmias,
palpitations & cardiac arrest, hypotension &
 dizziness, fainting & flushing. Tissue necrosis &
sloughing; myocardial & arterial necrosis.
I: Anorectic in short-term treatment of moderate
to severe obesity. DI: Increased risk of HTN & arrhythmias if given
w/ cardiac glycosides, quinidine or TCAs.
CI: Pulmonary hypertension, advanced Increased risk of vasoconstrictor effects if given
arteriosclerosis, moderate to severe hypertension, w/ ergot alkaloids or oxytocin. Co-admin w/ MAOIs
hyperthyroidism, CV disease, glaucoma, history may cause hypertensive crisis. Anaesthetics e.g.
of alcohol/drug abuse, agitated states, use during cyclopropane, halothane & other halogenated
or w/in 14 days following MAOI therapy. Lactation. anaesthestics; antihypertensive agents.
SP: Hypertension, DM, seizure disorder, Tourette’
s syndrome, patients who have used other
anorexigens w/in the past year, children. May
impair ability to drive & operate machinery. Potential TEMAZEPAM
for drug dependency. Discontinue if results are
not satisfactory w/in 4 wk or tolerance develops.
History of epilepsy. Renal or hepatic disease. 
Pregnancy.
AR: Urticaria, GI upsets, palpitations, tachycardia, I: Short-term management of insomnia.
elevated blood pressure, overstimulation, CI: Severe hepatic impairment. Pregnancy.
restlessness, insomnia, tremor, headache, dry SP: Chronic pulmonary insufficiency, elderly or
mouth, dizziness, dysphoria, euphoria, psychosis, debilitated patients, impaired liver or kidney
changes in libido & impotence. Primary pulmonary function, personality disorders or organic brain
HTN & valvular heart disease. changes, history of alcohol or drug addiction,
DI: Decreased excretion by antacids, carbonic lactation.
anhydrase inhibitors (e.g. acetazolamide, AR: Confusion, dizziness, drowsiness, fatigue,
dichlorphenamide, methazolamide). Excretion is headache, lethargy, hangover, euphoria, difficulty
increased by urinary acidifiers. Increased risk of w/ coordination, ataxia, anorexia, tremor, vomiting
adverse effects w/ other sympathomimetic agents. & backache.
There is a risk of arrhythmias when used w/ TCA.
May reduce serum concentrations of phenytoin, DI: Enhanced sedation, resp & CV depression w/
phenobarbital and ethosuximide. Severe drugs w/ CNS depressant properties.
hypertensive episodes w/ MAOI. Primary
pulmonary HTN or valvular heart disease may
occur when phentermine is used concurrently w/
fenfluramine or dexfenfluramine. Avoid concurrent TRIAZOLAM
use w/ sibutramine.


PSEUDOEPHEDRINE I: Short-term management of insomnia.
CI: Preexisting CNS depression or coma; resp
depression; acute pulmonary insufficiency or sleep
 apnoea; myasthenia gravis; chronic psychosis,
I: Nasal congestion. phobic or obsessional states; may precipitate
suicide or aggressive behaviour so it should not
CI: Severe hypertension, phaeochromocytoma. to be used alone to treat depression or anxiety
SP: Hyperthyroidism; ischaemic heart disease, associated w/ depression. Porphyria. Pregnancy
arrhythmia or tachycardia; occlusive vascular & lactation. Child.

Registration expired

Pink Pages_2010_Tip.pmd 52 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 53
SP: Chronic pulmonary insufficiency; elderly or
debilitated patients; sleep apnoea; muscle P3 - Psychotropic substance
weakness; impaired liver or kidney function; Schedule 3
drowsiness may affect skilled tasks; personality
disorders or organic brain changes; history of
alcohol or drug addiction. AMOBARBITAL
AR: Drowsiness, lightheadedness, dizziness,
sedation, agitation, hallucinations, abnormal            ⌫ ⌫     
behaviour, muscle weakness, ataxia, confusion, 
slurred speech, changes in libido, urinary retention, I: Severe intractable insomnia.
anterograde amnesia.
CI: Depression; pulmonary insufficiency; sleep
DI: Increased plasma triazolam concentrations w/ apnoea; preexisting CNS depression or coma;
oral contraceptives, ergotamine, ciclosporin, severe hepatic impairment. Porphyria. Pregnancy
isoniazid, ranitidine & CYP3A inhibitors e. g. some & lactation. Elderly & debilitated patients; young
macrolide antibiotics, cimetidine, isoniazid, adults & child.
fluvoxamine, sertraline, paroxetine, diltiazem, SP: Renal insufficiency; given to patients in pain
verapamil, amiodarone. Additive CNS depression may provoke a paradoxical excitatory reaction,
w/ other CNS depressants eg, antipsychotics, unless an analgesic is given concomitantly; may
other hypnotics or sedatives, opioid analgesics & impair ability to drive or operate machinery.
alcohol. Increased risk of prolonged sedation w/
potent CYP3A inhibitors e.g. azole antifungal AR: Dependence; drowsiness, sedation, ataxia;
agents, nefazodone, HIV protease inhibitors, non- resp depression; headache; GI disturbances; skin
nucleoside reverse transcriptase inhibitors. reactions; confusion & memory defects;
paradoxical excitement, irritability; hypersensitivity
reactions; haematologic disorders.
DI: Sedation or resp depression may be enhanced
ZOLPIDEM by drugs w/ CNS depressants; MAOIs may prolong
the CNS depressant effects & also reduce the
convulsive threshold, thereby antagonise the
anitconvulsant action of barbiturates. Others:
 Fenoprofen, methadone, pethidine & opioid
I: Short-term management of insomnia. analgesics; disopyramide, lidocaine & quinidine;
chloramphenicol, doxycycline; warfarin & coumarin;
CI: Severe hepatic insufficiency. antidepressants eg, bupropion, fluoxetine, lithium
SP: Obstructive sleep apnoea, myasthenia gravis, & mianserin; valproate & progabide; vigabatrin,
compromised resp function, hepatic impairment. oxcarbazepine, carbamazepine, clonazepam,
Caution in patients exhibiting symptoms of ethosuximide, lamotrigine, tiagabine & zonisamide,
depression. Patients should be warned from doing griseofulvin; teniposide; metronidazole;
any work involving mental alertness or motor chlorpromazine; HIV-protease inhibitors; β-
coordination after ingestion of the drug. Pregnancy blockers; calcium-channel blockers eg, nifedipine
& lactation. Re-evaulate if insomnia fail to remit & verapamil; digitoxin; ciclosporin; corticosteroids;
after 7-10 days. Max duration of treatment: 4 wk furosemide; montelukast; oral contraceptives;
including tapering. theophylline; levothyroxine; flu vaccination &
vitamins. Alcohol. St. John’s wort.
AR: Amnesia, drowsiness, dizziness, diarrhoea,
nausea, vomiting, abnormal thinking &
behaviour, drugged feelings, back pain, ataxia,
hiccups, confusion, euphoria, insomnia, vertigo, PENTAZOCINE
diplopia, abnormal vision. Hepatitis, anaphylactic
reactions, sleep-driving (driving while not fully
awake after drug ingestion, w/ no recollection ⌦
of the event).
DI: Increased sedation & incoordination w/ TCA. I: Moderate to severe pain.
Increased sedation w/ haloperidol & alcohol. Small CI: Head injury; narcotic dependence; resp
increase in zolpidem conc w/ ketoconazole. depression; raised intracranial pressure; MI; heart
Reduced effect of hypnotic effects w/ rifampicin. failure; arterial or pulmonary hypertension;
Increased risk of prolonged sedation & resp porphyria; pregnancy (prolonged use or high doses
depression w/ ritonavir. at term).

Registration expired

Pink Pages_2010_Tip.pmd 53 7/4/2553, 09:28


54 IMPORTANT DRUG NOTES PN DEX 2010
SP: May precipitate withdrawal in narcotic addicts. DI: Potentiates action of alcohol & CNS
Impaired respiratory, renal & hepatic function; depressants. Reduced conc w/ cigarette smoking
morbidly obese patients; thyroid dysfunction; by 50%. Cimetidine & fluoxetine reduce the
prostatic hyperplasia or urinary stricture; biliary clearance of alprazolam. Alprazolam enhances
tract impairment; adrenal insufficiency (including activity of imipramine & desipramine.
Addison’s disease); abdominal conditions. Elderly
or debilitated patients; seizure-prone patients; child
& infants (safety & efficacy not established in <1
yr); lactation. May impair ability to drive or operate BROMAZEPAM
machinery. Administer IM rather than SC (when
frequent inj are needed) & inj sites should be
varied. 
AR: Physical dependence; sedation, dizziness,
euphoria, lightheadedness, alterations of mood; I: Anxiety.
resp depression; visual hallucinations, CI: Preexisting CNS depression or coma, resp
disorientation, confusion; hypertension, depression, acute pulmonary insufficiency or sleep
tachycardia, circulatory depression; shock; apnea; severe hepatic impairment; not indicated
hypotension; nausea, vomiting, constipation; for chronic psychosis, phobic or obsessional
seizures, diaphoresis; rash; blood dyscrasias; states; may precipitate suicide or aggressive
local tissue damages (SC), muscle fibrosis (IM). behavior, not used alone to treat depression or
Respiratory depression, hypotension, circulatory anxiety associated w/ depression; glaucoma.
failure, deepening coma, convulsions. SP: Chronic pulmonary insufficiency; elderly or
DI: Depressant affects potentiated by alcohol, CNS debilitated patients; muscle weakness, impaired
depressants; concurrent use w/ fluoxetine may liver or kidney function; drowsiness may affect
lead to diaphoresis, ataxia flushing & tremor skilled tasks; monitor cardio-respiratory function
associated w/ serotonin syndrome. when used for deep sedation; patients w/
personality disorders or organic brain changes;
pregnancy & lactation; history of alcohol or drug
addiction due to risk of dependence; resp
depression & hypotension w/ parenteral
administration, therefore this route should only be
used when facilities for reversing resp depression
are available.
P4 - Psychotropic Substance
AR: Drowsiness, sedation, muscle weakness &
Schedule 4 ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
ALPRAZOLAM in libido, tremor, visual disturbances, urinary
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
  hypersensitivity reactions; pain & thrombophlebitis;
raised liver enzyme values; paradoxical excitation.
I: Panic attacks. Short-term management of anxiety.
DI: Enhanced sedation or resp & CV depression
CI: Acute narrow-angle glaucoma, preexisting
w/ drugs w/ CNS depressant properties eg,
CNS depression or coma, resp depression, acute
antidepressants, antihistamines, antipsychotics,
pulmonary insufficiency or sleep apnoea; severe
general anesthetics, other hypnotics or sedatives,
hepatic impairment; pregnancy, lactation.
opioid analgesics & cisapride. Alcohol. Drugs which
SP: Dosage reduction or gradual withdrawal. alter the hepatic microsomal enzymes.
Dependence. Geriatric or debilitated patients.
Muscle weakness, impaired hepatic or renal
function; arteriosclerosis; obesity; depression
particularly suicidal tendency; chronic pulmonary CHLORDIAZEPOXIDE
insufficiency. May impair ability to drive or operate
machinery. Children <18 yr.
AR: Psychological & physical dependence,
withdrawal syndrome; drowsiness, sedation, vertigo, 
headache, visual disturbances, GI disturbances, I: Acute anxiety. Acute symptoms of alcohol
jaundice; fatigue, muscle weakness, ataxia, withdrawal. Anxiety. Insomnia. Muscle spasms.
dizziness, confusion & depression. Blood dyscrasias. Premedication before anaesthesia. Severe

Registration expired

Pink Pages_2010_Tip.pmd 54 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 55
symptoms of alcohol withdrawal. Epilepsy. Panic disorder.
CI: Acute pulmonary insufficiency, resp depression, CI: Hypersensitivity to benzodiazepines, acute
patients w/ marked neuromuscular resp weakness; pulmonary insufficiency, acute narrow angle
hypersensitivity to benzodiazepines; chronic glaucoma.
psychosis; porphyria; pregnancy & lactation. SP: Neonates, chronic pulmonary insufficiency,
SP: Alcohol; sedation, dependence. Elderly & hepatic/renal dysfunction, porphyria, elderly;
debilitated patients. Liver or kidney dysfunction. pregnancy & lactation.
Avoid prolonged usage. AR: Drowsiness, fatigue, muscular hypotonia,
AR: Physical & psychological dependence; coordination disturbances, dizziness, vertigo,
withdrawal syndrome; impairs psychomotor anorexia, visual disturbances, libido changes.
performance, aggression (in predisposed individuals Salivary or bronchial hypersecretion leading to resp
esp in combination w/ alcohol); sedation; blood problems (children). May produce diminished
dyscrasias, jaundice, hepatic dysfunction. May rarely reflexes or coma. Rarely, blood dyscrasias.
cause hypoplastic or haemolytic anaemia. DI: Carbamazepine, phenobarbitone or phenytoin
DI: Cimetidine increases serum conc of may accelerate clonazepam metabolism.
chlordiazepoxide. Potentiates action of major Increased sedative effect w/ alcohol, general
neuroleptics. Alcohol potentiates CNS-depressant anaesthetics & TCAs.
effect of chlordiazepoxide.

CLORAZEPATE
CLOBAZAM

  


I: Alcohol withdrawal syndrome. Anxiety. Epilepsy.
I: Adjunct in epilepsy. Short-term management of
anxiety. CI: Hypersensitivity (cross-sensitivity w/ other
benzodiazepines may occur); narrow-angle
CI: Hypersensitivity; history of drug dependence;
glaucoma. Patients w/ depressive or psychotic
myasthaenia gravis; pregnancy (1 st trimester),
disorders. child <9 yr. Pregnancy; lactation.
lactation; serious liver damage; sleep apnoea
syndrome; impaired resp function. SP: Elderly, debilitated patients; hepatic disease,
SP: May impair ability to perform skilled tasks & alcoholics; renal impairment; resp disease;
hazardous activities; elderly; renal or hepatic impaired gag reflex; patients experiencing apnoea
impairment; alcoholics; obesity; withdrawal should during sleep; operating machines or driving;
be gradual. patients on CNS depressant or psychoactive drug
therapy; depression, esp those w/ suicidal
AR: Constipation, anorexia, nausea; dizziness, tendencies; history of drug-dependence.
fine tremors; worsening of resp symptoms in
predisposed individuals; ataxia, drowsiness, AR: Jaundice, hepatic necrosis; extrapyramidal
headache, confusion; loss of libido, motor disorders; acute attacks of porphyria in porphyric
dysfunction; dependence; visual disturbances & patients, hypotension; drowsiness, fatigue, ataxia,
wt gain. Respiratory depression. lightheadedness, memory impairment, insomnia,
anxiety, headache, depression, slurred speech,
DI: Increased hepatic clearance of clobazam confusion, nervousness, dizziness, irritability; rash;
when administered w/ phenytoin, phenobarbital decreased libido; xerostomia, constipation,
or carbamazepine. Cimetidine may increase levels diarrhoea, decreased salivation, nausea, vomiting,
of clobazam. Concurrent alcohol, hypnotics & increased or decreased appetite; dysarthria,
sedative antidepressants can potentiate CNS side tremor; blurred vision, diplopia.
effects of clobazam.
DI: Potentiates CNS effects of narcotic analgesics,
barbiturates, phenothiazines, ethanol,
antihistamines, MAO Inhibitors, sedative-
CLONAZEPAM hypnotics, cyclic antidepressants. CYP3A4
inhibitors eg, amprenavir, cimetidine, ciprofloxacin,
clarithromycin may increase serum conc & toxicity
of clorazepate. Carbamazepine, rifampin & rifabutin
  may decrease clorazepate therapeutic effects by
I: Emergency management of status epilepticus. enhancement of clorazepate metabolism.

Registration expired

Pink Pages_2010_Tip.pmd 55 7/4/2553, 09:28


56 IMPORTANT DRUG NOTES PN DEX 2010

DIAZEPAM ETHYL LOFLAZEPATE

  


I: Adjunct in the management of seizures. Alcohol I: Short-term management of anxiety.
withdrawal syndrome. Insomnia associated w/ CI: Preexisting CNS depression or coma, resp
anxiety. Muscle spasms. Premedication before depression, acute pulmonary insufficiency or sleep
anaesthesia. Sedation in minor surgical & medical apnoea; severe hepatic impairment; not indicated
procedures. Severe anxiety. for chronic psychosis, phobic or obsessional states;
CI: Hypersensitivity; myasthenia gravis, may precipitate suicide or aggressive behaviour,
preexisting CNS depression or coma, resp not used alone to treat depression or anxiety
depression; acute pulmonary insufficiency or sleep associated w/ depression; glaucoma.
apnoea syndrome; severe hepatic impairment; SP: Chronic pulmonary insufficiency; elderly or
acute narrow angle glaucoma; child <6 mth (oral); debilitated patients; muscle weakness, impaired
pregnancy & lactation. liver or kidney function; drowsiness may affect
SP: Impaired renal & hepatic function, resp skilled tasks; monitor cardio-respiratory function
disease, organic cerebral changes, elderly, when used for deep sedation; patients w/
psychotic patients, epileptics, history of alcohol personality disorders or organic brain changes;
or drug addiction, impaired gag reflex, obese pregnancy, lactation; history of alcohol or drug
patients. May cause CNS depression. Discontinue addiction due to risk of dependence. Resp
treatment if patient develops psychiatric & depression & hypotension may occur w/ parenteral
paradoxical reactions. Caution when used in admin.
patients w/ depression or anxiety associated w/ AR: Drowsiness, sedation, muscle weakness &
depression, esp if patient has suicidal risk. May ataxia; less frequently vertigo, headache,
increase risk of falls. Safety & efficacy of the inj confusion, depression, slurred speech, changes
have not been established in child <1 mth of age. in libido, tremor, visual disturbances, urinary
Safety & efficacy of oral use have not been retention, GI disturbances, changes in salivation
established in child <6 mth of age. Safety & & amnesia; rarely, jaundice, blood disorders &
efficacy of rectal gel have not been established hypersensitivity reactions; pain & thrombophlebitis;
in child <2 yr of age. Abrupt withdrawal or large raised liver enzyme values; paradoxical excitation.
dose reduction may cause rebound or withdrawal
symptoms. DI: Enhanced sedation or resp & CV depression
w/ drugs that have CNS depressant properties e.g.
AR: Psychological & physical dependence w/ antidepressants, antihistamines, antipsychotics,
withdrawal syndrome, fatigue, drowsiness, general anesthetics, other hypnotics or sedatives,
sedation, ataxia, vertigo, confusion, depression, opioid analgesics & cisapride. Drugs which alter
GI disturbances, changes in salivation, amnesia, the hepatic microsomal enzymes.
jaundice, paradoxical excitation, elevated liver
enzyme values; muscle weakness, visual
disturbances, headache, slurring of speech &
dysarthria, mental changes, incontinence, LORAZEPAM
constipation, hypotension, tachycardia, changes
in libido, pain & thrombophlebitis at inj site (IV).
Respiratory & CNS depression, coma.
DI: Increased clearance of diazepam when used 
w/ phenytoin, carbamazepine & phenobarbital. I: Acute anxiety. Anxiety. Insomnia associated w/
Reversible deterioration of parkinsonism may occur anxiety. Premedication in surgery. Prophylaxis of
when given together w/ levodopa. Combination nausea & vomiting associated w/ cytotoxic therapy.
w/ lithium may produce hypothermia. May need to Sedation in critical care. Status epilepticus.
reduce dose of narcotics when used concurrently.
Phenothiazines, barbiturates, MAOIs potentiate CI: Severe hepatic impairment; resp depression;
action of diazepam. Additive CNS depressant acute narrow-angle glaucoma; pregnancy & lactation.
effects w/ alcohol & CNS depressants or SP: Hepatic & renal dysfunction; pulmonary
psychoactive medications. Mutual potentiation of insufficiency; myasthenia gravis; may impair ability
action w/ analgesics, anaesthetics & some to drive or operate machinery; elderly or debilitated
anticonvulsants. patients.

Registration expired

Pink Pages_2010_Tip.pmd 56 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 57
AR: Drowsiness, headache, dizziness, confusion; function. Patients w/ acute pain & depressive
blurred vision; nausea; weakness; unsteadiness. disorders. May impair ability to drive or operate
Resp depression. machinery. Lactation.
DI: Potentiation of CNS depression produced by AR: Bradycardia, hypotension, syncope;
alcohol; general anaesthetics; narcotic analgesics; drowsiness, lethargy, CNS excitation or
TCAs; MAOIs; phenothiazines; antipsychotics; depression, impaired judgment, hangover effect,
barbiturates; scopolamine. confusion, somnolence, agitation, hyperkinesia,
ataxia, nervousness, headache, insomnia,
nightmares, hallucinations, anxiety, dizziness;
rash, exfoliative dermatitis; nausea, vomiting,
MEDAZEPAM constipation; agranulocytosis, thrombocytopenia,
megaloblastic anaemia; pain at inj site,
thrombophlebitis (IV); oliguria: laryngospasm, resp
 depression, apnoea (especially w/ rapid IV admin),
I: Short-term management of anxiety. hypoventilation. Stevens-Johnson syndrome.
CI: Glaucoma. DI: May enhance the hepatotoxic potential of
paracetemaol overdoses. May decrease levels/
SP: Severe hepatic impairment. Elderly or effects of various CYP isoenzyme substrates e.g.
debilitated patients; muscle weakness or teniposide, methotrexate, antipsychotics,
myasthenia gravis; impaired liver or kidney function; b-blockers, calcium-channel blockers, other
predisposition to seizures; depression; severe resp anticonvulsants, chloramphenicol, cimetidine,
dysfunction; sleep apnoea; movement disorders; corticosteroids, ciclosporin, doxycycline,
drowsiness may affect skilled tasks; history of oestrogens, felbamate, griseofulvin, tacrolimus,
alcohol or drug addiction. Treatment withdrawal furosemide, methadone, oral contraceptives,
should be gradual. Avoid long-term use. Pregnancy theophylline, TCAs, warfarin. May reduce effects
& lactation. of guanfacine. Reduced metabolism & or increased
AR: Fatigue, drowsiness, dizziness, prolonged toxicity w/ chloramphenicol, felbamate, MAOIs,
reaction time, headache, coordination disorders valproic acid. May enhance the nephrotoxic effects
(ataxia), confusion, anterograde amnesia. Rarely, of methoxyflurane. Additive sedation and/or resp
GI symptoms, laryngeal spasm, chest pain, depression w/ ethanol, sedatives, antidepressants,
hypotension, bradycardia, depression, decreased opioid analgesics, benzodiazepines & other CNS
libido, increased appetite, dry mouth, muscle depressants. May decrease levels/effects of
weakness, resp failure. antiarrhythmic drugs e.g. disopyramide,
DI: Additive CNS depression or sedative effects propafenone, quinidine.
w/ drugs that have CNS depressant properties e.g.
alcohol, antidepressants, sedating antihistamines,
antipsychotics, general anaesthetics, other
hypnotics or sedatives, opioid analgesics, PINAZEPAM
cisapride. Increased risk of toxicity w/ hepatic
microsomal enzyme inhibitors.
 
I: Insomnia associated w/ anxiety. Short-term
PHENOBARBITAL management of anxiety.
CI: Preexisting CNS depression or coma, resp
depression, acute pulmonary insufficiency,
    myasthenia gravis, sleep apnoea, severe hepatic
  impairment; not indicated for chronic psychosis,
phobic or obsessional states; glaucoma.
I: Emergency management of acute seizures.
Generalised tonic-clonic seizures. Hypnotic. Partial SP: Chronic pulmonary insufficiency; elderly or
seizures. Preoperative sedation. Sedation. Status debilitated patients; muscle weakness, impaired
epilepticus. liver or kidney function; drowsiness may affect
skilled tasks; monitor cardio-respiratory function
CI: Severe renal & hepatic disorders. Severe resp when used for deep sedation; patients w/
depression, dyspnoea or airway obstruction; personality disorders or organic brain changes;
porphyria. Pregnancy. pregnancy, lactation; history of alcohol or drug
SP: Elderly or debilitated patients, children. addiction, hypotension & apnoea w/ IV admin,
Withdraw gradually. Impaired renal, hepatic & resp therefore this route should only be used when

Registration expired

Pink Pages_2010_Tip.pmd 57 7/4/2553, 09:28


58 IMPORTANT DRUG NOTES PN DEX 2010
facilities for reversing resp depression are available. general anaesthetics, other hypnotics or sedatives,
Monitor for signs of suicidal tendency or aggressive opioid analgesics & cisapride. Decreased serum
behavior; not to be used alone to treat depression levels when used w/ phenytoin. May increase the
or anxiety associated w/ depression. plasma levels of bupivacaine. Serum levels may be
AR: Drowsiness, sedation, muscle weakness & increased by valproate & modafinil.
ataxia; less frequently vertigo, headache,
confusion, depression, slurred speech, changes
in libido, tremor, visual disturbances, urinary TOFISOPAM
retention, GI disturbances, changes in salivation
& amnesia; rarely, jaundice, blood disorders &
hypersensitivity reactions; pain &
thrombophloebitis; raised liver enzyme values; 
paradoxical excitation. I: Alcohol withdrawal syndrome. Short-term
DI: Enhanced sedation or resp & CV depression management of anxiety.
w/ drugs w/ CNS depressant properties e.g. CI: Aggressive-impulsive psychopathy. Pregnancy.
alcohol, antidepressants, antihistamines, SP: Discontinue if sleep disturbances occur. Avoid
antipsychotics, general anaesthetics, other sleep disturbances by taking last dose earlier (e.g.
hypnotics or sedatives, opioid analgesics & before 5 pm).
cisapride.
AR: Nausea, rash, epigastric pain, itching, extreme
liveliness, hyperactivity, aggressiveness.

PRAZEPAM

 N2 - Narcotic Drug Schedule 2


I: Short-term management of anxiety.
CI: Preexisting CNS depression or coma, resp CODEINE (ANALGESIC)
depression, acute pulmonary insufficiency or sleep
apnoea; severe hepatic impairment; chronic
psychosis, phobic or obsessional states; glaucoma; ⌦
porphyria. Myasthenia gravis. I: Mild to moderate pain.
SP: Chronic pulmonary insufficiency; elderly or CI: Resp depression, obstructive airway disease,
debilitated patients; muscle weakness, impaired liver asthma. Acute alcoholism, convulsive disorders,
or kidney function; drowsiness may affect skilled head injuries, comatose patients, raised
tasks; monitor cardio-respiratory function when used intracranial pressure. Pregnancy (prolonged use
for deep sedation; patients w/ personality disorders or high doses at term).
or organic brain changes; pregnancy & lactation; SP: Hypothyroidism, adrenocortical insufficiency;
history of alcohol or drug addiction due to risk of asthma, impaired hepatic or renal function,
depression. resp depression & hypotension w/ prostatic hyperplasia, hypotension, shock,
parenteral admin, therefore this route should only inflammatory or obstructive bowel disorders,
be used when facilities for reversing resp depression myasthenia gravis. Infants, neonates; Reduce dose
are available. May precipitate suicide or aggressive in elderly or debilitated patients. May impair ability
behavior, not used alone to treat depression or to drive or operate machinery. Lactation.
anxiety associated w/ depression.
AR: Dependence, withdrawal symptoms; nausea,
AR: Drowsiness, sedation, muscle weakness & vomiting, constipation; drowsiness, confusion;
ataxia; less frequently vertigo, headache, confusion, difficulty in micturition, ureteric or biliary spasms,
depression, slurred speech, changes in libido, urinary retention; dry mouth, dizziness, sweating,
tremor, visual disturbances, urinary retention, GI facial flushing, headache, vertigo, bradycardia,
disturbances, changes in salivation & amnesia; tachycardia, palpitations, orthostatic hypotension,
rarely, jaundice, blood disorders & hypersensitivity hypothermia, restlessness, mood changes,
reactions; pain & thrombophloebitis; raised liver decreased libido or potency, hallucination, miosis;
enzyme values; paradoxical excitation. raised intracranial pressure, muscle rigidity. Resp
DI: Enhanced sedation or resp & CV depression w/ depression & hypotension, w/ circulatory failure
alcohol, drugs w/ CNS depressant properties eg, & deepening coma (larger doses). Convulsions
antidepressants, antihistamines, antipsychotics, (especially in child & infants). Rhabdomyolysis.

Registration expired

Pink Pages_2010_Tip.pmd 58 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 59
DI: Enhanced depressant effects w/ alcohol,
anaesthetics, anxiolytics, hypnotics, TCAs, METHADONE
antipsychotics. Possible CNS depression or
excitation w/ MAOIs. May alter effects of other
compounds e.g. cyclizine, mexiletine, cisapride,
metoclopramide & domperidone. ⌫ 
⌫ ⌫  
I: Analgesia. Intractable cough associated w/ lung
cancer. Neonatal abstinence syndrome. Opioid
FENTANYL dependence.
CI: Acute resp depression; acute bronchial asthma;
acute alcoholism; risk of paralytic ileus; raised
⌫  intracranial pressure or head injury.

  SP: Dose should be individualised. Prolonged QT


interval; CV disease; hepatic impairment;
I: Adjunct to general anaesthesia. Breakthrough electrolyte abnormalities; concommitant use of QT
cancer pain. Intractable chronic pain. Premedication prolonging drug; resp disease; elderly. May impair
before anaesthesia. ability to drive or operate machinery.
CI: Hypersensitivity. AR: Nausea; vomiting; constipation; anorexia;
abdominal pain; drowsiness; resp depression;
SP: Myasthaenia gravis. Head injury; increased hypotension; bradycardia; euphoria; headache;
intracranial pressure; intracranial lesions; renal or dysphoria; urinary retention; miosis; visual
hepatic impairment; neonates; opioid-nontolerant disturbances; impotence; dizziness; sweating;
patients. Increased risk of resp depression in pruritis; asthenia; arrythmias; QT prolongation.
elderly, debilitated patients, patient w/ hypoxia or Cardiac arrest; resp arrest; shock.
hypercapnia. Hypothyroidism, prostatic
hyperplasia, inflammatory bowel disorders, DI: Withdrawal symptoms may be experienced w/
bradycardia or bradyarrhythmias. Rapid IV infusion naloxone, naltrexone, pentazocine, nalbuphine,
may cause skeletal muscle & chest wall rigidity, butorphanol, & buprenorphine. Increased
impaired ventilation or resp distress/arrest. clearance & possible reduced efficacy w/ some
Prolonged use may cause tolerance, psychological antiretrovirals (abacavir, amprenavir, efavirenz,
& physical dependence. Abrupt withdrawal after nelfinavir, nevirapine, ritonavir, lopinavir); rifampin;
prolonged admin may lead to withdrawal phenytoin; phenobarbital; carbamazepine.
symptoms. Lactation. Pregnancy (avoid high doses Decreased clearance & possibly increased toxicity
w/ CYP3A4 inhibitors (e.g. ketoconazole,
or prolonged usage).
voriconazole, sertraline, fluvoxamine). Increased
AR: Nausea, vomiting; bradycardia, oedema, CNS chance of cardiac toxicity w/ other QT prolonging
depression, confusion, dizziness,drowsiness, drugs. Increased CNS depression w/ alcohol, other
headache, sedation, transient hypotension, opioids or CNS depressants. Methadone may
peripheral vasodilation; increased intracranial increase plasma levels of desipramine, zidovudine.
pressure. High IV dose may cause chest wall
rigidity. Transdermal: Rash, erythema & itching.
Respiratory depression, trunk rigidity,
laryngospasm, bronchoconstriction. MORPHINE
DI: Depressant effects may be enhanced by other
CNS depressants e.g. alcohol, anaesthetics,
anxiolytics, hypnotics, TCAs & antipsychotics.
Ammonium Cl may increase excretion of fentanyl.
⌦
Phenothiazines may increase hypotensive effect I: Acute pain. Acute pulmonary oedema. Analgesia
of opioid analgesics. Serum levels may be during labour. Chronic pain. Intractable cough
increased by CYP3A4 inhibitors (e.g. azole associated w/ lung cancer. Moderate to severe
antifungals, clarithromycin, diclofenac, doxycycline, pain. Pain associated w/ myocardial infarction. Pain
erythromycin, imatinib, isoniazid, nefazodone, relief. Premedication in surgery. Unstable angina
nicardipine, propofol, protease inhibitors, quinidine, not responsive to anti-ischaemic therapy.
telithromycin & verapamil). May reduce the efficacy CI: Respiratory depression, acute or severe
of pegvisomant. Serum levels may be reduced by asthma; paralytic ileus; obstructive airway disease;
rifamycin derivatives. May increase serotonergic acute liver disease; comatose patients; increased
effect of SSRIs & sibutramine. intracranial pressure; acute alcoholism. Pulmonary

Registration expired

Pink Pages_2010_Tip.pmd 59 7/4/2553, 09:28


60 IMPORTANT DRUG NOTES PN DEX 2010
oedema resulting from a chemical resp irritant. nausea, vomiting, constipation, anorexia, stomach
SP: Elderly; hypothyroidism; renal & liver disease; cramps, xerostomia, biliary spasm, paralytic ileus,
head injury, intracranial lesions; hypotension, sphincter of Oddi spasm; ureteral spasms,
circulatory shock; adrenocortical insufficiency; decreased urination; pain at inj site; weakness;
asthma; prostatic hyperplasia; inflammatory or dyspnoea; histamine release, physical &
obstructive bowel disease; myasthaenia gravis; psychological dependence.
infants <3 mth; pregnancy, lactation; hypovolaemia, DI: Increased pethidine metabolite levels w/
biliary tract disorders. aciclovir, cimetidine, ritonavir. Reduced analgesic
AR: Convulsions; nausea, vomiting, dry mouth, effects w/ phenytoin, barbiturates. Additive sedative
constipation; urinary retention; headache, vertigo; and/or resp depressive effects w/ alcohol,
palpitations; hypothermia; pruritus, urticaria; barbiturates, benzodiazepines, phenothiazines,
tachycardia, bradycardia; blurred vision; miosis; TCAs, other CNS depressants. Increased risk of
dependency; drowsiness; lightheadedness; serotonin syndrome w/ MAOIs (not be given
dizziness; sweating; dysphoria; euphoria. concurrently or w/in 14 days of their
Respiratory depression; circulatory failure; discontinuation), serotonin agonists, serotonin
hypotension; deepening coma; anaphylactic reuptake inhibitors, sibutramine, TCAs.
reactions.
DI: May potentiate effects of TCAs; increased risk
of serotonin syndrome w/ serotonergic drugs; risk
of cardiac arrythmias w/ QT prolonging drugs;
sedative effects may be increased by
N3 - Narcotic Drug Schedule 3
metoclopramide; antagonises efficacy of diuretics;
morphine levels decreased by rifampicin. CODEINE
Increased CNS depression w/ other CNS (ANTITUSSIVE/ANALGESIC)
depressants (e.g. other opioids, general
anaesthetics, benzodiazepines, barbiturates),
alcohol. Risk of severe hypotension w/ MAOIs. 
⌦
PETHIDINE I: Cough suppressant. Mild to moderate pain.
CI: Resp depression, obstructive airway disease,
asthma. Acute alcoholism, convulsive disorders,
⌦ head injuries, comatose patients, raised
intracranial pressure. Pregnancy (prolonged use
 or high doses at term).
I: Adjunct to anaesthesia. Moderate to severe acute SP: Hypothyroidism, adrenocortical insufficiency;
pain. Obstetric analgesia. Postoperative pain. asthma, impaired hepatic or renal function,
Preoperative medication. prostatic hyperplasia, hypotension, shock,
SP: May impair ability to drive or operate inflammatory or obstructive bowel disorders,
machinery. Hypovolaemia, CV disease; adrenal myasthenia gravis. Infants, neonates; Reduce dose
insufficiency; biliary tract disorder; CNS depression in elderly or debilitated patients. May impair ability
or coma; history of drug abuse or acute alcoholism; to drive or operate machinery. Lactation.
head injury, intracranial lesions, elevated AR: Dependence, withdrawal symptoms; nausea,
intracranial pressure; hepatic or renal impairment; vomiting, constipation; drowsiness, confusion;
morbidly obese; prostatic hyperplasia; toxic difficulty in micturition, ureteric or biliary spasms,
psychoses; pre-existing resp compromise (hypoxia urinary retention; dry mouth, dizziness, sweating,
and/or hypercapnia), COPD or other obstructive facial flushing, headache, vertigo, bradycardia,
airway disease; sickle-cell disease; supraventricular tachycardia, palpitations, orthostatic hypotension,
tachycardia; thyroid dysfunction. Elderly & debilitated hypothermia, restlessness, mood changes,
patients. Withdraw gradually. Pregnancy (avoid decreased libido or potency, hallucination, miosis;
prolonged use or high doses at term) & lactation. raised intracranial pressure, muscle rigidity. Resp
AR: Hypotension; fatigue, drowsiness, dizziness, depression & hypotension, w/ circulatory failure &
nervousness, headache, restlessness, malaise, deepening coma (larger doses). Convulsions
confusion, depression, hallucinations, tremors, (especially in child & infants). Rhabdomyolysis.
muscle twitches, increased intracranial pressure, DI: Enhanced depressant effects w/ alcohol,
seizure, serotonin syndrome; rash, urticaria; anaesthetics, anxiolytics, hypnotics, TCAs,


Registration expired

Pink Pages_2010_Tip.pmd 60 7/4/2553, 09:28


PN DEX 2010 IMPORTANT DRUG NOTES 61
antipsychotics. Possible CNS depression or
excitation w/ MAOIs. May alter effects of other OPIUM TINCTURE /
compounds e.g. cyclizine, mexiletine, cisapride, CAMPORATED OPIUM TINCTURE
metoclopramide & domperidone.

⊗ 
DEXTROPROPOXYPHENE
I: Cough suppressant.
CI: Severe hepatic & renal diseases; raised
intracranial pressure; acute resp depression or
⌦ obstructive airways disease; comatose patients;
prolonged use or high dosages near term.
I: Mild to moderate pain.
SP: Hepatic or renal diseases; head injury, CNS
CI: Hypersensitivity, chronic resp diseases, depression, history of opioid agonist dependence;
porphyria, pregnancy. Patients on MAOI treatment biliary tract or acute abdominal disorders; Addison’
or w/in 2 wk of stopping treatment. s disease; obesity; urinary difficulties; resp
SP: Suicidal patients, hepatic or renal disease; disease; thyroid disease; infants<3 mths,
lactation, elderly. debilitated patients & elderly; pregnancy.
AR: Dizziness, sedation, weakness; nausea, AR: CNS depression, hypotension, drowsiness &
vomiting, constipation; rash, urticaria; visual palpitation, bradycardia; sweating, flushing,
disturbances; physiological dependence. pruritis; malaise; urinary tract spasm & reduction
Convulsions in long-term therapy. Cardiac in urination; constipation; miosis. Severe resp
conduction abnormalities & arrhythmias; liver depression; increased intracranial pressure.
impairment. DI: Increased CNS depression w/ alcohol, other
DI: Inhibits hepatic metabolism of benzo- opiate agonists, general anesthetics, tranquillizers,
diazepines, b-blockers, carbamazepine, phenytoin sedatives & hypnotics. However, some
& warfarin. Increased risk of toxicity when co- tranquillizers e.g. phenothiazines may antagonize
administered w/ ritonavir. Potentiation of the effect of opiate analgesia; opium prep may
depressant effects when used w/ alcohol or CNS increase the effect of TCA & MAOIs. Reduced
depressants. Accidental or intentional overdosage effectiveness of diuretics in patients w/ CHF.
fatal (especially if combined w/ alcohol, & Should not be given to patients bitten by
analgesics e.g. paracetamol & aspirin). Centruroides sculpturatus, Ewing & C. gertschi
Stahnke scorpions as opiate agonist may potentiate
the effect of the venoms. May cause serotonin
syndrome if used w/ MAOIs.
DIPHENOXYLATE

⌫⌫
 ⌫
I: Acute diarrhoea. Chronic diarrhoea.
CI: Infants & child <4 yr. Jaundice, intestinal
obstruction. Diarrhoea associated w/
pseudomembranous colitis or enterotoxin-
producing bacteria.
SP: Hepatic dysfunction, inflammatory bowel
disease. Pregnancy, lactation; young children.
AR: GI effects; headache, drowsiness, dizziness,
restlessness, euphoria, depression, numbness of
the extremities; hypersensitivity reactions,
swelling of the gums.
DI: Potentiates effects of other CNS depressants
(alcohol, barbiturates) & some anxiolytics.
Theoretical hypertensive crisis w/ MAOIs.

Registration expired

Pink Pages_2010_Tip.pmd 61 7/4/2553, 13:01


Color profile: Disabled
Composite 150 lpi at 45 degrees

CONTROLLED SUBSTANCE CLASS


´Ñª¹ÕàÀÊѪÀѳ±ì¨Ñ´àÃÕ§µÒÁ¡ÅØèÁ/»ÃÐàÀ·¢Í§·ÐàºÕ¹

P2 Ketamine HCl Pseudoephedrine HCl


Calypsol 50 mg/mL x 10 mL 641 Pseudoephedrine
Keta-Hameln Asian Pharm 30 mg 143
50 mg/mL x 10 mL 642 Pseudoephedrine
Buprenorphine HCl Ketalar 50 mg/mL x 10 mL 643 Asian Pharm 60 mg 047
Buprine 0.2 mg 002 Pseudoephedrine
Temgesic 0.2 mg 007 BJ Benjaosoth 60 mg 135
Temgesic Pseudoephedrine
0.3 mg/mL x 1 mL 619
Lormetazepam Medicine Products 60 mg 184
Loramet 1 mg 102 Pseudoephedrine
Milano 30 mg 136
Pseudoephedrine
D-Norpseudoephedrine Methylphenidate HCl
Milano 60 mg 045
Pseudoephedrine Syrup
HCl Concerta 18 mg 169 Asian Pharm
Mirapront N 20 mg 504 Concerta 36 mg 114 30 mg/5 mL x 60 mL 518
Methylphenidate Pseudoephedrine Syrup
Hexal 10 mg 117 BJ Benjaosoth
Ritalin 10 mg 041 30 mg/5 mL x 60 mL 523
D-Norpseudoephedrine Rubifen 10 mg 038 Pseudoephedrine Syrup
Resinate Milano 30 mg/5 mL x 60 mL 547
D-Norpseudoephedrine SR
Osmopharm 20 mg 505
Midazolam
Dormicum
5 mg/mL x 1 mL 621 Temazepam
Diethylpropion HCl Dormicum 15 mg 351 Euhypnos 20 20 mg 398
Dietil Retard 75 mg 084 Dormicum
Prefamone 75 mg 174 15 mg/3 mL x 3 mL 622
Regenon Retard 75 mg 115
Regenon Retard 75 mg 486
Triazolam
Nitrazepam Halcion 0.25 mg 350
Alodorm 5 mg 078 Trialam 0.25 mg 168
Diethylpropion Resinate Mogadon 5 mg 081 Trycam 0.25 mg 348
Atractil 75 mg 497 Nitrados 5 mg 062

Phentermine HCl Zolpidem Tartrate


Ephedrine HCl Stilnox 10 mg 110
Ephedrine GPO Panbesy 15 mg 425
30 mg/mL x 1 mL 604 Panbesy 30 mg 461
Phentermine
Osmopharm 15 mg 451

Flunitrazepam P3
Rohypnol 1 mg 394
Phentermine Resinate
Duromine 15 mg 499
Duromine 30 mg 488
Flurazepam Phentermine Trenker 15 mg 466 Amobarbital
Dalmadorm 15 mg 478 Phentermine Trenker 30 mg 424 Ama† 50 mg 144

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 CONTROLLED SUBSTANCE CLASS 63


Pentazocine Prazol 0.5 mg 234 Clonazepam

CONTROLLED SUBSTANCE CLASS


Pangon Siampraxol 0.25 mg 098 Clonaril 1 mg 342
30 mg/mL x 1 mL 607 Siampraxol 0.5 mg 243 Povanil 0.5 mg 186
Sosegon Xanacine 0.25 mg 091 Povanil 2 mg 067
30 mg/mL x 1 mL 624 Xanacine 0.5 mg 236 Prenarpil 0.5 mg 407
Xanacine 1 mg 284 Prenarpil 1 mg 337
Xanax 0.25 mg 096 Prenarpil 2 mg 054
Xanax 0.5 mg 240 Rivotril 0.5 mg 408
Pentobarbital Na Xanax 1 mg 287 Rivotril 2 mg 055
Nembutal Xanax XR 0.5 mg 344
50 mg/mL x 20 mL 639 Xanax XR 1 mg 069
Xanax XR 2 mg 353
Xiemed 0.25 mg 108 Clorazepate
Xiemed 0.5 mg 249
Xiemed 1 mg 296
Dipotassium
P4 Zolam 0.25 mg 093
Cloraxene 5 5 mg 436
Cloraze 5 mg 433
Zolam 0.5 mg 237
Deda 5 mg 437
Zolam 1 mg 285
Deda 10 mg 265
Alprazolam Dipot 5 mg 432
Alcelam 0.25 mg 097 Polizep 5 mg 444
Alcelam 0.5 mg 241 Pomadom 10 mg 423
Alcelam 1 mg 288 Bromazepam Tenmed 5 mg 440
Allam 0.25 mg 103 Lexotan 1.5 mg 070 Tenmed 10 mg 269
Allam 0.5 mg 250 Lexotan 3 mg 228 Trancap 5 mg 470
Allam 1 mg 293 Trancon 5 mg 456
Alpralan 0.25 mg 042 Tranmed 5 mg 428
Alpralan 0.5 mg 214 Tranpate 5 mg 416
Alpramed 0.25 mg 252 Tranxene 5 mg 438
Alpramed 0.5 mg 105
Chlordiazepoxide HCl
Benpine 5 mg 412
Alpramed 1 mg 393
Benpine 10 mg 498
Alprax 0.25 mg 156
Benpine 25 mg 194
Alprazolam Frx 0.5 mg 256
Cebarax† 5 mg 380 Diazepam
Anax 0.25 mg 085 A-Zerax 2 mg 453
Chlordiazepoxide
Anax 0.5 mg 230 A-Zerax 5 mg 463
March Pharma 25 mg 467
Anpress 0.25 mg 088 Diamed 2 mg 503
Chlordiazepoxide
Anpress 0.5 mg 248 Diamed 5 mg 482
T Man 10 mg 373
Anpress 1 mg 282 Diano 2 mg 015
Chlordixide 5 mg 358
Dizolam 0.25 mg 089 Diano 5 mg 140
Chlordixide 10 mg 195
Dizolam 0.5 mg 233 Diapam 2 mg 369
Comoben 5 mg 362
Dizolam 1 mg 297 Diapam 5 mg 329
Comoben 10 mg 491
Inzolam 0.25 mg 104 Diapine 2 mg 010
Cozep 10 mg 138
Inzolam 0.5 mg 251 Diapine 2 mg 473
Cozep 25 mg 181
Inzolam 1 mg 294 Diapine 5 mg 166
Dirax† 5 mg 385
Manex 0.25 mg 099 Diapine 5 mg 484
Kenspa† 5 mg 223
Manex 0.5 mg 244 † Diapine
Librax 5 mg 381
Manex 1 mg 291 5 mg/mL x 1 mL 600
Metaxide 10 mg 481
Marzolam 0.25 mg 090 Diapine 10 mg 386
Minoxide 10 mg 477
Marzolam 0.5 mg 235 Diapine
Modurax† 5 mg 377
Marzolam 1 mg 283 10 mg/2 mL x 2 mL 601
Pondnebium 5 mg 371
Mitranax 0.25 mg 106 Diazepam
Tumax† 5 mg 400
Mitranax 0.5 mg 253 BJ Benjaosoth 2 mg 050
Zepoxide 10 mg 279
Mitranax 1 mg 295 Diazepam
Moxinax 0.25 mg 094 BJ Benjaosoth 5 mg 374
Moxinax 0.5 mg 238 Diazepam
Pharnax 0.25 mg 101 BJ Benjaosoth 10 mg 222
Pharnax 0.5 mg 247 Clobazam Diazepam
Pharnax 1 mg 292 Frisium 5 mg 043 General Drugs House 2 mg 318
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Color profile: Disabled
Composite 150 lpi at 45 degrees

64 CONTROLLED SUBSTANCE CLASS PN DEX 2010


Diazepam V Day Zepam NL Phenobarbital Na
CONTROLLED SUBSTANCE CLASS

General Drugs House 5 mg 148 10 mg/2 mL x 2 mL 617 Gardenal


Diazepam GPO 2 mg 052 Vason 2 mg 396 200 mg/4 mL 638
Diazepam GPO 5 mg 149 Vescopam †
Neuramizone
Diazepam GPO 10 mg 334 10 mg/2 mL x 2 mL 636 20 mg 403
Diazepam GPO Vispam 10 mg 323 Phenobarbital
10 mg/2 mL x 2 mL 603 Vorapam 2 mg 064 Atlantic 32.5 mg 011
Diazepam Vorapam 5 mg 159 Phenobarbital
H K Pharm 2 mg 218 Zepaxid 2 mg 506 Atlantic 65 mg 012
Diazepam Zepaxid 5 mg 462 Phenobarbital
H K Pharm 5 mg 160 Zepaxid Atlantic 100 mg 277
Diazepam 10 mg/2 mL x 2 mL 634 Phenoco Elixir
H K Pharm 10 mg 343 Zopam 2 mg 048 20 mg/5 mL x 450 mL 584
Diazepam Phenotal Elixir
Zopam 5 mg 145
Lerd Singh 2 mg 066 Zopam 10 mg 20 mg/5 mL x 60 mL 517
331
Diazepam
Lerd Singh 5 mg 161
Diazepam
Pinazepam
Pond’s Chemical 2 mg 367
Domar 5 mg 464
Diazepam Lorazepam
Pond’s Chemical 5 mg 216 Anta 0.5 mg 304
Diazepam T Man 2 mg 364 Anta 1 mg 020
211 Anta 2 mg 125
Diazepam T Man 5 mg Prazepam
Diazepam T P Drug Anxira 0.5 mg 300
Pozapam 5 mg 459
10 mg/2 mL x 2 mL 627 Anxira 1 mg 022
Pozapam 10 mg 175
Diazepam Vesco 2 mg 325 Hawkcopax 0.5 mg 321
Diazepam Vesco 5 mg 134 Kemora 0.5 mg 411
Ditran 2 mg 418 Kemora 1 mg 024
Ditran 5 mg 476 Lonza 0.5 mg 313 Tofisopam
Divopan 2 mg 049 Lonza 1 mg 019 Grandaxin 50 mg 051
Divopan 5 mg 146 Lora 0.5 mg 368
Dizep 2 mg 171 Lora 1 mg 036
Lora 2 mg 217
Dizep 5 mg 190
Loramed 2 mg 210
Dizepam 2 mg 224
Dizepam 5 mg 151
Loravan 0.5 mg
Loravan 1 mg
302
027
N2
Manodiazo 2 mg 469
Lorazep 0.5 mg 309
Manodiazo 5 mg 502
Lorazep 1 mg 003
Manodiazo 10 mg 335 Codeine Phosphate
Lorazep 2 mg 357
Manolium
10 mg/2 mL x 2 mL 613
Lorazin 0.5 mg 324 (Analgesic)
Lorazin 1 mg 044 Codeine GPO 15 mg 004
Monozide-10
Lorazin 2 mg 227 Codeine GPO 30 mg 018
10 mg/2 mL x 2 mL 632
Ora 0.5 mg 310
Ropam
Ora 1 mg 030
10 mg/2 mL x 2 mL 608
Tranavan 0.5 mg 307
Sipam 2 mg 056 Fentanyl
Tranavan 1 mg 034
Sipam 5 mg 154 Durogesic
Zeda 0.5 mg 014
Sipam 10 mg 339 25 mcg/hr x 2.5 mg 651
Zeda 1 mg 360
Sipam Durogesic
Zora 0.5 mg 328
10 mg/2 mL x 2 mL 626 Zora 2 mg 179 50 mcg/hr x 5 mg 652
Tranolan 2 mg 130 Durogesic
Tranolan 5 mg 177 100 mcg/hr x 10 mg 653
Tranolan Fentanyl GPO
10 mg/2 mL x 2 mL 615 12 mcg/hr 645
V Day Zepam 2 mg 475 Medazepam Fentanyl GPO
V Day Zepam 5 mg 465 Celium 5 mg 397 25 mcg/hr 646
V Day Zepam Medazine 5 mg 487 Fentanyl GPO
10 mg/2 mL x 2 mL 616 Medazine 10 mg 483 50 mcg/hr 647

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 CONTROLLED SUBSTANCE CLASS 65


Fentanyl Hexal Pethidine M & H Manufacturing Codeine Phosphate

CONTROLLED SUBSTANCE CLASS


12 mcg/hr 648 50 mg/mL x 1 mL 611
Fentanyl Hexal Pethidine M & H Manufacturing
(Antitussive)

25 mcg/hr 649 Bluco 10 mg 355
100 mg/2 mL x 2 mL 612 †
Fentanyl Hexal Bronpect 10 mg 298
Pethidine T.P. Drug †
50 mcg/hr 650 Centrodine CD 10 mg 225
50 mg/mL x 1 mL 631
Clinopront† 10 mg 378
Co-Cof† 10 mg 165

Codee-C 10 mg 388
Fentanyl Citrate †
Codepect 10 mg 202
Fentanyl Antigen †
Codesia 10 mg 391
0.05 mg/mL x 2 mL 598 N3 Codesia

Fentanyl Antigen 10 mg/5 mL x 60 mL 516
0.05 mg/mL x 10 mL 599 Codyl Cough †
Fentanyl Janssen-Cilag 9 mg/5 mL x 60 mL 540
0.05 mg/mL x 2 mL 605 Camphorated Opium Codyl Cough

Fentanyl Janssen-Cilag Tinct 9 mg/5 mL x 100 mL 541
0.05 mg/mL x 10 mL 606 Brown Mixture GPO† Decos† 9 mg/5 mL x 100 mL 572
Fentanyl Sandoz †
0.6 mL/5 mL x 180 mL 527 Mila-Tercon 8 mg 167
0.05 mg/mL x 2 mL 623 Brown Mixture GPO† Neopect† 10 mg 199
Fentanyl Sandoz †
0.6 mL/5 mL x 450 mL 528 Nordyl Linctus
0.05 mg/mL x 10 mL 644 Brown Mixture Osoth Interlab† 9 mg/5 mL x 100 mL 566

0.6 mL/5 mL x 180 mL 554 Phencodin

Mist Tussis 9 mg/5 mL x 60 mL 586
0.6 mL/5 mL x 450 mL 590 Phensedyl†
Methadone HCl Mist. Scill Ammon. GPO

9 mg/5 mL x 100 mL 553
Methadone GPO 5 mg 126
0.6 mL/5 mL x 180 mL 531 Poly-Cof Syrup†
Methadone GPO †
Mixture Tussis 9 mg/5 mL x 60 mL 548
10 mg/mL x 1000 mL 596
0.45 mL/5 mL x 30 mL 574 Poly-Cof Syrup†
Mixture Tussis† 9 mg/5 mL x 100 mL 549
0.45 mL/5 mL x 60 mL 575 Pondnadyl†
Mixture Tussis† 9 mg/5 mL x 60 mL 563
Morphine Sulfate Pondnadyl†
0.45 mL/5 mL x 120 mL 576
Kapanol 20 mg 119
Mixture Tussis† 9 mg/5 mL x 100 mL 564
Kapanol 50 mg 120 †
0.45 mL/5 mL x 240 mL 577 Rolar 10 mg 203
Kapanol 100 mg 121
Mixture Tussis† Ropect† 10 mg 201
Morphine Sulfate Inj Blue
0.45 mL/5 mL x 450 mL 578 Rotuss† 10 mg 204
10 mg/mL x 1 mL 609
Squill and Ammonia Mixture† †
Seco 10 mg 389
Morphine Sulfate Inj Purple †
1.3 mL/10 mL x 450 mL 591 Terco-C 10 mg 387
10 mg/mL x 1 mL 610
Tussidyl†
Morphine T.P. Drug
9 mg/5 mL x 60 mL 589
10 mg/mL x 1 mL 628
Morphine T.P. Drug
10 mg/mL x 1 mL 629 Codeine Phosphate
Morphine T.P. Drug (Analgesic) Codeine Resinate

10 mg/mL x 1 mL 630 Codicet 15 mg 414 Codipront† 30 mg 494
MST Continus 10 mg 406 Codicet Blue† 15 mg 352

MST Continus 30 mg 278 Codigesic 15 mg 112

MST Continus 60 mg 183 Masapara With Codeine
Oramorph 15 mg

410 Diphenoxylate HCl
10 mg/5 mL x 250 mL 594 Nasa With Codeine Lomotil† 2.5 mg 006
Oramorph 15 mg 080 Spasil† 2.5 mg 009
20 mg/mL x 30 mL 595 Para-Co 15 mg 347
Paradeine† 15 mg 074
Parcono† 8 mg 079
Tylenol With Codeine† Opium Tinct
Pethidine HCl 15 mg 075 Camphorated Opium Tincture

Pethidine Biolab Tylenol With Codeine† BP 1980
100 mg/2 mL x 2 mL 602 30 mg 076 5 mL/100 mL x 1000 mL 529
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\ControlSubstanceClass_Index.vp
Monday, April 05, 2010 1:45:06 PM
Color profile: Disabled
Composite 150 lpi at 45 degrees

MANUFACTURER'S INDEX
´Ñª¹ÕàÀÊѪÀѳ±ì¨Ñ´àÃÕ§µÒÁª×èͼÙé¼ÅÔµ
2M (MED-MAKER) Dipot 5 mg 432 BANGKOK LAB & COSMETIC
2 àÍçÁ (àÁ´-àÁà¡ÍÃì) Lorazep 0.5 mg 309 ºÒ§¡Í¡áÅç»á͹´ì¤ÍÊàÁµÔ¤
Lorazep 1 mg 003 †
Anpress 0.25 mg 088 Clinopront 10 mg 378
Lorazep 2 mg 357 †
Anpress 1 mg 282 Codigesic 15 mg 112
Phenotal Elixir
Xiemed 0.5 mg 249
20 mg/5 mL x 60 mL 517

3M PHARMA/FDA BARD/FDA
3 àÍçÁ ¿ÒÃìÁÒ/ÍÂ. ASIAN PHARM/FDA ºÒÃì´/ÍÂ.
Duromine 15 mg 499
àÍàªÕ蹿ÒÃìÁÒ«ÙµÔ¤ÑÅ/ÍÂ. MST Continus 10 mg 406
Duromine 30 mg 488 Pseudoephedrine MST Continus 30 mg 278
Asian Pharm 30 mg 143 MST Continus 60 mg 183
Pseudoephedrine
Asian Pharm 60 mg 047
A N H PRODUCTS
àÍ àÍç¹ àͪ â»Ã´Ñ¤Êì Pseudoephedrine Syrup
Asian Pharm BIOLAB/FDA
Comoben 5 mg 362 30 mg/5 mL x 60 mL 518 äºâÍáÅ»/ÍÂ.
Comoben 10 mg 491 Pethidine Biolab
Divopan 2 mg 049 100 mg/2 mL x 2 mL 602
Divopan 5 mg 146
ATLANTIC LAB
á͵ᏵԤ
ALPHAPHARM/FDA Ama† 50 mg 144 BJ BENJAOSOTH
ÍÑÅ¿Ò¿ÒÃìÁ/ÍÂ. Benpine 5 mg
Benpine 10 mg
412
498
ºÕਠ(ອ¨âÍʶ)
Alodorm 5 mg 078 Diazepam BJ Benjaosoth
Benpine 25 mg 194
Trialam 0.25 mg 168 2 mg 050
Diapine 2 mg 010
Diazepam BJ Benjaosoth
Diapine 2 mg 473
5 mg 374
Diapine 5 mg 166
Diazepam BJ Benjaosoth
ALZA CORP/FDA Diapine 5 mg 484
ÍÑÅ«Ò ¤ÍÃìà»ÍàêÑè¹/ÍÂ. Diapine 5 mg/mL x 1 mL
Diapine 10 mg
600
386
10 mg
Minoxide 10 mg
222
477
Concerta 18 mg 169
Diapine 10 mg/2 mL x 2 mL 601
Concerta 36 mg 114
Dizolam 0.25 mg 089
Dizolam 0.5 mg 233 BJ BENJAOSOTH/FDA
ANTIGEN/FDA
Dizolam 1 mg
Lora 0.5 mg
297
368 ºÕਠ(ອ¨âÍʶ)/ÍÂ.
á͹µÔਹ/ÍÂ. Lora 1 mg 036 Pseudoephedrine
Lora 2 mg 217 BJ Benjaosoth 60 mg 135
Fentanyl Antigen
Phenobarbital Atlantic Pseudoephedrine Syrup
0.05 mg/mL x 2 mL 598
32.5 mg 011 BJ Benjaosoth
Fentanyl Antigen
Phenobarbital Atlantic 30 mg/5 mL x 60 mL 523
0.05 mg/mL x 10 mL 599
65 mg 012
Phenobarbital Atlantic
100 mg 277
ASIAN PHARM BOEHRINGER
àÍàªÕ蹿ÒÃìÁÒ«ÙµÔ¤ÑÅ INGELHEIM/FDA
A-Zerax 2 mg 453 B L HUA àºÍÃÔ§à¡ÍÃì ÍÔ¹à¡ÅäÎÁì/ÍÂ.
A-Zerax 5 mg
Codesia† 10 mg
463
391 ºÕ àÍçÅ ÎÑéÇ Oramorph
10 mg/5 mL x 250 mL 594
Codesia† Codicet† 15 mg 414 Oramorph
10 mg/5 mL x 60 mL 516 Terco-C† 10 mg 387 20 mg/mL x 30 mL 595

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 MANUFACTURER'S INDEX 67


BRITISH DISPENSARY GLAXOSMITHKLINE/FDA HAMELN/FDA
Íѧ¡ÄɵÃÒ§Ù (áÍÅ ¾Õ) á¡Åç¡â«ÊÁÔ·ä¤Åì¹/ÍÂ. ÎÒàÁŹ/ÍÂ.
Zeda 0.5 mg 014 Kapanol 20 mg 119 Keta-Hameln
Zeda 1 mg 360 Kapanol 50 mg 120 50 mg/mL x 10 mL 642
Kapanol 100 mg 121

CARDINAL HEALTH
AUSTRALIA HEXAL AG/FDA
¤ÒÃì´Ô¹ÑÅ àÎÅ·ì ÍÍÊàµÃàÅÕ GPO àΡ«ÒÅ àͨÕ/ÍÂ.
Ropect† 10 mg

201 ͧ¤ì¡ÒÃàÀÊѪ¡ÃÃÁ Fentanyl GPO 12 mcg/hr 645
Rotuss 10 mg 204 Brown Mixture GPO† Fentanyl GPO 25 mcg/hr 646
Fentanyl GPO 50 mcg/hr 647
0.6 mL/5 mL x 180 mL 527
† Fentanyl Hexal 12 mcg/hr 648
Brown Mixture GPO
Fentanyl Hexal 25 mcg/hr 649
CEVA ANIMAL HEALTH 0.6 mL/5 mL x 450 mL 528
«ÕÇÒ á͹ÔÁÍÅ àÎÅì· Camphorated Opium Tincture
BP 1980

Fentanyl Hexal 50 mcg/hr 650

Nembutal
5 mL/100 mL x 1000 mL 529
50 mg/mL x 20 mL 639
Diazepam GPO 2 mg 052
Diazepam GPO 5 mg 149 INPAC PHARMA
Diazepam GPO 10 mg 334 ÍԹᾤ¿ÒÃìÁÒ
CHAROEN BHAESAJ Diazepam GPO
à¨ÃÔ­àÀÊѪ
Inzolam 0.25 mg 104
10 mg/2 mL x 2 mL 603 Inzolam 0.5 mg 251
Mist. Scill Ammon. GPO†

MANUFACTURER'S INDEX
† Inzolam 1 mg 294
Paradeine 15 mg 074
0.6 mL/5 mL x 180 mL 531 Lorazin 0.5 mg 324
Lorazin 1 mg 044
Lorazin 2 mg 227
DEXO/FDA Tenmed 5 mg 440
à´¤â«/ÍÂ. GPO/FDA Tenmed 10 mg 269
Prefamone 75 mg 174 ͧ¤ì¡ÒÃàÀÊѪ¡ÃÃÁ/ÍÂ.
Codeine GPO 15 mg 004
Codeine GPO 30 mg 018 INTERTHAI
DOUGLAS/FDA
´Ñ¡ÅÒÊ/ÍÂ.
Ephedrine GPO
30 mg/mL x 1 mL 604
ÍÔ¹àµÍÃìä·Â
126 Tranxene 5 mg 438
Nitrados 5 mg 062 Methadone GPO 5 mg
Methadone GPO
Trycam 0.25 mg 348
10 mg/mL x 1000 mL 596

JANSSEN-CILAG/FDA
EGIS
ÍÕ¨ÕÊ á¨¹à«è¹-«ÕáÅ¡/ÍÂ.
GREATER PHARMA Durogesic
Grandaxin 50 mg 051
à¡Ãê·àµÍÃì¿ÒÃìÁèÒ 25 mcg/hr x 2.5 mg
Durogesic
651
Diapam 2 mg 369
50 mcg/hr x 5 mg 652
Diapam 5 mg 329
GEDEON RICHTER/FDA Durogesic
¡Õà´Õ¹ ÃÔªàµÍÃì/ÍÂ. 100 mcg/hr x 10 mg
Fentanyl Janssen-Cilag
653

Calypsol 50 mg/mL x 10 mL 641 0.05 mg/mL x 2 mL 605


H K PHARM Fentanyl Janssen-Cilag

GENERAL DRUGS HOUSE


àͪ ठ¿ÒÃìÁÒ«ÙµÔ¤ÍÅ 0.05 mg/mL x 10 mL 606

à¹à¹ÍÃìÃÒÅ´ÃÑê¡ÊìàÎéÒÊì Allam 0.25 mg


Allam 0.5 mg
103
250
Diazepam Allam 1 mg 293 KENYAKU
General Drugs House 2 mg
Diazepam
318 Deda 5 mg
Deda 10 mg
437
265 हÂÒ¡Ø

General Drugs House 5 mg 148 Diazepam H K Pharm 2 mg 218 Bronpect 10 mg 298
Zora 0.5 mg 328 Diazepam H K Pharm 5 mg 160 Kenspa† 5 mg 223
Zora 2 mg 179 Diazepam H K Pharm 10 mg 343 Prazol 0.5 mg 234
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

68 MANUFACTURER'S INDEX PN DEX 2010


LBS Marzolam 0.5 mg 235 MILANO
áÍÅ ºÕ àÍÊ áźºÍàõÍÃÕè Marzolam 1 mg 283 ÁÔÅÒâ¹
Hawkcopax 0.5 mg 321 Diano 2 mg 015
Pangon 30 mg/mL x 1 mL 607 Diano 5 mg 140

Ropam 10 mg/2 mL x 2 mL 608 MASA LAB Mila-Tercon 8 mg 167
ÁÒ«Òáź †
Parcono 8 mg 079

Cebarax 5 mg 380
LAB RUBIO/FDA Dizepam 2 mg 224
áÅçº ÃÙºÔâÍ/ÍÂ. Dizepam 5 mg

151
MILANO/FDA
Masapara With Codeine
Rubifen 10 mg 038
15 mg

410 ÁÔÅÒâ¹/ÍÂ.
Neopect 10 mg 199 Pseudoephedrine
Ora 0.5 mg 310 Milano 30 mg 136
LERD SINGH Ora 1 mg 030 Pseudoephedrine
àÅÔÈÊÔ§Ëì Milano 60 mg 045
Alpramed 0.25 mg 252 Pseudoephedrine Syrup
Alpramed 0.5 mg 105 MEDICINE PRODUCTS Milano 30 mg/5 mL x 60 mL 547
Alpramed 1 mg
Chlordixide 5 mg
393
358
àÁ´Ô«Õ¹â»Ã´Ñ¡Êì
Chlordixide 10 mg 195 Lonza 0.5 mg 313
Diazepam Lerd Singh 2 mg 066 Lonza 1 mg 019 MILLIMED
Diazepam Lerd Singh 5 mg 161 Xanacine 0.25 mg
Xanacine 0.5 mg
091
236
ÁÔÅÅÔàÁ´
Xanacine 1 mg 284 Anax 0.25 mg 085
MANUFACTURER'S INDEX

Anax 0.5 mg 230


M & H MANUFACTURING Co-Cof† 10 mg 165
àÍçÁ á͹´ì àÍçª áÁ¹Ùῤà¨ÍÃÔè§ MEDICINE PRODUCTS/FDA
Nasa With Codeine† 15 mg 080
Poly-Cof Syrup†

Bluco 10 mg

Codicet Blue 15 mg
355
352
àÁ´Ô«Õ¹â»Ã´Ñ¡Êì/ÍÂ. 9 mg/5 mL x 60 mL 548
Pseudoephedrine Poly-Cof Syrup†
Medicine Products 60 mg 184 9 mg/5 mL x 100 mL 549
Vason 2 mg 396
M & H MANUFACTURING/FDA
àÍçÁ á͹´ì àÍçª áÁ¹Ùῤà¨ÍÃÔè§/ÍÂ. MEDICPHARMA
Morphine Sulfate Inj Blue
10 mg/mL x 1 mL 609
ÊËá¾·ÂìàÀÊѪ MODERN MANU
Morphine Sulfate Inj Purple Codee-C† 10 mg
Codyl Cough

388 âÁà´ÍÃì¹áÁ¹Ù
10 mg/mL x 1 mL 610 Cloraze 5 mg 433
Pethidine M & H Manufacturing 9 mg/5 mL x 60 mL 540
† Moxinax 0.25 mg 094
50 mg/mL x 1 mL 611 Codyl Cough
9 mg/5 mL x 100 mL 541 Moxinax 0.5 mg 238
Pethidine M & H Manufacturing
100 mg/2 mL x 2 mL 612 Diamed 2 mg 503
Diamed 5 mg 482
Dirax† 5 mg 385
Medazine 5 mg 487 NOVARTIS/FDA
MACK/FDA â¹ÇÒÃìµÕÊ/ÍÂ.
áÁç¤/ÍÂ.
Medazine 10 mg 483
Para-Co 15 mg 347 Ritalin 10 mg 041
Mirapront N 20 mg 504 Prenarpil 0.5 mg 407
Prenarpil 1 mg 337
Prenarpil 2 mg 054
Tranmed 5 mg 428 OLAN-KEMED
MARCH PHARMA
áËÅÁ·Í§¡ÒÃá¾·Âì Zolam 0.25 mg
Zolam 0.5 mg
093
237 âÍÅѹ-à¤ÁàÁ´
Chlordiazepoxide Zolam 1 mg 285 Alpralan 0.25 mg 042
March Pharma 25 mg 467 Alpralan 0.5 mg 214
Manodiazo 2 mg 469 Kemora 0.5 mg 411
Manodiazo 5 mg 502 MEGA LIFESCIENCES Kemora 1 mg 024
Manodiazo 10 mg
Manolium
335
àÁ¡éÒ äÅ¿ìä«áÍ繫ì Loramed 2 mg
Tranolan 2 mg
210
130
10 mg/2 mL x 2 mL 613 Codepect† 10 mg 202 Tranolan 5 mg 177
Marzolam 0.25 mg 090 Rolar† 10 mg 203 Tranolan 10 mg/2 mL x 2 mL 615

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 MANUFACTURER'S INDEX 69


OLIC PHARMASANT LAB ROCHE
âÍÅÔ¤ ¿ÒÃìÁÒÊѹµì áÅçº âê
Alprazolam Frx 0.5 mg 256 Alcelam 0.25 mg 097 Lexotan 1.5 mg 070

Codipront 30 mg 494 Alcelam 0.5 mg 241 Lexotan 3 mg 228
Librax† 5 mg 381 Alcelam 1 mg 288 Rivotril 0.5 mg 408

Lomotil 2.5 mg 006 Anta 0.5 mg 304 Rivotril 2 mg 055

Phensedyl Anta 1 mg 020
9 mg/5 mL x 100 mL 553 Anta 2 mg 125
† †
Tylenol With Codeine 15 mg 075 Centrodine CD 10 mg 225

Tylenol With Codeine 30 mg 076 Cozep 10 mg 138 ROCHE/FDA
Cozep 25 mg 181 âê/ÍÂ.
Pomadom 10 mg 423
Dalmadorm 15 mg 478
OSMOPHARM/FDA Povanil 0.5 mg 186
Dormicum 5 mg/mL x 1 mL 621
ÍÍÊâÁ¿ÒÃìÁ/ÍÂ. Povanil 2 mg
Pozapam 5 mg
067
459
Dormicum 15 mg 351
D-Norpseudoephedrine SR Dormicum 15 mg/3 mL x 3 mL 622
Pozapam 10 mg 175
Osmopharm 20 mg 505 Mogadon 5 mg 081
Zopam 2 mg 048
Panbesy 15 mg 425 Rohypnol 1 mg 394
Zopam 5 mg 145
Panbesy 30 mg 461 Zopam 10 mg 331
Phentermine
Osmopharm 15 mg 451
ROSEMONT PHARM

POLIPHARM
âÃÊÁ͹·ì ¿ÒÃìÁ

OSOTH INTERLAB â»ÅÔ¿ÒÃìÁ Nordyl Linctus
âÍʶÍÔ¹àµÍÃì

MANUFACTURER'S INDEX
9 mg/5 mL x 100 mL 566
Domar 5 mg 464

Brown Mixture Osoth Interlab Mitranax 0.25 mg 106
0.6 mL/5 mL x 180 mL 554 Mitranax 0.5 mg 253
Mitranax 1 mg 295 SALUTAS PHARMA/FDA
Polizep 5 mg
Tranavan 0.5 mg
444
307
«ÒÅÙ·ÑÊ ¿ÒÃìÁÒ/ÍÂ.
P P LAB
¾Õ ¾Õ áźÍÃÒµÍÃÕèÊì
Methylphenidate Hexal 10 mg 117
Tranavan 1 mg 034

V Day Zepam 2 mg 475


V Day Zepam 5 mg 465
V Day Zepam SANDOZ CANADA/FDA
POND’S CHEMICAL
᫹´ÍÊ á¤¹Ò´Ò/ÍÂ.
¾Í¹´ìà¤ÁÕ¤ÍÅ
10 mg/2 mL x 2 mL 616
V Day Zepam NL Fentanyl Sandoz
10 mg/2 mL x 2 mL 617 Diazepam 0.05 mg/mL x 2 mL 623
Pond’s Chemical 2 mg 367 Fentanyl Sandoz
Diazepam 0.05 mg/mL x 10 mL 644
PARKE-DAVIS/FDA Pond’s Chemical 5 mg 216
¾ÒÃì¤à´ÇÔÊ/ÍÂ.

Pondnadyl
9 mg/5 mL x 60 mL 563
Ketalar 50 mg/mL x 10 mL 643 Pondnadyl† SANOFI-AVENTIS
9 mg/5 mL x 100 mL
Pondnebium 5 mg
564
371
«Ò⹿Õè-ÍàǹµÕÊ
Frisium 5 mg 043
PFIZER
ä¿à«ÍÃì Gardenal 200 mg/4 mL 638

Xanax 0.25 mg 096 R P SCHERER/FDA


Xanax 0.5 mg
Xanax 1 mg
240
287 ÍÒÃì ¾Õ àªÍàÃÍÃì/ÍÂ. SANOFI-SYNTHELABO
Xanax XR 0.5 mg 344 Euhypnos 20 20 mg 398 «Ò⹿Õè-«Ô¹àµÅÒâº
Xanax XR 1 mg 069
Sosegon 30 mg/mL x 1 mL 624
Xanax XR 2 mg 353

RECKITT BENCKISER/FDA
PHARMACIA/FDA àá¤Ô··ì ູ¤Õà«ÍÃì/ÍÂ. SANOFI-WINTHROP/FDA
¿ÒÃìÁÒà«ÕÂ/ÍÂ. Temgesic 0.2 mg 007 «Ò⹿Õè-ÇÔ¹·ÃÍ»/ÍÂ.
Halcion 0.25 mg 350 Temgesic 0.3 mg/mL x 1 mL 619 Stilnox 10 mg 110
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

70 MANUFACTURER'S INDEX PN DEX 2010


SIAM BHEASACH Phenoco Elixir UDOMPHON (PHIHALAB)
ÊÂÒÁàÀÊѪ 20 mg/5 mL x 450 mL 584 ÍØ´Á¾Ã (¿ÕÎÒáÅçº)
Siampraxol 0.25 mg 098 Metaxide 10 mg 481
Siampraxol 0.5 mg 243 Zepaxid 2 mg 506
Sipam 2 mg 056 T P DRUG Zepaxid 5 mg 462
Sipam 5 mg
Sipam 10 mg
154
339
·Õ ¾Õ ´ÃÑ¡ Zepaxid 10 mg/2 mL x 2 mL 634

Sipam 10 mg/2 mL x 2 mL 626 Diazepam T P Drug


10 mg/2 mL x 2 mL 627
Trancap 5 mg 470 UTOPIAN
SIAM BHEASACH/FDA
Zepoxide 10 mg 279
ÂÙâ·à»Õé¹
ÊÂÒÁàÀÊѪ/ÍÂ. Anpress 0.5 mg 248
Buprine 0.2 mg 002 Anxira 0.5 mg 300
T P DRUG/FDA Anxira 1 mg 022
·Õ ¾Õ ´ÃÑ¡/ÍÂ. Celium 5 mg 397
Morphine T.P. Drug Clonaril 1 mg 342
SRIPRASIT PHARMA †
àÀÊѪ¡ÃÃÁÈÃÕ»ÃÐÊÔ·¸Ôì 10 mg/mL x 1 mL
Morphine T.P. Drug
628 Modurax 5 mg
Trancon 5 mg
377
456
† 323
Decos 9 mg/5 mL x 100 mL 572 10 mg/mL x 1 mL 629 Vispam 10 mg
† Xiemed 0.25 mg 108
Neuramizone 20 mg 403 Morphine T.P. Drug
† 296
Seco 10 mg 389 10 mg/mL x 1 mL 630 Xiemed 1 mg

Spasil 2.5 mg 009 Pethidine T.P. Drug
Tumax† 5 mg 400 50 mg/mL x 1 mL 631
MANUFACTURER'S INDEX

V S PHARMA
SUPHONG BHAESAJ ÇÕ àÍÊ ¿ÒÃìÁèÒ
Êؾ§ÉìàÀÊѪ
TEMMLER/FDA
à·ÁàÅÍÃì/ÍÂ. Pharnax 0.25 mg
Pharnax 0.5 mg
101
247
Dizep 2 mg 171
Regenon Retard 75 mg 115 Pharnax 1 mg 292
Dizep 5 mg 190
Regenon Retard 75 mg 486 Phencodin†
Loravan 0.5 mg 302
Loravan 1 mg 027 9 mg/5 mL x 60 mL 586
Mixture Tussis† Tussidyl†
0.45 mL/5 mL x 30 mL 574 THAI P D CHEMICALS 9 mg/5 mL x 60 mL 589
Mixture Tussis†
ä·Â ¾Õ ´Õ à¤ÁÕ¤ÍÅÊì
Vorapam 2 mg 064
0.45 mL/5 mL x 60 mL 575 Vorapam 5 mg 159
Mixture Tussis† Monozide-10
0.45 mL/5 mL x 120 mL 576 10 mg/2 mL x 2 mL 632

Mixture Tussis
0.45 mL/5 mL x 240 mL 577 VESCO PHARM
Mixture Tussis

THAIPHARMED 1942 àÇÊâ¡¿ÒÃìÁÒ«ÙµÔ¤ÍÅ
ËéÒ§ÂÒä·Â 1942
0.45 mL/5 mL x 450 mL 578
Diazepam Vesco 2 mg 325
Diazepam Vesco 5 mg 134
Ditran 2 mg 418 Vescopam 10 mg/2 mL x 2 mL 636
T MAN PHARMA Ditran 5 mg 476
·Õ áÁ¹ ¿ÒÃìÁÒ
Chlordiazepoxide
373 TORRENT VIDHYASOM
ÇÔ·ÂÒÈÃÁ
T Man 10 mg
Diazepam T Man 2 mg
Diazepam T Man 5 mg
364
211
·ÍÃìàù·ì †
Manex 0.25 mg 099 Alprax 0.25 mg 156 Mist Tussis
0.6 mL/5 mL x 450 mL 590
Manex 0.5 mg 244 Squill and Ammonia Mixture†
Manex 1 mg 291 1.3 mL/10 mL x 450 mL 591
Tranpate 5 mg 416 TRENKER/FDA
à·Ã¹à¡ÍÃì/ÍÂ.
T O CHEMICALS Atractil 75 mg 497 WYETH-AYERST/FDA

·Õ âÍ à¤ÁÕ¤ÍÅÊì Dietil Retard 75 mg


Phentermine Trenker 15 mg
084
466 äÇàÍ·-àÍàÂÔÃìÊ·ì/ÍÂ.
Cloraxene 5 5 mg 436 Phentermine Trenker 30 mg 424 Loramet 1 mg 102

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\MNF_Index.vp
Wednesday, March 31, 2010 10:04:03 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

GENERIC & BRAND NAME INDEX


´Ñª¹ÕÃÇÁª×èÍÊÒÁÑ­áÅЪ×èÍ·Ò§¡ÒäéÒ
Registration No. Frame No. Registration No. Frame No.

- Alprazolam Frx
A 0.5 mg P1A 10/51 256
- Anax 0.25 mg P1A 9/46 085
Alcelam 0.25 mg P1A 1/52 097
Alcelam 0.5 mg P1A 23/49 241 - Anax 0.5 mg P1A 10/46 230
Alcelam 1 mg P1A 24/49 288 - Anpress 0.25 mg P1A 33/50 088
Allam 0.25 mg P1A 1/48 103 - Anpress 0.5 mg P1A 4/48 248
Allam 0.5 mg P1A 2/48 250 - Anpress 1 mg P1A 35/50 282
Allam 1 mg P1A 3/48 293 - Anzion 0.25 mg - 086
Alnax 0.25 mg - 087 - Anzion 0.5 mg - 231
Alnax 0.5 mg - 232 - Anzion 1 mg - 280
Alnax 1 mg - 281 - Dizolam 0.25 mg P1A 5/48 089
Alodorm 5 mg - 078 - Dizolam 0.5 mg P1A 15/50 233
Alpazam 0.25 mg - 100 - Dizolam 1 mg P1A 6/48 297
Alpazam 0.5 mg - 245 - Farzolam 0.25 mg - 092
Alpazam 1 mg - 246 - Farzolam 0.5 mg - 242
Alpralan 0.25 mg P1A 51/50 042 - Farzolam 1 mg - 289
Alpralan 0.5 mg P1A 52/50 214 - Inzolam 0.25 mg P1A 58/50 104
Alpramed 0.25 mg P1A 47/50 252 - Inzolam 0.5 mg P1A 59/50 251
Alpramed 0.5 mg P1A 48/50 105 - Inzolam 1 mg P1A 60/50 294
Alpramed 1 mg P1A 7/48 393 - Manex 0.25 mg P1A 36/51 099
Alprax 0.25 mg P1C 1/46 156 - Manex 0.5 mg P1A 21/46 244
Alprax 0.5 mg - 409 - Manex 1 mg P1A 8/47 291
Alprax 1 mg - 057 - Marzolam 0.25 mg P1A 5/47 090
Alprazolam: - Marzolam 0.5 mg P1A 42/52 235
- Alcelam 0.25 mg P1A 1/52 097 - Marzolam 1 mg P1A 43/52 283
- Alcelam 0.5 mg P1A 23/49 241 - Mitranax 0.25 mg P1A 36/50 106
- Alcelam 1 mg P1A 24/49 288 - Mitranax 0.5 mg P1A 37/50 253
- Allam 0.25 mg P1A 1/48 103 - Mitranax 1 mg P1A 38/50 295
- Allam 0.5 mg P1A 2/48 250 - Moxinax 0.25 mg P1A 19/49 094
- Allam 1 mg P1A 3/48 293 - Moxinax 0.5 mg P1A 20/49 238
- Alnax 0.25 mg - 087 - Pharnax 0.25 mg P1A 28/51 101
- Alnax 0.5 mg - 232 - Pharnax 0.5 mg P1A 29/51 247
- Alnax 1 mg - 281 - Pharnax 1 mg P1A 30/51 292
- Alpazam 0.25 mg - 100 - Prazol 0.5 mg P1A 3/51 234
- Alpazam 0.5 mg - 245 - Siampraxol 0.25 mg P1A 6/52 098
- Alpazam 1 mg - 246 - Siampraxol 0.5 mg P1A 7/52 243
- Alpralan 0.25 mg P1A 51/50 042 - Siampraxol 1 mg - 290
- Alpralan 0.5 mg P1A 52/50 214 - Sunax 0.25 mg - 107
- Alpramed 0.25 mg P1A 47/50 252 - Sunax 0.5 mg - 254
- Alpramed 0.5 mg P1A 48/50 105 - Xalam 0.25 mg - 095
- Alpramed 1 mg P1A 7/48 393 - Xalam 0.5 mg - 239
- Alprax 0.25 mg P1C 1/46 156 - Xalam 1 mg - 286
- Alprax 0.5 mg - 409 - Xanacine 0.25 mg P1A 13/48 091
- Alprax 1 mg - 057 - Xanacine 0.5 mg P1A 14/48 236
- Alprazolam Frx - Xanacine 1 mg P1A 15/48 284
0.25 mg - 109 - Xanax 0.25 mg P1C 20/52 096
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

72 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

- Xanax 0.5 mg P1C 21/52 240 Benpine 5 mg P1A 8/49 412


- Xanax 1 mg P1C 22/52 287 Benpine 10 mg P1A 3/49 498
- Xanax XR 0.5 mg P1C 17/50 344 Benpine 25 mg P1A 1/49 194

- Xanax XR 1 mg P1C 18/50 069 Benylin CD 60 mL - 552

- Xanax XR 2 mg P1C 19/50 353 Bluco 10 mg N2A 12/47 355

- Xiemed 0.25 mg P1A 27/49 108 Blucon 10 mg - 332

- Xiemed 0.5 mg P1A 34/50 249 Bonadine CD 60 mL - 561
- Xiemed 1 mg P1A 28/49 296 Bromazepam:
- Zolam 0.25 mg P1A 44/50 093 - Lexotan 1.5 mg P1C 5/49 070
- Zolam 0.5 mg P1A 45/50 237 - Lexotan 3 mg P1C 6/49 228

- Zolam 1 mg P1A 46/50 285 Bromtussia DC 60 mL - 515

Alprazolam Frx Bronpect 10 mg N2A 1/51 298
0.25 mg - 109 Brown Mixture GPO†
Alprazolam Frx 0.6 mL/5 mL x 180 mL N2A 15/45 527

0.5 mg P1A 10/51 256 Brown Mixture GPO
† 0.6 mL/5 mL x 450 mL N2A 15/45 528
Ama 50 mg P2A 60/43 144
Brown Mixture
Amobarbital:
Osoth Interlab†
- Ama † 50 mg P2A 60/43 144 0.6 mL/5 mL x 180 mL N2A 7/43 554
Amobarbital Na: Buprenorphine HCl:
- Amytal 0.5 g - 640 - Buprine 0.2 mg - 002
Amytal 0.5 g - 640 - Temgesic 0.2 mg - 007
Anax 0.25 mg P1A 9/46 085 - Temgesic
Anax 0.5 mg P1A 10/46 230 0.3 mg/mL x 1 mL - 619
Anpress 0.25 mg P1A 33/50 088 Buprine 0.2 mg - 002
Anpress 0.5 mg P1A 4/48 248 Butobarbital:
Anpress 1 mg P1A 35/50 282 - Belloid † 30 mg - 124
Anta 0.5 mg P1A 29/50 304
Anta 1 mg P1A 28/50 020
Anta 2 mg P1A 29/52 125
C
Anxene 5 mg - 430 Calmipam 2 mg - 361
Anxene 10 mg - 262 Calmipam 5 mg - 276
Anxielax 5 mg - 460 Calypsol 50 mg/mL x 10 mL - 641
Anxira 0.5 mg P1A 24/52 300 Camphorated Opium Tinct:
Anxira 1 mg P1A 25/52 022 - Brown Mixture GPO †
Anzion 0.25 mg - 086 0.6 mL/5 mL x 180 mL N2A 15/45 527
Anzion 0.5 mg - 231 - Brown Mixture GPO †
0.6 mL/5 mL x 450 mL N2A 15/45 528
Anzion 1 mg - 280
- Brown Mixture
Ativan 0.5 mg - 308 Osoth Interlab †
GENERIC & BRAND NAME INDEX

Ativan 1 mg - 028 0.6 mL/5 mL x 180 mL N2A 7/43 554


Ativan 2 mg - 129 - Cough Syrup GPO †
Atractil 75 mg - 497 0.6 mL/5 mL x 60 mL - 530
Azepam 2 mg - 219 - Mist. Scill Ammon. GPO †
0.6 mL/5 mL x 180 mL N2A 13/46 531
Azepam 5 mg - 299
- Mist Tussis †
A-Zerax 2 mg P1A 37/52 453 0.6 mL/5 mL x 450 mL N2A 14/45 590
A-Zerax 5 mg P1A 38/52 463 - Mixture Scillae Ammon †
2 mL/15 mL x 180 mL - 557
- Mixture Tussis †
B 0.45 mL/5 mL x 30 mL N2A 11/46 574
Belladonna Alkaloids With - Mixture Tussis †
Phenobarbital† 16.2 mg - 221 0.45 mL/5 mL x 60 mL N2A 11/46 575
Bellergal† 20 mg - 207 - Mixture Tussis †
0.45 mL/5 mL x 120 mL N2A 11/46 576
Belloid† 30 mg - 124
- Mixture Tussis †
Benadryl CD† 60 mL - 550 0.45 mL/5 mL x 240 mL N2A 11/46 577
Benadryl CD† 1000 mL - 551 - Mixture Tussis †
Benera† 20 mg - 404 0.45 mL/5 mL x 450 mL N2A 11/46 578

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 73


Registration No. Frame No. Registration No. Frame No.
† †
- Mixture Tussis - Zepobrax 5 mg - 384
0.45 mL/5 mL x 1800 mL - 579 - Zepoxide 5 mg - 413
- Mixture Tussis † - Zepoxide 10 mg P1A 3/44 279
0.45 mL/5 mL x 3600 mL - 580
- Zepoxin 5 mg - 205
- Squill and Ammonia Mixture †
1.33 mL/10 mL x 450 mL N2A 9/47 591 - Zepoxin 10 mg - 118
Camphorated Opium Tincture Chlordiazepoxide
BP 1980† March Pharma 25 mg P1A 13/44 467
5 mL/100 mL x 1000 mL N2A 9/45 529 Chlordiazepoxide
† 373
Cebarax 5 mg P2A 22/51 380 T Man 10 mg P1A 4/51

Celium 5 mg P1A 24/51 397 Chlordibrax 5 mg - 382
† Chlordixide 5 mg P1A 9/51 358
Cemol Codeine 15 mg - 072
Centrodine CD† 10 mg N2A 11/47 225 Chlordixide 10 mg P1A 26/51 195
Cexene 5 mg - 450 Chlorzep 5 mg - 359

Cexene 10 mg - 273 Clinepect 10 mg - 495

Chlordiazepoxide Clinopect 10 mg - 196
Acdhon 10 mg - 501 †
Clinopront 10 mg N2A 1/50 378
Chlordiazepoxide Clobazam:
Charoen Bhaesaj 10 mg - 500
- Frisium 5 mg P1C 25/49, 043
Chlordiazepoxide HCl: P1B 26/49
- Benpine 5 mg P1A 8/49 412 - Frisium 10 mg - 037
- Benpine 10 mg P1A 3/49 498 Clonaril 1 mg P1A 15/51 342
- Benpine 25 mg P1A 1/49 194 Clonazepam:
- Cebarax † 5 mg P2A 22/51 380 - Clonaril 1 mg P1A 15/51 342
- Chlordiazepoxide - Povanil 0.5 mg P1A 33/52 186
Acdhon 10 mg - 501 - Povanil 2 mg P1A 34/52 067
- Chlordiazepoxide - Prenarpil 0.5 mg P1A 30/52 407
Charoen Bhaesaj 10 mg - 500
- Prenarpil 1 mg P1A 31/52 337
- Chlordiazepoxide
March Pharma 25 mg P1A 13/44 467 - Prenarpil 2 mg P1A 32/52 054
- Chlordiazepoxide - Rivotril 0.5 mg P1C 7/49 408
T Man 10 mg P1A 4/51 373 - Rivotril
- Chlordibrax † 5 mg - 382 1 mg/mL x 1 mL - 637
- Chlordixide 5 mg P1A 9/51 358 - Rivotril 2 mg P1C 17/48 055
- Chlordixide 10 mg P1A 26/51 195 Cloramed 5 mg - 429
- Chlorzep 5 mg - 359 Cloramed 10 mg - 264
- Comoben 5 mg P1A 30/49 362 Cloraxene 5 5 mg P1A 4/49 436
- Comoben 10 mg P1A 31/49 491 Cloraze 5 mg P1A 32/51 433
- Cozep 10 mg P1A 3/50 138 Cloraze 10 mg - 266
- Cozep 25 mg P1A 4/50 181 Clorazepate Dipotassium:
- Dirax † 5 mg P2A 4/46 385 - Anxene 5 mg - 430
GENERIC & BRAND NAME INDEX

- Epoxide 10 mg - 187 - Anxene 10 mg - 262


- Epoxide 25 mg - 193 - Anxielax 5 mg - 460
- Kenspa † 5 mg P2A 36/52 223 - Cexene 5 mg - 450
- Librax † 5 mg P2A 85/43 381 - Cexene 10 mg - 273
- Licon † 5 mg - 379 - Cloramed 5 mg - 429
- Med-Zepoxide 5 mg - 468 - Cloramed 10 mg - 264
- Med-Zepoxide 10 mg - 053 - Cloraxene 5 5 mg P1A 4/49 436
- Metaxide 10 mg P1A 7/51 481 - Cloraze 5 mg P1A 32/51 433
- Minoxide 10 mg P1A 47/44 477 - Cloraze 10 mg - 266
- Modurax † 5 mg P2A 46/44 377 - Clozene 5 mg - 421
- Pobrax † 5 mg - 376 - Clozene 10 mg - 452
- Pondnebium 5 mg P1A 13/49 371 - Clozepate 5 mg - 442
- Pondnebium 10 mg - 192 - Conzep 5 mg - 454
- Radibrax † 5 mg - 392 - Conzep 10 mg - 420
- Tumax † 5 mg P2A 25/51 400 - Deda 5 mg P1A 14/46 437
- Utorax † 5 mg - 383 - Deda 10 mg P1A 15/46 265
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:49 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

74 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

- Diposef 5 mg - 427 Codeine GPO 30 mg - 018


- Diposef 10 mg - 260 Codeine Phosphate (Analgesic):
- Dipot 5 mg P1A 40/52 432 - Cemol Codeine † 15 mg - 072
- Dopam 5 mg - 133 - Cocet † 15 mg - 071
- Exan 5 mg - 489 - Codeine GPO 15 mg - 004
- Exan 10 mg - 492 - Codeine GPO 30 mg - 018
- Flulium 5 mg - 443 - Codicet † 15 mg N1A 1/52 414
- Flulium 10 mg - 274 - Codicet Blue † 15 mg N2A 10/51 352
- Frexene 5 mg - 415 - Codicet Pink † 15 mg - 255
- Frexene 10 mg - 419 - Codigesic † 15 mg N2A 3/50 112
- Gaxene 5 mg - 448 - Cotenol † 15 mg - 073
- Manotran 5 mg - 435 - Masapara With Codeine †
- Manotran 10 mg - 263 15 mg N2A 5/50 410
- Polizep 5 mg P1A 23/50 444 - Nasa With Codeine †
15 mg N2A 4/51 080
- Polizep 10 mg - 268
- Pacogesic † 8 mg - 189
- Pomadom 5 mg - 455
- Para-Co 15 mg N2A 7/42 347
- Pomadom 10 mg P1A 2/46 423
- Paradeine † 15 mg N2A 2/50 074
- Posene 5 mg - 172
- Posene 10 mg - 402 - Paradyl 8 mg - 083
- Sanor 5 mg - 426 - Paragen Co † 15 mg - 113
- Sanor 10 mg - 258 - Paramed-Co † 15 mg - 395
- Serene - Parcod † 15 mg - 077
Masa Lab 10 mg - 259 - Parcono † 8 mg N2A 4/50 079
- Serene - Tylenol With Codeine †
V S Pharma 5 mg - 431 15 mg N2A 6/43 075
- Tamylab-S 5 mg - 445 - Tylenol With Codeine †
- Tenmed 5 mg P1A 54/42 440 30 mg N2A 11/43 076
- Tenmed 10 mg P1A 55/42 269 Codeine Phosphate (Antitussive):
- T-Five 5 mg - 446 - Benadryl CD † 60 mL - 550
- Tranadon-S 5 mg - 447 - Benadryl CD † 1000 mL - 551
- Trancap 5 mg P1A 27/42 470 - Benylin CD † 60 mL - 552
- Trancap 10 mg - 173 - Bluco † 10 mg N2A 12/47 355
- Tranclor 5 mg - 439 - Blucon † 10 mg - 332
- Tranclor 10 mg - 272 - Bonadine CD † 60 mL - 561
- Trancon 5 mg P1A 4/44 456 - Bromtussia DC † 60 mL - 515
- Trancon 10 mg - 422 - Bronpect † 10 mg N2A 1/51 298
- Tranmed 5 mg P1A 39/52 428 - Centrodine CD † 10 mg N2A 11/47 225
- Tranmed 10 mg - 261 - Clinepect † 10 mg - 495
- Clinopect † 10 mg - 196
GENERIC & BRAND NAME INDEX

- Tranpate 5 mg P1A 61/43 416


- Tranpon 5 mg - 441 - Clinopront † 10 mg N2A 1/50 378
- Transpon Forte 257 - Co-Cof † 10 mg N2A 6/51 165
10 mg - - Codee-C † 10 mg N2A 5/45 388
- Tranxene 5 mg P1A 16/46 438 - Codepect † 10 mg N2A 4/52 202
- Tranxene 10 mg - 271 - Codesia † 10 mg N2A 4/47 391
- Tranzep 5 mg - 434 - Codesia †
- Uptran 10 mg - 267 10 mg/5 mL x 60 mL N2A 3/47 516
- Upzene 5 mg - 490 - Codyl Cough †
- Zetran 5 mg - 449 9 mg/5 mL x 60 mL N2A 6/50 540
Clozene 5 mg - 421 - Codyl Cough †
9 mg/5 mL x 100 mL N2A 6/50 541
Clozene 10 mg - 452
- Codyl Cough †
Clozepate 5 mg - 442 9 mg/5 mL x 1000 mL - 542

Cocet 15 mg - 071 - Codyl Cough †

Co-Cof 10 mg N2A 6/51 165 9 mg/5 mL x 4500 mL - 543

Codee-C 10 mg N2A 5/45 388 - Cofcodyl Cough † 60 mL - 521
Codeine GPO 15 mg - 004 - Cofcodyl Cough † 100 mL - 522

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 75


Registration No. Frame No. Registration No. Frame No.
† †
- Comodine Cough 60 mL - 507 - Pondnadyl
- Conadyl † 60 mL - 583 9 mg/5 mL x 1000 mL - 565
- Corynil † 10 mg - 200 - Rolar † 10 mg N2A 3/52 203
- Cosedyl Cough Linctus † - Ropect † 10 mg N2C 12/46 201
60 mL - 582 - Rotuss † 10 mg N2C 9/46 204
- Decos † - Seco † 10 mg N2A 2/47 389
9 mg/5 mL x 100 mL N2A 8/51 572
- Tenadrin-C † 60 mL - 519
- Dimetane Expectorant DC †
2.5 L - 592 - Teradene † 60 mL - 520
- Hisedyl † 60 mL - 555 - Teradyl Syrup † 60 mL - 532
- Hisedyl † 120 mL - 556 - Teradyl Syrup † 1000 mL - 533
- Mantadyl Cough † 60 mL - 581 - Terco-C † 10 mg N2A 1/49 387
- Masadyl Cough † 60 mL - 534 - Tocodyl † 10 mg - 390
- Masadyl Cough † 100 mL - 535 - Tussidyl †
- Masadyl Cough † 240 mL - 536 9 mg/5 mL x 60 mL N2A 6/45 589
- Mila-Cono † 60 mL - 546 - Zorituss 10 mg - 197
- Mila-Tercon † 8 mg N2A 7/47 167 Codeine Resinate:
- Neo Cough † 60 mL - 537 - Codipront † 30 mg - 493
- Neo Cough † 100 mL - 538 - Codipront † 30 mg N2A 9/51 494
- Neo Cough † 240 mL - 539 - Codipront † 60 mL - 593
- Neocod † 10 mg - 345 Codepect† 10 mg N2A 4/52 202
- Neo-Codein † 10 mg - 346 Codesia† 10 mg N2A 4/47 391
- Neocof † 10 mg - 188 Codesia†
- Neo-Cophen 10 mg - 198 10 mg/5 mL x 60 mL N2A 3/47 516
- Neopect † 10 mg N2A 10/46 199 Codicet† 15 mg N1A 1/52 414
- Nordyl Linctus † Codicet Blue† 15 mg N2A 10/51 352
9 mg/5 mL x 100 mL N2C 3/51 566 Codicet Pink† 15 mg - 255
- Nordyl Linctus † Codigesic† 15 mg N2A 3/50 112
9 mg/5 mL x 500 mL - 567 Codipront† 30 mg - 493
- Nortuss Linctus † Codipront† 30 mg N2A 9/51 494
100 mL 568
Codipront† 60 mL
-
- 593
- Nortuss Linctus †
569 Codyl Cough †
500 mL - 540
9 mg/5 mL x 60 mL N2A 6/50
- P-Codyl †
558 Codyl Cough †
9 mg/5 mL x 60 mL - 541
9 mg/5 mL x 100 mL N2A 6/50
- P-Codyl † Codyl Cough

9 mg/5 mL x 120 mL - 559 542
9 mg/5 mL x 1000 mL -
- Percidyl Cough † 100 mL - 562 Codyl Cough †
- Phencodin † 9 mg/5 mL x 4500 mL - 543
9 mg/5 mL x 60 mL N2A 10/43 586 Cofcodyl Cough† 60 mL - 521
GENERIC & BRAND NAME INDEX

- Phencodin † †
Cofcodyl Cough 100 mL - 522
9 mg/5 mL x 500 mL - 587
Comoben 5 mg P1A 30/49 362
- Phencodin †
9 mg/5 mL x 1000 mL - 588 Comoben 10 mg P1A 31/49 491
- Phensedyl † Comodine Cough† 60 mL - 507
9 mg/5 mL x 100 mL N2A 8/43 553 Conadyl† 60 mL - 583
- Phensodi † 60 mL - 524 Concerta 18 mg - 169
- Phensodi † 120 mL - 525 Concerta 36 mg - 114
- Phensodi † 1000 mL - 526 Conzep 5 mg - 454
- Poly-Cof Syrup † Conzep 10 mg - 420
9 mg/5 mL x 60 mL N2A 5/51 548 Corynil† 10 mg - 200
- Poly-Cof Syrup † Cosedyl Cough Linctus† 582
9 mg/5 mL x 100 mL N2A 5/51 549 60 mL -
- Polydine CD † 10 mg - 270 Cotenol† 15 mg - 073
- Pondnadyl † Cough Syrup GPO† 530
9 mg/5 mL x 60 mL N2A 3/48 563 0.6 mL/5 mL x 60 mL -
- Pondnadyl † Cozep 10 mg P1A 3/50 138
9 mg/5 mL x 100 mL N2A 3/48 564 Cozep 25 mg P1A 4/50 181
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

76 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

- Diapine 10 mg P1A 18/49 386


D - Diapine
10 mg/2 mL x 2 mL P1A 21/51 601
Dalmadorm 15 mg - 478
- Diaz 2 mg - 061
Davol† 32.5 mg - 275
† - Diaz 5 mg - 157
Decos 572
9 mg/5 mL x 100 mL N2A 8/51 - Diaz 10 mg - 341
Deda 5 mg P1A 14/46 437 - Diaza 2 mg - 338
Deda 10 mg P1A 15/46 265 - Diaza 5 mg - 153
Dextropropoxyphene HCl: - Diaza
- Davol † 32.5 mg - 275 10 mg/2 mL x 2 mL - 625
Dextropropoxyphene Napsylate: - Diazepam Acdhon 2 mg - 472
- Pardex 32.5 mg - 116 - Diazepam
BJ Benjaosoth 2 mg P1A 13/52 050
Diadon 5 mg - 349
Diamed 2 mg P1A 9/49 503 - Diazepam
BJ Benjaosoth 5 mg P1A 14/52 374
Diamed 5 mg P1A 10/49 482
- Diazepam
Diano 2 mg P1A 9/48 015 BJ Benjaosoth 10 mg P1A 15/52 222
Diano 5 mg P1A 10/48 140 - Diazepam
Diapam 2 mg P1A 5/51 369 Charoen Bhaesaj 2 mg - 333
Diapam 5 mg P1A 6/51 329 - Diazepam
Diapine 2 mg P1A 13/50 010 General Drugs House
2 mg P1A 14/49 318
Diapine 2 mg P1A 12/50 473
- Diazepam
Diapine 5 mg P1A 11/51 166 General Drugs House
Diapine 5 mg P1A 14/50 484 5 mg P1A 24/50 148
Diapine - Diazepam GPO 2 mg - 052
5 mg/mL x 1 mL P1A 21/51 600 - Diazepam GPO 5 mg - 149
Diapine 10 mg P1A 18/49 386 - Diazepam GPO 10 mg - 334
Diapine - Diazepam GPO
10 mg/2 mL x 2 mL P1A 21/51 601 10 mg/2 mL x 2 mL - 603
Diaz 2 mg - 061 - Diazepam
Diaz 5 mg - 157 H K Pharm 2 mg P1A 32/49 218
Diaz 10 mg - 341 - Diazepam
Diaza 2 mg - 338 H K Pharm 5 mg P1A 33/49 160
Diaza 5 mg - 153 - Diazepam
H K Pharm 10 mg P1A 34/49 343
Diaza
10 mg/2 mL x 2 mL - 625 - Diazepam
Lerd Singh 2 mg P1A 49/50 066
Diazepam:
- Diazepam
- Azepam 2 mg - 219 Lerd Singh 5 mg P1A 50/50 161
- Azepam 5 mg - 299 - Diazepam
- A-Zerax 2 mg P1A 37/52 453 Pond’s Chemical 2 mg P1A 32/45 367
GENERIC & BRAND NAME INDEX

- A-Zerax 5 mg P1A 38/52 463 - Diazepam


Pond’s Chemical 5 mg - 162
- Calmipam 2 mg - 361
- Diazepam
- Calmipam 5 mg - 276 Pond’s Chemical 5 mg P1A 33/45 216
- Diadon 5 mg - 349 - Diazepam
- Diamed 2 mg P1A 9/49 503 Samakeephaesaj 2 mg - 363
- Diamed 5 mg P1A 10/49 482 - Diazepam
- Diano 2 mg P1A 9/48 015 Samakeephaesaj 5 mg - 142
- Diano 5 mg P1A 10/48 140 - Diazepam
Sommai Bhaesaj 5 mg - 320
- Diapam 2 mg P1A 5/51 369 - Diazepam T Man 2 mg P1A 12/52 364
- Diapam 5 mg P1A 6/51 329 - Diazepam T Man 5 mg - 163
- Diapine 2 mg P1A 13/50 010 - Diazepam T Man 5 mg P1A 62/44 211
- Diapine 2 mg P1A 12/50 473 - Diazepam T Man 10 mg - 327
- Diapine 5 mg P1A 11/51 166 - Diazepam
- Diapine 5 mg P1A 14/50 484 T P Drug 2 mg - 017
- Diapine - Diazepam
5 mg/mL x 1 mL P1A 21/51 600 T P Drug 5 mg - 155

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 77


Registration No. Frame No. Registration No. Frame No.

- Diazepam T P Drug - Tranolan


10 mg - 340 10 mg/2 mL x 2 mL P1A 41/52 615
- Diazepam T P Drug - V Day Zepam 2 mg P1A 88/42 475
10 mg/2 mL x 2 mL P1A 27/51 627 - V Day Zepam 5 mg P1A 89/42 465
- Diazepam Vesco 2 mg P1A 53/50 325
- V Day Zepam
- Diazepam Vesco 5 mg P1A 54/50 134 10 mg/2 mL x 2 mL P2A 82/43 616
- Diazepion 2 mg - 480 - V Day Zepam NL
- Diazepion 5 mg - 474 10 mg/2 mL x 2 mL P1A 11/46 617
- Diazepion 10 mg - 191 - Valax 2 mg - 031
- Dilium 2 mg - 178 - Valax 5 mg - 132
- Dilium 5 mg - 326 - Valax 10 mg - 322
- Dimed 2 mg - 068 - Valenium 2 mg - 065
- Dimed 5 mg - 164 - Valenium 5 mg - 150
- Dipam 2 mg - 040 - Valium 5 mg - 152
- Dipam 5 mg - 137 - Valium
- Dipam 10 mg - 330 10 mg/2 mL x 2 mL - 620
- Ditran 2 mg P1A 8/50 418 - Vason 2 mg P1A 16/48 396
- Ditran 5 mg P1A 61/50 476 - Vescopam
- Divopan 2 mg P1A 11/48 049 10 mg/2 mL x 2 mL P1A 7/50 636
- Divopan 5 mg P1A 12/48 146 - Vispam 2 mg - 366
- Dizan 2 mg - 457 - Vispam 5 mg - 213
- Dizan 5 mg - 417 - Vispam 10 mg P1A 16/50 323
- Dizep 2 mg P1A 5/50 171 - Vomed 2 mg - 059
- Dizep 5 mg P1A 6/50 190 - Vomed 5 mg - 147
- Dizepam 2 mg P1A 21/49 224 - Vorapam 2 mg P1A 40/50 064
- Dizepam 5 mg P1A 22/49 151 - Vorapam 5 mg P1A 41/50 159
- DZP2 2 mg - 471 - Winopam 2 mg - 063
- Laylium-10 - Winopam 5 mg - 375
10 mg/2 mL x 2 mL - 635
- Zepam 2 mg - 399
- Manodiazo 2 mg P1A 83/43 469
- Zepam 5 mg - 354
- Manodiazo 5 mg P1A 84/43 502
- Zepam
- Manodiazo 10 mg P1A 23/51 335 10 mg/2 mL x 2 mL - 614
- Manolium - Zepaxid 2 mg P1A 20/50 506
10 mg/2 mL x 2 mL P1A 12/49 613
- Zepaxid 5 mg P1A 21/50 462
- Med-Zepam 2 mg - 039
- Zepaxid
- Med-Zepam 5 mg - 336 634
10 mg/2 mL x 2 mL P1A 32/50
- Monozide 2 mg - 496
- Zopam 2 mg P1A 35/49 048
- Monozide-10
10 mg/2 mL x 2 mL P1A 37/49 632 - Zopam 5 mg P1A 36/49 145
- Zopam 10 mg P1A 3/46 331
GENERIC & BRAND NAME INDEX

- Pam-5 5 mg - 206
- Popam 2 mg - 111 Diazepam Acdhon 2 mg - 472
- Popam 5 mg - 170 Diazepam
BJ Benjaosoth 2 mg P1A 13/52 050
- Ropam 5 mg - 158
Diazepam
- Ropam BJ Benjaosoth 5 mg P1A 14/52 374
10 mg/2 mL x 2 mL P1A 13/45 608
Diazepam
- S.Co Zepam 5 mg - 220 BJ Benjaosoth 10 mg P1A 15/52 222
- Sipam 2 mg P1A 15/49 056 Diazepam
- Sipam 5 mg P1A 16/49 154 Charoen Bhaesaj 2 mg - 333
- Sipam 10 mg P1A 17/49 339 Diazepam
- Sipam General Drugs House
2 mg P1A 14/49 318
10 mg/2 mL x 2 mL P1A 39/50 626
Diazepam
- Stesolid 2 mg - 401 General Drugs House
- Stesolid 5 mg - 485 5 mg P1A 24/50 148
- Stesolid 10 mg - 479 Diazepam GPO 2 mg - 052
- Tranolan 2 mg P1A 42/50 130 Diazepam GPO 5 mg - 149
- Tranolan 5 mg P1A 43/50 177 Diazepam GPO 10 mg - 334
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

78 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

Diazepam GPO Diphenoxylate HCl:


10 mg/2 mL x 2 mL - 603 - Dilomil † 2.5 mg - 001
Diazepam - Ditropine † 2.5 mg - 008
218
H K Pharm 2 mg P1A 32/49
- Lomotil † 2.5 mg N2A 4/48 006
Diazepam
- Spasil † 2.5 mg N2A 2/51 009
H K Pharm 5 mg P1A 33/49 160
Diposef 5 mg - 427
Diazepam
H K Pharm 10 mg P1A 34/49 343 Diposef 10 mg - 260
Diazepam Dipot 5 mg P1A 40/52 432

Lerd Singh 2 mg P1A 49/50 066 Dirax 5 mg P2A 4/46 385
Diazepam Ditran 2 mg P1A 8/50 418
Lerd Singh 5 mg P1A 50/50 161 Ditran 5 mg P1A 61/50 476
Diazepam Ditropine† 2.5 mg - 008
Pond’s Chemical 2 mg P1A 32/45 367 Divopan 2 mg P1A 11/48 049
Diazepam Divopan 5 mg P1A 12/48 146
Pond’s Chemical 5 mg - 162
Dizan 2 mg - 457
Diazepam
216 Dizan 5 mg - 417
Pond’s Chemical 5 mg P1A 33/45
Diazepam Dizep 2 mg P1A 5/50 171
Samakeephaesaj 2 mg - 363 Dizep 5 mg P1A 6/50 190
Diazepam Dizepam 2 mg P1A 21/49 224
Samakeephaesaj 5 mg - 142 Dizepam 5 mg P1A 22/49 151
Diazepam Dizolam 0.25 mg P1A 5/48 089
Sommai Bhaesaj 5 mg - 320 Dizolam 0.5 mg P1A 15/50 233
Diazepam T Man 2 mg P1A 12/52 364 Dizolam 1 mg P1A 6/48 297
Diazepam T Man 5 mg - 163 D-Norpseudoephedrine HCl:
Diazepam T Man 5 mg P1A 62/44 211 - Mirapront N 20 mg - 504
Diazepam T Man 10 mg - 327 D-Norpseudoephedrine Resinate:
Diazepam T P Drug 2 mg - 017 D-Norpseudoephedrine SR
Diazepam T P Drug 5 mg - 155 Osmopharm 20 mg - 505
Diazepam T P Drug 10 mg - 340 D-Norpseudoephedrine SR
Osmopharm 20 mg - 505
Diazepam T P Drug
10 mg/2 mL x 2 mL P1A 27/51 627 Domar 5 mg P1A 5/52 464

Diazepam Vesco 2 mg P1A 53/50 325 Donnatal 16.2 mg - 060
Diazepam Vesco 5 mg P1A 54/50 134 Dopam 5 mg - 133
Diazepion 2 mg - 480 Dormicum
5 mg/mL x 1 mL - 621
Diazepion 5 mg - 474
Dormicum 15 mg - 351
Diazepion 10 mg - 191
Dormicum
Diethylpropion HCl: 15 mg/3 mL x 3 mL - 622
- Dietil Retard 75 mg - 084 Durogesic
25 mcg/hr x 2.5 mg - 651
GENERIC & BRAND NAME INDEX

- Prefamone 75 mg - 174
Durogesic
- Regenon Retard 75 mg - 115 50 mcg/hr x 5 mg - 652
- Regenon Retard 75 mg - 486 Durogesic
100 mcg/hr x 10 mg - 653
Diethylpropion Resinate:
Duromine 15 mg - 499
- Atractil 75 mg - 497
Duromine 30 mg - 488
Dietil Retard 75 mg - 084
DZP2 2 mg - 471
Dilium 2 mg - 178
Dilium 5 mg - 326
Dilomil† 2.5 mg - 001 E
Dimed 2 mg - 068 Elixir Phenobarb 60 mL - 573
Dimed 5 mg - 164 Ephedrine GPO

Dimetane Expectorant DC 30 mg/mL x 1 mL - 604
2.5 L - 592 Ephedrine HCl:
Dipam 2 mg - 040 - Ephedrine GPO
Dipam 5 mg - 137 30 mg/mL x 1 mL - 604
Dipam 10 mg - 330 Epoxide 10 mg - 187

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 79


Registration No. Frame No. Registration No. Frame No.

Epoxide 25 mg - 193 Fentanyl Sandoz


0.05 mg/mL x 10 mL - 644
Ethyl Loflazepate:
- Meilax 1 mg - 021 Flulium 5 mg - 443
- Meilax 2 mg - 176 Flulium 10 mg - 274
- Victan 2 mg - 182 Flunitrazepam:
Euhypnos 20 20 mg - 398 - Rohypnol 1 mg - 394
Exan 5 mg - 489 Flurazepam:
Exan 10 mg - 492 - Dalmadorm 15 mg - 478
Fortwin 30 mg/mL x 1 mL - 618
F Frexene 5 mg
Frexene 10 mg
-
-
415
419
Farzolam 0.25 mg - 092 Frisium 5 mg P1C 25/49, 043
Farzolam 0.5 mg - 242 P1B 26/49
Farzolam 1 mg - 289 Frisium 10 mg - 037

Fentanyl:
- Durogesic
25 mcg/hr x 2.5 mg - 651 G
- Durogesic
50 mcg/hr x 5 mg - 652 Gardenal 200 mg/4 mL P1C 1/50 638
Gaxene 5 mg - 448
- Durogesic
100 mcg/hr x 10 mg - 653 Grandaxin 50 mg P1C 27/50 051
- Fentanyl GPO 12 mcg/hr - 645
- Fentanyl GPO 25 mcg/hr - 646
- Fentanyl GPO 50 mcg/hr - 647 H
- Fentanyl Hexal 12 mcg/hr - 648 Halcion 0.25 mg - 350
- Fentanyl Hexal 25 mcg/hr - 649 Hawkcopax 0.5 mg P1A 8/51 321
- Fentanyl Hexal 50 mcg/hr - 650 Hawkcopax 1 mg - 365
Fentanyl Antigen Hisedyl† 60 mL - 555
0.05 mg/mL x 2 mL - 598 Hisedyl† 120 mL - 556
Fentanyl Antigen
0.05 mg/mL x 10 mL - 599
Fentanyl Citrate:
- Fentanyl Antigen I
0.05 mg/mL x 2 mL - 598 Inzolam 0.25 mg P1A 58/50 104
- Fentanyl Antigen Inzolam 0.5 mg P1A 59/50 251
0.05 mg/mL x 10 mL - 599
Inzolam 1 mg P1A 60/50 294
- Fentanyl Janssen-Cilag
0.05 mg/mL x 2 mL - 605
- Fentanyl Janssen-Cilag
GENERIC & BRAND NAME INDEX

0.05 mg/mL x 10 mL - 606 K


- Fentanyl Sandoz
0.05 mg/mL x 2 mL - 623 Kapanol 20 mg - 119
- Fentanyl Sandoz Kapanol 50 mg - 120
0.05 mg/mL x 10 mL - 644 Kapanol 100 mg - 121
Fentanyl GPO 12 mcg/hr - 645 Kemora 0.5 mg P1A 18/47 411
Fentanyl GPO 25 mcg/hr - 646 Kemora 1 mg P1A 21/47 024

Fentanyl GPO 50 mcg/hr - 647 Kenspa 5 mg P2A 36/52 223
Fentanyl Hexal 12 mcg/hr - 648 Keta-Hameln 642
50 mg/mL x 10 mL -
Fentanyl Hexal 25 mcg/hr - 649
Ketalar 50 mg/mL x 10 mL - 643
Fentanyl Hexal 50 mcg/hr - 650
Fentanyl Janssen-Cilag Ketamine HCl:
0.05 mg/mL x 2 mL - 605 - Calypsol
50 mg/mL x 10 mL - 641
Fentanyl Janssen-Cilag
0.05 mg/mL x 10 mL - 606 - Keta-Hameln
Fentanyl Sandoz 50 mg/mL x 10 mL - 642
0.05 mg/mL x 2 mL - 623 - Ketalar 50 mg/mL x 10 mL - 643
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

80 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

- Lora 1 mg P1A 18/51 036


L - Lora 2 mg P1A 19/51 217
Laylium-10 - Lora-P 0.5 mg - 319
10 mg/2 mL x 2 mL - 635 - Lora-P 1 mg - 016
Lexotan 1.5 mg P1C 5/49 070 - Lora-P 2 mg - 123
Lexotan 3 mg P1C 6/49 228 - Loramed 0.5 mg - 306

Librax 5 mg P2A 85/43 381 - Loramed 1 mg - 025

Licon 5 mg - 379 - Loramed 2 mg P1A 23/47 210
Lizavan 0.5 mg - 305 - Lorapam 0.5 mg - 311
Lizavan 1 mg - 023 - Lorapam 1 mg - 026
Lomotil† 2.5 mg N2A 4/48 006 - Lorapam 2 mg - 128
Lonza 0.5 mg P1A 11/49 313 - Lorapine 0.5 mg - 314
Lonza 1 mg P1A 18/48 019 - Lorapine 1 mg - 035
Lora 0.5 mg P1A 17/51 368
- Loravan 0.5 mg P1A 22/50 302
Lora 1 mg P1A 18/51 036
- Loravan 1 mg P1A 2/49 027
Lora 2 mg P1A 19/51 217
- Lorazene 0.5 mg - 301
Lora-P 0.5 mg - 319
- Lorazene 1 mg - 013
Lora-P 1 mg - 016
- Lorazene 2 mg - 127
Lora-P 2 mg - 123
- Lorazep 0.5 mg P1A 17/47 309
Loramed 0.5 mg - 306
- Lorazep 1 mg P1A 20/47 003
Loramed 1 mg - 025
- Lorazep 2 mg P1A 22/47 357
Loramed 2 mg P1A 23/47 210
- Lorazepam
Loramet 1 mg - 102 Acdhon 0.5 mg - 317
Lorapam 0.5 mg - 311 - Lorazepam
Lorapam 1 mg - 026 Acdhon 1 mg - 033
Lorapam 2 mg - 128 - Lorazepam
Lorapine 0.5 mg - 314 Macrophar 1 mg - 372
Lorapine 1 mg - 035 - Lorazin 0.5 mg P1A 28/45 324
Loravan 0.5 mg P1A 22/50 302 - Lorazin 1 mg P1A 29/45 044
Loravan 1 mg P1A 2/49 027 - Lorazin 2 mg P1A 30/45 227
Lorazene 0.5 mg - 301 - Lozepam 0.5 mg - 303
Lorazene 1 mg - 013 - Lozepam 1 mg - 405
Lorazene 2 mg - 127 - Ora 0.5 mg P1A 12/51 310
Lorazep 0.5 mg P1A 17/47 309 - Ora 1 mg P1A 13/51 030
Lorazep 1 mg P1A 20/47 003 - Ora 2 mg - 212
Lorazep 2 mg P1A 22/47 357 - Pora 0.5 mg - 370
Lorazepam: - Pora 1 mg - 139
- Anta 0.5 mg P1A 29/50 304 - Pora 2 mg - 215
GENERIC & BRAND NAME INDEX

- Anta 1 mg P1A 28/50 020 - Razepam 0.5 mg - 315


- Anta 2 mg P1A 29/52 125 - Razepam 1 mg - 032
- Anxira 0.5 mg P1A 24/52 300 - Razepam 2 mg - 131
- Anxira 1 mg P1A 25/52 022 - Tranavan 0.5 mg P1A 3/52 307
- Ativan 0.5 mg - 308 - Tranavan 1 mg P1A 4/52 034
- Ativan 1 mg - 028 - Vemed 0.5 mg - 316
- Ativan 2 mg - 129 - Zeda 0.5 mg P1A 8/52 014
- Hawkcopax 0.5 mg P1A 8/51 321 - Zeda 1 mg P1A 9/52 360
- Hawkcopax 1 mg - 365 - Zora 0.5 mg P1A 25/50 328
- Kemora 0.5 mg P1A 18/47 411 - Zora 2 mg P1A 26/50 179
- Kemora 1 mg P1A 21/47 024 Lorazepam
- Lizavan 0.5 mg - 305 Acdhon 0.5 mg - 317
- Lizavan 1 mg - 023 Lorazepam
Acdhon 1 mg - 033
- Lonza 0.5 mg P1A 11/49 313 Lorazepam
- Lonza 1 mg P1A 18/48 019 Macrophar 1 mg - 372
- Lora 0.5 mg P1A 17/51 368 Lorazin 0.5 mg P1A 28/45 324

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 81


Registration No. Frame No. Registration No. Frame No.

Lorazin 1 mg P1A 29/45 044 Methylphenidate HCl:


Lorazin 2 mg P1A 30/45 227 - Concerta 18 mg - 169
Lormetazepam: - Concerta 36 mg - 114
- Loramet 1 mg - 102 - Methylphenidate
Lozepam 0.5 mg - 303 Hexal 10 mg - 117
Lozepam 1 mg - 405 - Ritalin 10 mg - 041
- Rubifen 10 mg - 038
Methylphenidate
M Hexal 10 mg - 117
Midazolam:
Manex 0.25 mg P1A 36/51 099 - Dormicum
Manex 0.5 mg P1A 21/46 244 5 mg/mL x 1 mL - 621
Manex 1 mg P1A 8/47 291 - Dormicum 15 mg - 351
Manodiazo 2 mg P1A 83/43 469 - Dormicum
Manodiazo 5 mg P1A 84/43 502 15 mg/3 mL x 3 mL - 622

Manodiazo 10 mg P1A 23/51 335 Mila-Cono 60 mL - 546
Manolium Mila-Tercon† 8 mg N2A 7/47 167
10 mg/2 mL x 2 mL P1A 12/49 613 Minoxide 10 mg P1A 47/44 477
Manotran 5 mg - 435 Mirapront N 20 mg - 504
Manotran 10 mg - 263 Mist Tussis†
Mantadyl Cough† 60 mL - 581 0.6 mL/5 mL x 450 mL N2A 14/45 590
Marzolam 0.25 mg P1A 5/47 090 Mist. Scill Ammon. GPO†
0.6 mL/5 mL x 180 mL N2A 13/46 531
Marzolam 0.5 mg P1A 42/52 235
Mitranax 0.25 mg P1A 36/50 106
Marzolam 1 mg P1A 43/52 283
Mitranax 0.5 mg P1A 37/50 253
Masadyl Cough† 60 mL - 534
Mitranax 1 mg P1A 38/50 295
Masadyl Cough† 100 mL - 535 †
Mixture Scillae Ammon
Masadyl Cough† 240 mL - 536 2 mL/15 mL x 180 mL - 557
Masapara With Codeine† Mixture Tussis†
15 mg N2A 5/50 410 0.45 mL/5 mL x 30 mL N2A 11/46 574
Medazepam: Mixture Tussis†
- Celium 5 mg P1A 24/51 397 0.45 mL/5 mL x 60 mL N2A 11/46 575
- Medazine 5 mg P1A 30/50 487 Mixture Tussis†
0.45 mL/5 mL x 120 mL N2A 11/46 576
- Medazine 10 mg P1A 31/50 483 †
Mixture Tussis
Medazine 5 mg P1A 30/50 487 0.45 mL/5 mL x 240 mL N2A 11/46 577
Medazine 10 mg P1A 31/50 483 Mixture Tussis†
Med-Zepam 2 mg - 039 0.45 mL/5 mL x 450 mL N2A 11/46 578
Med-Zepam 5 mg - 336 Mixture Tussis†
Med-Zepoxide 5 mg - 468 0.45 mL/5 mL x 1800 mL - 579
Med-Zepoxide 10 mg - 053 Mixture Tussis†
0.45 mL/5 mL x 3600 mL - 580
GENERIC & BRAND NAME INDEX

Meilax 1 mg - 021 †
Modurax 5 mg P2A 46/44 377
Meilax 2 mg - 176
Mogadon 5 mg - 081
Menobarb 60 mg - 185
Monozide 2 mg - 496
Menobarb Elixir
Monozide-10
15 mg/5 mL x 60 mL - 544 632
10 mg/2 mL x 2 mL P1A 37/49
Menobarb-20 Elixir
20 mg/5 mL x 60 mL - 545 Morphine Sulfate:
- Kapanol 20 mg - 119
Meprobamate:
- Kapanol 50 mg - 120
- Reinbamate 400 mg - 082
- Kapanol 100 mg - 121
Metaxide 10 mg P1A 7/51 481
Methadone GPO 5 mg - 126 - Morphine Sulfate Inj Blue
10 mg/mL x 1 mL - 609
Methadone GPO
10 mg/mL x 1000 mL - 596 - Morphine Sulfate Inj Purple
10 mg/mL x 1 mL - 610
Methadone HCl: - Morphine T.P. Drug
- Methadone GPO 5 mg - 126 10 mg/mL x 1 mL - 628
- Methadone GPO - Morphine T.P. Drug
10 mg/mL x 1000 mL - 596 10 mg/mL x 1 mL - 629
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

82 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

- Morphine T.P. Drug Ora 0.5 mg P1A 12/51 310


10 mg/mL x 1 mL - 630 Ora 1 mg P1A 13/51 030
- MST Continus 10 mg - 406 Ora 2 mg - 212
- MST Continus 30 mg - 278 Oramorph
- MST Continus 60 mg - 183 10 mg/5 mL x 250 mL - 594
- Oramorph Oramorph
10 mg/5 mL x 250 mL - 594 20 mg/mL x 30 mL - 595
- Oramorph
20 mg/mL x 30 mL - 595
Morphine Sulfate Inj Blue
P
10 mg/mL x 1 mL - 609 †
Pacogesic 8 mg - 189
Morphine Sulfate Inj Purple
10 mg/mL x 1 mL - 610 Pam-5 5 mg - 206
Morphine T.P. Drug Panbesy 15 mg - 425
10 mg/mL x 1 mL - 628 Panbesy 30 mg - 461
Morphine T.P. Drug Pangon
10 mg/mL x 1 mL - 629 30 mg/mL x 1 mL P1A 20/51 607
Morphine T.P. Drug Para-Co 15 mg N2A 7/42 347
10 mg/mL x 1 mL - 630 Paradeine† 15 mg N2A 2/50 074
Moxinax 0.25 mg P1A 19/49 094 Paradyl 8 mg - 083
Moxinax 0.5 mg P1A 20/49 238 †
Paragen Co 15 mg - 113
MST Continus 10 mg - 406 Paramed-Co† 15 mg - 395
MST Continus 30 mg - 278 †
Parcod 15 mg - 077
MST Continus 60 mg - 183 Parcono† 8 mg N2A 4/50 079
Pardex 32.5 mg - 116
N P-Codyl†
9 mg/5 mL x 60 mL - 558
† †
Nasa With Codeine P-Codyl
15 mg N2A 4/51 080 9 mg/5 mL x 120 mL - 559
Nembutal Pentazocine:
50 mg/mL x 20 mL P1F 2/50 639 - Fortwin
Neo Cough† 60 mL - 537 30 mg/mL x 1 mL - 618
Neo Cough† 100 mL - 538 - Pangon
Neo Cough† 240 mL - 539 30 mg/mL x 1 mL P1A 20/51 607
Neocod† 10 mg - 345 - Pentazocine All Plants
30 mg/mL x 1 mL - 597
Neo-Codein† 10 mg - 346
- Sosegon
Neocof† 10 mg - 188 30 mg/mL x 1 mL P1C 29/49 624
Neo-Cophen 10 mg - 198 - Tazcine
Neopect† 10 mg N2A 10/46 199 30 mg/mL x 1 mL - 633
Neuramizone† 20 mg P2A 5/45 403 Pentazocine All Plants
Nitrados 5 mg - 062 30 mg/mL x 1 mL - 597
GENERIC & BRAND NAME INDEX

Nitrazepam: Pentazocine HCl:


- Alodorm 5 mg - 078 - Tazcine 25 mg - 058
- Mogadon 5 mg - 081 - Tazcine 50 mg - 226
- Nitrados 5 mg - 062 Pentobarbital Na:
Nordyl Linctus† - Nembutal
9 mg/5 mL x 100 mL N2C 3/51 566 50 mg/mL x 20 mL P1F 2/50 639
Nordyl Linctus
† Percidyl Cough† 100 mL - 562
9 mg/5 mL x 500 mL - 567 Pethidine Biolab
Nortuss Linctus† 100 mL - 568 100 mg/2 mL x 2 mL - 602
Nortuss Linctus† 500 mL - 569 Pethidine HCl:
- Pethidine Biolab
100 mg/2 mL x 2 mL - 602
O - Pethidine
M & H Manufacturing
Opium Tinct: 50 mg/mL x 1 mL - 611
- Camphorated Opium Tincture - Pethidine
BP 1980 † M & H Manufacturing
5 mL/100 mL x 1000 mL N2A 9/45 529 100 mg/2 mL x 2 mL - 612

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 83


Registration No. Frame No. Registration No. Frame No.

- Pethidine T.P. Drug - Menobarb Elixir


50 mg/mL x 1 mL - 631 15 mg/5 mL x 60 mL - 544
Pethidine M & H Manufacturing - Menobarb-20 Elixir
50 mg/mL x 1 mL - 611 20 mg/5 mL x 60 mL - 545
Pethidine M & H Manufacturing
612 - Neuramizone † 20 mg P2A 5/45 403
100 mg/2 mL x 2 mL -
Pethidine T.P. Drug - Phenobarb 30 mg - 209
50 mg/mL x 1 mL - 631 - Phenobarb 60 mg - 046
Pharnax 0.25 mg P1A 28/51 101 - Phenobarb Elixir
Pharnax 0.5 mg P1A 29/51 247 20 mg/5 mL x 60 mL - 560
Pharnax 1 mg P1A 30/51 292 - Phenobarbital
† Acdhon 15 mg - 356
Phencodin
9 mg/5 mL x 60 mL N2A 10/43 586 - Phenobarbital

Phencodin Acdhon 30 mg - 122
9 mg/5 mL x 500 mL - 587 - Phenobarbital
Phencodin† Acdhon 60 mg - 029
9 mg/5 mL x 1000 mL - 588
- Phenobarbital
Phenobarb 30 mg - 209 Atlantic 16.25 mg - 208
Phenobarb 60 mg - 046 - Phenobarbital
Phenobarb Elixir Atlantic 32.5 mg P1A 33/51 011
20 mg/5 mL x 60 mL - 560
- Phenobarbital
Phenobarbital Atlantic 65 mg P1A 34/51 012
Acdhon 15 mg - 356
- Phenobarbital
Phenobarbital
122 Atlantic 100 mg P1A 35/51 277
Acdhon 30 mg -
Phenobarbital - Phenobarbital
Acdhon 60 mg - 029 Chew Brothers 30 mg - 312
Phenobarbital - Phenobarbital Elixir Acdhon
Atlantic 16.25 mg - 208 20 mg/5 mL x 30 mL - 508
Phenobarbital - Phenobarbital Elixir Acdhon
Atlantic 32.5 mg P1A 33/51 011 20 mg/5 mL x 60 mL - 509
Phenobarbital - Phenobarbital Elixir Acdhon
Atlantic 65 mg P1A 34/51 012 20 mg/5 mL x 120 mL - 510
Phenobarbital - Phenobarbital Elixir Acdhon
Atlantic 100 mg P1A 35/51 277
20 mg/5 mL x 240 mL - 511
Phenobarbital
Chew Brothers 30 mg - 312 - Phenobarbital Elixir Acdhon
20 mg/5 mL x 450 mL - 512
Phenobarbital Elixir Acdhon
20 mg/5 mL x 30 mL - 508 - Phenobarbital Elixir Acdhon
Phenobarbital Elixir Acdhon 20 mg/5 mL x 500 mL - 513
20 mg/5 mL x 60 mL - 509 - Phenobarbital Elixir Acdhon
Phenobarbital Elixir Acdhon 20 mg/5 mL x 1000 mL - 514
20 mg/5 mL x 120 mL - 510 - Phenobarbitone
GENERIC & BRAND NAME INDEX

Phenobarbital Elixir Acdhon New Life Pharma 30 mg - 005


20 mg/5 mL x 240 mL - 511 - Phenobarbitone
Phenobarbital Elixir Acdhon New Life Pharma 60 mg - 180
20 mg/5 mL x 450 mL - 512
- Phenoco Elixir
Phenobarbital Elixir Acdhon 20 mg/5 mL x 450 mL P1A 26/47 584
20 mg/5 mL x 500 mL - 513
- Phenoco Elixir
Phenobarbital Elixir Acdhon
20 mg/5 mL x 1000 mL - 514 20 mg/5 mL x 3800 mL - 585
- Phenocon 60 mg - 229
Phenobarbital Na:
- Phenosil Elixir
- Belladonna Alkaloids With
20 mg/5 mL x 60 mL 570
Phenobarbital † 16.2 mg
-
- 221
- Phenosil Elixir
- Bellergal † 20 mg - 207 20 mg/5 mL x 450 mL - 571
- Benera † 20 mg - 404 - Phenotal Elixir
- Donnatal † 16.2 mg - 060 20 mg/5 mL x 60 mL P1A 16/52 517
- Elixir Phenobarb 60 mL - 573 Phenobarbitone
New Life Pharma 30 mg - 005
- Gardenal 200 mg/4 mL P1C 1/50 638
Phenobarbitone
- Menobarb 60 mg - 185 New Life Pharma 60 mg - 180
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

84 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.

Phenoco Elixir Pondnebium 10 mg - 192


20 mg/5 mL x 450 mL P1A 26/47 584 Popam 2 mg - 111
Phenoco Elixir
Popam 5 mg - 170
20 mg/5 mL x 3800 mL - 585
Pora 0.5 mg - 370
Phenocon 60 mg - 229
Pora 1 mg - 139
Phenosil Elixir
20 mg/5 mL x 60 mL - 570 Pora 2 mg - 215
Phenosil Elixir Posene 5 mg - 172
20 mg/5 mL x 450 mL - 571 Posene 10 mg - 402
Phenotal Elixir Povanil 0.5 mg P1A 33/52 186
20 mg/5 mL x 60 mL P1A 16/52 517 Povanil 2 mg P1A 34/52 067
Phensedyl† Pozapam 5 mg P1A 23/52 459
9 mg/5 mL x 100 mL N2A 8/43 553
† Pozapam 10 mg P1A 39/51 175
Phensodi 60 mL - 524
† Prasepine 5 mg - 458
Phensodi 120 mL - 525
Phensodi† 1000 mL - 526 Prazepam:
- Pozapam 5 mg P1A 23/52 459
Phentermine HCl:
- Pozapam 10 mg P1A 39/51 175
- Panbesy 15 mg - 425
- Prasepine 5 mg - 458
- Panbesy 30 mg - 461
Prazol 0.5 mg P1A 3/51 234
- Phentermine
Osmopharm 15 mg - 451 Prefamone 75 mg - 174
Phentermine Osmopharm Prenarpil 0.5 mg P1A 30/52 407
15 mg - 451 Prenarpil 1 mg P1A 31/52 337
Phentermine Resinate: Prenarpil 2 mg P1A 32/52 054
- Duromine 15 mg - 499 Pseudoephedrine
Asian Pharm 30 mg - 143
- Duromine 30 mg - 488
Pseudoephedrine
- Phentermine Asian Pharm 60 mg - 047
Trenker 15 mg - 466
Pseudoephedrine
- Phentermine
BJ Benjaosoth 60 mg - 135
Trenker 30 mg - 424
Phentermine Trenker 15 mg - 466 Pseudoephedrine HCl:
Phentermine Trenker 30 mg - 424 - Pseudoephedrine
Asian Pharm 30 mg - 143
Phenylpropanolamine HCl:
- Pseudoephedrine
- Phenylpropanolamine Asian Pharm 60 mg - 047
Pharmasant 25 mg - 141
- Pseudoephedrine
Phenylpropanolamine
BJ Benjaosoth 60 mg - 135
Pharmasant 25 mg - 141
- Pseudoephedrine
Pinazepam: Medicine Products 60 mg - 184
- Domar 5 mg P1A 5/52 464
- Pseudoephedrine
GENERIC & BRAND NAME INDEX


Pobrax 5 mg - 376 Milano 30 mg - 136
Polizep 5 mg P1A 23/50 444 - Pseudoephedrine
Polizep 10 mg - 268 Milano 60 mg - 045

Poly-Cof Syrup - Pseudoephedrine Syrup
9 mg/5 mL x 60 mL N2A 5/51 548 Asian Pharm
Poly-Cof Syrup† 30 mg/5 mL x 60 mL - 518
9 mg/5 mL x 100 mL N2A 5/51 549 - Pseudoephedrine Syrup

Polydine CD 10 mg - 270 BJ Benjaosoth
Pomadom 5 mg - 455 30 mg/5 mL x 60 mL - 523
Pomadom 10 mg P1A 2/46 423 - Pseudoephedrine Syrup
† Milano 30 mg/5 mL x 60 mL - 547
Pondnadyl
9 mg/5 mL x 60 mL N2A 3/48 563 Pseudoephedrine
Pondnadyl† Medicine Products 60 mg - 184
9 mg/5 mL x 100 mL N2A 3/48 564 Pseudoephedrine
† Milano 30 mg - 136
Pondnadyl
9 mg/5 mL x 1000 mL - 565 Pseudoephedrine
Pondnebium 5 mg P1A 13/49 371 Milano 60 mg - 045

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:50 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

PN DEX 2010 GENERIC & BRAND NAME INDEX 85


Registration No. Frame No. Registration No. Frame No.

Pseudoephedrine Syrup Stesolid 5 mg - 485


Asian Pharm Stesolid 10 mg - 479
30 mg/5 mL x 60 mL - 518
Stilnox 10 mg - 110
Pseudoephedrine Syrup
BJ Benjaosoth Sunax 0.25 mg - 107
30 mg/5 mL x 60 mL - 523 Sunax 0.5 mg - 254
Pseudoephedrine Syrup
Milano 30 mg/5 mL x 60 mL - 547
T
R Tamylab-S 5 mg - 445

Tazcine 25 mg - 058
Radibrax 5 mg - 392 Tazcine 30 mg/mL x 1 mL - 633
Razepam 0.5 mg - 315 Tazcine 50 mg - 226
Razepam 1 mg - 032
Temazepam:
Razepam 2 mg - 131 - Euhypnos 20 20 mg - 398
Regenon Retard 75 mg - 115 Temgesic 0.2 mg - 007
Regenon Retard 75 mg - 486 Temgesic 0.3 mg/mL x 1 mL - 619
Reinbamate 400 mg - 082 Tenadrin-C† 60 mL - 519
Ritalin 10 mg - 041 Tenmed 5 mg P1A 54/42 440
Rivotril 0.5 mg P1C 7/49 408 Tenmed 10 mg P1A 55/42 269
Rivotril Teradene† 60 mL - 520
1 mg/mL x 1 mL - 637 Teradyl Syrup† 60 mL - 532
Rivotril 2 mg P1C 17/48 055 †
Teradyl Syrup 1000 mL - 533
Rohypnol 1 mg - 394 Terco-C† 10 mg N2A 1/49 387
Rolar† 10 mg N2A 3/52 203 T-Five 5 mg - 446
Ropam 5 mg - 158 Tocodyl† 10 mg - 390
Ropam
Tofisopam:
10 mg/2 mL x 2 mL P1A 13/45 608
- Grandaxin 50 mg P1C 27/50 051
Ropect† 10 mg N2C 12/46 201
Tranadon-S 5 mg - 447
Rotuss† 10 mg N2C 9/46 204
Tranavan 0.5 mg P1A 3/52 307
Rubifen 10 mg - 038
Tranavan 1 mg P1A 4/52 034
Trancap 5 mg P1A 27/42 470
S Trancap 10 mg - 173
Tranclor 5 mg - 439
S.Co Zepam 5 mg - 220 Tranclor 10 mg - 272
Sanor 5 mg - 426 Trancon 5 mg P1A 4/44 456
Sanor 10 mg - 258 Trancon 10 mg - 422

Seco 10 mg N2A 2/47 389 Tranmed 5 mg P1A 39/52 428
Serene Tranmed 10 mg - 261
GENERIC & BRAND NAME INDEX

Masa Lab 10 mg - 259


Tranolan 2 mg P1A 42/50 130
Serene
Tranolan 5 mg P1A 43/50 177
V S Pharma 5 mg - 431
Tranolan
Siampraxol 0.25 mg P1A 6/52 098 10 mg/2 mL x 2 mL P1A 41/52 615
Siampraxol 0.5 mg P1A 7/52 243 Tranpate 5 mg P1A 61/43 416
Siampraxol 1 mg - 290 Tranpon 5 mg - 441
Sipam 2 mg P1A 15/49 056 Transpon Forte 10 mg - 257
Sipam 5 mg P1A 16/49 154 Tranxene 5 mg P1A 16/46 438
Sipam 10 mg P1A 17/49 339 Tranxene 10 mg - 271
Sipam Tranzep 5 mg - 434
10 mg/2 mL x 2 mL P1A 39/50 626
Trialam 0.25 mg - 168
Sosegon
30 mg/mL x 1 mL P1C 29/49 624 Triazolam:
Spasil† 2.5 mg N2A 2/51 009 - Halcion 0.25 mg - 350
Squill And Ammonia Mixture† - Trialam 0.25 mg - 168
1.3 mL/10 mL x 450 mL N2A 9/47 591 - Trycam 0.25 mg - 348
Stesolid 2 mg - 401 Trycam 0.25 mg - 348
Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ Frame Numbers in Bold Italics

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM
Color profile: Disabled
Composite 150 lpi at 45 degrees

86 GENERIC & BRAND NAME INDEX PN DEX 2010


Registration No. Frame No. Registration No. Frame No.


Tumax 5 mg P2A 25/51 400 Xanax 0.25 mg P1C 20/52 096

Tussidyl Xanax 0.5 mg P1C 21/52 240
9 mg/5 mL x 60 mL N2A 6/45 589 Xanax 1 mg P1C 22/52 287

Tylenol With Codeine Xanax XR 0.5 mg P1C 17/50 344
15 mg N2A 6/43 075 Xanax XR 1 mg P1C 18/50 069

Tylenol With Codeine Xanax XR 2 mg P1C 19/50 353
30 mg N2A 11/43 076
Xiemed 0.25 mg P1A 27/49 108
Xiemed 0.5 mg P1A 34/50 249
U Xiemed 1 mg P1A 28/49 296

Uptran 10 mg - 267
Upzene 5 mg - 490 Z

Utorax 5 mg - 383 Zeda 0.5 mg P1A 8/52 014
Zeda 1 mg P1A 9/52 360
V Zepam 2 mg
Zepam 5 mg
-
-
399
354
V Day Zepam 2 mg P1A 88/42 475 Zepam
V Day Zepam 5 mg P1A 89/42 465 10 mg/2 mL x 2 mL - 614
V Day Zepam Zepaxid 2 mg P1A 20/50 506
10 mg/2 mL x 2 mL P2A 82/43 616 Zepaxid 5 mg P1A 21/50 462
V Day Zepam NL Zepaxid
10 mg/2 mL x 2 mL P1A 11/46 617 10 mg/2 mL x 2 mL P1A 32/50 634

Valax 2 mg - 031 Zepobrax 5 mg - 384
Valax 5 mg - 132 Zepoxide 5 mg - 413
Valax 10 mg - 322 Zepoxide 10 mg P1A 3/44 279
Valenium 2 mg - 065 Zepoxin 5 mg - 205
Valenium 5 mg - 150 Zepoxin 10 mg - 118
Valium 5 mg - 152 Zetran 5 mg - 449
Valium Zolam 0.25 mg P1A 44/50 093
10 mg/2 mL x 2 mL - 620 Zolam 0.5 mg P1A 45/50 237
Vason 2 mg P1A 16/48 396 Zolam 1 mg P1A 46/50 285
Vemed 0.5 mg - 316
Zolpidem Tartrate:
Vescopam - Stilnox 10 mg - 110
10 mg/2 mL x 2 mL P1A 7/50 636
Zopam 2 mg P1A 35/49 048
Victan 2 mg - 182
Zopam 5 mg P1A 36/49 145
Vispam 2 mg - 366
Zopam 10 mg P1A 3/46 331
Vispam 5 mg - 213
Zora 0.5 mg P1A 25/50 328
Vispam 10 mg P1A 16/50 323
Zora 2 mg P1A 26/50 179
Vomed 2 mg - 059
Zorituss 10 mg - 197
Vomed 5 mg - 147
GENERIC & BRAND NAME INDEX

Vorapam 2 mg P1A 40/50 064


Vorapam 5 mg P1A 41/50 159

W
Winopam 2 mg - 063
Winopam 5 mg - 375

X
Xalam 0.25 mg - 095
Xalam 0.5 mg - 239
Xalam 1 mg - 286
Xanacine 0.25 mg P1A 13/48 091
Xanacine 0.5 mg P1A 14/48 236
Xanacine 1 mg P1A 15/48 284

Indicates brands that contain more than 1 ingredient ¡Í§¤Çº¤ØÁÇѵ¶ØàʾµÔ´

C:\ANNUALS\PNDEX\PIC Index\G&B_Index.vp
Wednesday, March 31, 2010 10:04:51 AM
แบบสำ�รวจและแจ้งความต้องการหนังสือและ/หรือแผ่นซีดี
หน่วยงานต้นสังกัด
 กระทรวงสาธารณสุข
 สำ�นักงานคณะกรรมการป้องกันและปราบปรามยาเสพติด
 สำ�นักงานตำ�รวจแห่งชาติ
 อื่น ๆ………………………………………………………………

1. ความเห็นของท่านต่อ PNdex ในการพิสูจน์เอกลักษณ์ เพื่อค้นหาชื่อยา


มากที่สุด มาก ปานกลาง น้อย ไม่แน่ใจ
ความสำ�คัญของการพิสูจน์เอกลักษณ์
เม็ดยาต่องานของท่าน
ประโยชน์ของ PNdex ที่ช่วยท่าน
ในการพิสูจน์หรือค้นหาชื่อยา
รูปแบบของหนังสือ ช่วยให้ท่านพิสูจน์
หรือค้นหาได้อย่างรวดเร็ว
รูปแบบของซีดีรอม ช่วยท่านให้พิสูจน์
หรือค้นหาได้อย่างรวดเร็ว
2. ข้อผิดพลาดของหนังสือ หรือ /ซีดี-รอม ที่ควรแก้ไข

3. ข้อเสนอแนะในการพัฒนาการจัดทำ�หนังสือเล่มต่อๆ ไป

4. หน่วยงานของท่านมีความต้องการหนังสือเล่มปัจจุบัน (PNdex 2010) เพิ่ม จำ�นวน เล่ม


และ/หรือแผ่นซีดี-รอม จำ�นวน แผ่น เหตุผลความจำ�เป็น

5. ผู้ให้ข้อมูลเพศ ชาย หญิง


6. ผูใ้ ห้ข้อมูลอายุ 21-30 ปี 31-40 ปี 41-50 ปี 51-60 ปี
7. ชื่อหน่วยงาน
8. ทีอ่ ยู่หน่วยงาน เพื่อส่งของทางไปรษณีย์ และเบอร์โทรเพื่อติดต่อกลับ

กรุณาส่งแบบสำ�รวจนี้กลับมายังที่อยู่ด้านหลัง และขอขอบคุณท่านในการให้ข้อมูลที่เป็นประโยชน์ข้างต้นมา ณ ที่นี้

P87-88 Feed back.indd 1 5/4/2553 13:21:29


ส่ง แสตมป์

กองควบคุมวัตถุเสพติด
สำ�นักงานคณะกรรมการอาหารและยา
กระทรวงสาธารณสุข
ถ.ติวานนท์ อ.เมือง
จ.นนทบุรี 11000

P87-88 Feed back.indd 2 2/4/2553 12:34:42

You might also like